Iodine Status in Pregnant &amp; Breastfeeding Women:A Danish Regional Investigation by Andersen, Stine Linding
 
  
 
Aalborg Universitet
Iodine Status in Pregnant & Breastfeeding Women
A Danish Regional Investigation
Andersen, Stine Linding
DOI (link to publication from Publisher):
10.5278/vbn.phd.med.00032
Publication date:
2015
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Andersen, S. L. (2015). Iodine Status in Pregnant & Breastfeeding Women: A Danish Regional Investigation.
Aalborg Universitetsforlag. Ph.d.-serien for Det Sundhedsvidenskabelige Fakultet, Aalborg Universitet
https://doi.org/10.5278/vbn.phd.med.00032
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: November 27, 2020
IODINE STATUS IN PREGNANT 
& BREASTFEEDING WOMEN
A DANISH REGIONAL INVESTIGATION
BY
STINE LINDING ANDERSEN
DISSERTATION SUBMITTED 2014
IO
D
IN
E STATU
S IN
 PR
EG
N
A
N
T &
 B
R
EA
STFEED
IN
G
 W
O
M
EN
STIN
E LIN
D
IN
G
 A
N
D
ER
SEN
 
 
 
 
IODINE STATUS IN PREGNANT & 
BREASTFEEDING WOMEN 
A DANISH REGIONAL INVESTIGATION 
by 
Stine Linding Andersen 
 
 
. 
  
Thesis submitted: October 21, 2014
PhD supervisor:  Prof. PETER LAURBERG,
   Aalborg University
Assistant PhD supervisor: Prof. JØRN OLSEN,
   Aarhus University
   PhD CHUNSEN WU,
   Aarhus University
PhD committee:  Prof. FINN EBBESEN,
   Aalborg University
   Prof. JENS FABER,
   University of Copenhagen
   Prof. PETER SMYTH,
   National University of Ireland   
PhD Series: Faculty of Medicine, Aalborg University
ISSN: 2246-1302
ISBN: 978-87-7112-207-7
Published by:
Aalborg University Press
Skjernvej 4A, 2nd floor
DK – 9220 Aalborg Ø
Phone: +45 99407140
aauf@forlag.aau.dk
forlag.aau.dk
© Copyright: Stine Linding Andersen
Printed in Denmark by Rosendahls, 2015
I 
 
CV 
Stine Linding Andersen obtained her medical degree at Aarhus University in 2011. 
She had her 6-month internal medicine training in the Department of 
Endocrinology, Aalborg University Hospital, and her 6-month general practice 
training in Aalborg. She was enrolled as a PhD student at Aalborg University on 
March 1, 2012. Her research focuses on iodine status and thyroid disease in and 
around pregnancy. The four publications combined in her PhD thesis address iodine 
status in pregnant and breastfeeding women. Within this field, she has contributed 
with invited lectures at Nordic Iodine meetings and at ICCIDD (International 
Council for the Control of Iodine Deficiency Disorders) European meetings. 
Simultaneously with her work on iodine, her research has focused on maternal 
thyroid dysfunction in and around pregnancy. Using Danish nationwide registers, 
she has examined the association between maternal thyroid dysfunction in 
pregnancy, pregnancy outcomes and child development, and she has studied the 
risk of birth defects associated with the drugs used for the treatment of 
hyperthyroidism in pregnancy. She is the first author of more than 10 publications 
within this field and the winner of three national and international awards. Since 
July 1, 2014 her employment has been split between the research fellowship in the 
Department of Endocrinology and employment at the Department of Clinical 
Biochemistry, Aalborg University Hospital, and she is planning to do her medical 
specialist training within this field.

III 
 
ENGLISH SUMMARY 
Iodine is required for the synthesis of thyroid hormones which are crucial regulators 
of early brain development. Denmark was previously iodine deficient with regional 
differences. The Danish mandatory iodine fortification of salt was introduced in the 
year 2000 and has improved iodine status in the general Danish population. The 
consequences of maternal iodine deficiency for the fetus and the breastfed infant 
may be severe and of major concern. Severe maternal iodine deficiency can cause 
brain damage and cretinism with stunted physical and mental growth, but also mild 
to moderate iodine deficiency has been associated with low child IQ.  
Maternal thyroid hormones are essential for fetal brain development in the early 
pregnancy, but the fetal thyroid gland is increasingly able to synthesize thyroid 
hormones from the beginning of the second trimester which requires the transport 
of maternal iodide across the placenta. Several studies have shown that the transport 
of iodide in the human placenta is mediated by the sodium-iodide symporter (NIS), 
and studies in rats and in vitro have suggested that the transport of iodide in the 
placenta is autoregulated similar to in the thyroid gland. Our clinical data from a 
study performed before the introduction of the mandatory iodine fortification of salt 
in Denmark, at a time with a higher frequency of maternal smoking in pregnancy, 
support the hypothesis that placental iodide transport is autoregulated.  
Before the introduction of the mandatory iodine fortification of salt in Denmark, 
Danish pregnant were iodine deficient with signs of thyroidal stress and also Danish 
breastfeeding women and their breastfed infants were iodine deficient.  
The recommended method to evaluate iodine status in a population is to collect spot 
urine samples and to estimate the median urinary iodine concentration (UIC). In our 
new regional investigation performed more than 10 years after the introduction of 
the mandatory iodine fortification of salt in Denmark, Danish pregnant women 
living in an area with previously moderate iodine deficiency still had median UIC 
below the recommended range. However, even if the use of iodine-containing 
supplements had considerably increased since the previous investigation, 15% of 
the pregnant women did not use iodine-containing supplements, and this subgroup 
of pregnant women was particularly at risk of being iodine deficient. Maternal use 
of iodine-containing supplements was less frequent during breastfeeding, and iodine 
status in Danish breastfeeding women was inadequate both when evaluated by 
maternal UIC and breast milk iodine concentration. The use of iodine-containing 
supplements in pregnant and breastfeeding women should be officially 
recommended in Denmark.  
The evaluation of urinary iodine status from spot urine samples in pregnant and 
breastfeeding women can be challenging. Our methodological considerations 
suggest that location and time of spot urine sampling, time of most recent iodine 
supplement intake prior to spot urine sampling, and urinary creatinine concentration 
optimally should be considered and reported. 
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DANSK RESUME 
Jod indgår i dannelsen af stofskiftehormoner (thyroidea hormoner), som er 
essentielle udviklingsfaktorer, særligt hvad angår hjernens udvikling. I Danmark 
var der tidligere jodmangel med regionale forskelle betinget af geografisk 
varierende indhold af jod i drikkevandet. Således var der mild jodmangel i øst 
Danmark og moderat jodmangel i vest Danmark. En obligatorisk jodberigelse af 
husholdningssalt og salt anvendt til industriel fremstilling af brød blev indført i år 
2000 og har generelt øget jodindtaget i den danske befolkning.  
Jodmangel hos gravide og ammende kan have alvorlige konsekvenser for fosteret 
og det nyfødte barn. Svær jodmangel kan føre til irreversibel hjerneskade og 
kretinisme med hæmmet fysisk og psykisk udvikling hos barnet, men også lettere 
grader af jodmangel er fundet associeret med lav IQ hos barnet.  
I den tidlige graviditet er fosterets hjerneudvikling helt afhængig af thyroidea 
hormoner fra moderen, men fra andet trimester af graviditeten bliver fosteret i 
stigende grad selv i stand til at producere thyroidea hormoner, og der er behov for, 
at jod transporteres via moderkagen (placenta) til fosteret. Flere studier har vist, at 
jodid transporten i den humane placenta ligesom i skjoldbruskkirtlen (glandula 
thyroidea) og i den lakterende mamma medieres af natrium-jodid symporteren 
(NIS), og studier i rotter og in vitro har antydet, at transporten af jodid i placenta er 
autoreguleret, ligesom det er tilfældet i glandula thyroidea. Vore kliniske data fra et 
dansk studie, der blev gennemført før indførelsen af den danske jodberigelse af salt, 
på et tidspunkt hvor hyppigheden af rygning hos danske gravide var større end i 
dag, støtter hypotesen om, at jodid transporten over placenta er autoreguleret.  
Jodindtaget hos danske gravide og ammende blev senest undersøgt før indførelsen 
af den obligatoriske jodberigelse af salt i Danmark. På det tidspunkt havde danske 
gravide og ammende jodmangel. Den anbefalede metode til at vurdere jodindtaget i 
en befolkning er at indsamle spot urin prøver og beregne den mediane urinjods-
koncentration. I vor nye regionale undersøgelse mere end 10 år efter indførelsen af 
den obligatoriske jodberigelse af salt i Danmark, var jodindtaget hos danske gravide 
fortsat for lavt vurderet ved den mediane urinjodskoncentration. Der var sket en 
markant stigning i antallet af gravide, som indtog jodholdigt kosttilskud i forhold til 
en tidligere undersøgelse, men der var fortsat 15% af de gravide, som ikke tog 
jodholdigt kosttilskud, og denne gruppe af gravide var særligt i risiko for at have 
jodmangel. Indtag af jodholdigt kosttilskud under amning var mindre hyppigt, og 
jodindholdet i mødrenes urin samt i ammemælk var under anbefalet niveau. 
Jodholdigt kosttilskud bør officielt anbefales til gravide og ammende i Danmark.  
Evaluering af jodstatus hos gravide og ammende ud fra urinjodskoncentrationen 
være vanskelig. Vore metodemæssige overvejelser indikerer, at sted og tidspunkt 
for urinprøvetagningen, tidspunkt for seneste indtag af jodholdigt kosttilskud forud 
for urinprøvetagningen samt urin kreatinin koncentrationen optimalt set bør 
vurderes og rapporteres. 
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CHAPTER 1. INTRODUCTION 
Iodine is required for the synthesis of thyroid hormones which are crucial regulators 
of early brain development [1,2]. The World Health Organization (WHO) describes 
iodine deficiency as the single most common preventable cause of brain damage 
[3], and adequate maternal iodine intake during pregnancy and breastfeeding is of 
major concern [4]. Historically, large parts of the world were iodine deficient, but 
preventive efforts have been made and today programs of universal salt iodization 
have been implemented in many countries [5]. Iodine is found naturally in foods 
and drinking water, artificially in foods fortified with iodine, in iodine-containing 
dietary supplements, radiographic contrasts agents, and in medicaments [6].  
1.1. IODINE STATUS IN DENMARK 
The main dietary sources of iodine in Denmark are milk, fish and drinking water 
[7]. Denmark was previously iodine deficient with regional differences caused by 
different levels of iodine in drinking water; moderate iodine deficiency in West 
Denmark and mild iodine deficiency in East Denmark [8,9]. A Danish voluntary 
iodine fortification (8 parts per million (ppm)) of household salt and salt used by the 
food industry was initiated in June 1998, but a voluntary program was not sufficient 
when evaluated after two years, and from July 2000 a mandatory iodine 
fortification (13 ppm) of household salt and salt used for commercial production of 
bread has been introduced in Denmark [10].  
1.1.1. IODINE STATUS IN PREGNANT AND BREASTFEEDING WOMEN 
No official recommendations for intake of iodine-containing supplements during 
pregnancy and breastfeeding exist in Denmark [11,12]. The iodine status in Danish 
pregnant and breastfeeding women has been examined before the introduction of 
the Danish iodine fortification of salt [13-19]. At that time, Danish pregnant and 
breastfeeding women were iodine deficient [13-19]. The Danish iodine fortification 
of salt has increased iodine intake in the general Danish population [9,20], but the 
significance of iodine fortification for Danish pregnant and breastfeeding women 
specifically has not been evaluated. 
1.2. IODIDE TRANSPORT FROM MOTHER TO CHILD 
Iodide is transported into the thyroid gland by the sodium-iodide symporter (NIS) 
[21]. NIS is also identified in a number of extrathyroidal tissues including the 
gastrointestinal tract, the kidney, the lactating mammary gland, and the placenta 
[22], and a functional role of NIS in extrathyroidal iodide transport has been 
proposed [23-26]. In early pregnancy, the developing fetus is dependent on 
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maternal thyroid hormones [27,28], but the fetal thyroid gland is increasingly 
capable of synthesizing thyroid hormones from 12-16 weeks of pregnancy with a 
need for transport of iodide from the mother to the fetus across the placenta [29,30].  
1.2.1. PLACENTAL IODIDE TRANSPORT  
In the thyroid gland, NIS-mediated transport of iodide is autoregulated to keep the 
level of iodine sufficient for thyroid hormone synthesis [31]. On the other hand, 
there is no apparent autoregulation of NIS-mediated transport of iodide into breast 
milk in the lactating mammary gland [19]. In the placenta, autoregulation of iodide 
transport has been demonstrated in rats and in vitro [32,33], but details on the 
regulation of placental iodide transport are still to be elucidated.   
An indicator of fetal iodine deficiency is cord serum thyroglobulin (Tg) [34,35]. 
One way to evaluate the regulation of NIS-mediated placental iodide transport in 
vivo is to study the impact of a known NIS inhibitor such as thiocyanate from 
tobacco smoking [36]. The frequency of maternal smoking during pregnancy in 
Denmark has considerably declined during the last decades [37], but at the time of 
the previous investigation of iodine intake in Danish pregnant and breastfeeding 
women, maternal smoking was more frequent than today [19]. 
1.3. CHALLENGES IN EVALUATION OF IODINE STATUS 
The recommended method to assess iodine status in a population is to collect spot 
urine samples for measurement of urinary iodine concentration (UIC) and 
calculation of the population median UIC [3]. But several factors may influence 
UIC and challenge the interpretation of the results.  
1.3.1. IN PREGNANCY 
Traditionally, the median UIC of schoolchildren has been the recommended method 
to assess urinary iodine status in a population, including pregnant women [38]. 
However, disparity between results of schoolchildren examination and that of 
pregnant women has been reported [39], and it can be speculated if such disparity 
could be partly explained by differences in urine sampling conditions. In the 
majority of studies evaluating iodine status in pregnancy, the pregnant women are 
recruited during a routine hospital visit. It can be speculated if results of such iodine 
status evaluation are representative for urine samples which were instead obtained 
at home during daily living. In many populations, the use of iodine-containing 
supplements is recommended during pregnancy to ensure adequate iodine intake 
[40]. It can be speculated if the time span from most recent iodine supplement 
intake prior to spot urine sampling could influence UIC and the results of iodine 
status evaluation.  
CHAPTER 1. INTRODUCTION 
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1.3.2. DURING BREASTFEEDING 
Maternal intake of iodine-containing supplements is often recommended during 
breastfeeding to ensure adequate iodine supply of the mother and the breastfed 
infant [40]. Acute intake of high doses of iodine has been shown to affect breast 
milk iodine concentration (MIC) [41]. It can be speculated if also most recent 
iodine supplement prior to breast milk sampling could influence MIC and the 
results of iodine status evaluation. It is often difficult to obtain a breast milk sample 
or a urine sample from the breastfed infant, and it may be convenient to obtain a 
urine sample from the mother.  It has been considered whether maternal UIC can be 
used as a proxy for iodine supply to the breastfed infant, but correlations between 
UIC and MIC have not been consistent [42,43]. Maternal fluid intake may influence 
UIC and a proxy for fluid intake is the urinary creatinine concentration [44]. It can 
be speculated if maternal fluid intake may differently affect maternal UIC and MIC.  
1.4. OBJECTIVE OF THE PHD THESIS 
The objective of the PhD thesis was to evaluate iodine status in Danish pregnant 
and breastfeeding women after the introduction of the mandatory iodine 
fortification of salt in Denmark, and to study details on the transport of iodide from 
mother to child as well as challenges in the evaluation of urinary iodine status in 
pregnant and breastfeeding women. Data were retrieved from a previous 
investigation performed before the mandatory iodine fortification of salt [17,19] 
and from a new regional investigation performed after the introduction of the 
mandatory iodine fortification of salt in Denmark (Fig. 1-1). 
 
 
Fig. 1-1. Illustration of the investigations before and after the Danish mandatory iodine 
fortification of salt which was introduced in the year 2000. 
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1.4.1. SPECIFIED STUDY OBJECTIVES 
 
 
To use data from a previous Danish investigation performed before the 
introduction of the mandatory iodine fortification of salt at a time with a higher 
frequency of smoking in Danish pregnant women to evaluate if placental iodide 
transport is autoregulated (paper 1). 
 
 
To perform a new regional Danish investigation in an area with previously 
moderate iodine deficiency to evaluate the use of iodine-containing supplements 
and urinary iodine status in Danish pregnant women after the introduction of the 
mandatory iodine fortification of salt (paper 2). 
 
 
To include information on time of most recent iodine supplement intake prior to 
spot urine sampling, urine samples obtained both in the hospital and at home as 
well as urine samples from non-pregnant members of the household to study 
challenges in the evaluation of urinary iodine status in pregnancy (paper 3). 
 
 
To perform a regional Danish investigation in an area with previously 
moderate iodine deficiency to evaluate the use of iodine-containing 
supplements and urinary iodine status in Danish breastfeeding women after 
the introduction of the mandatory iodine fortification of salt (paper 4). 
 
 
To include information on time of most recent iodine supplement intake 
prior to breast milk and spot urine sampling as well as measurement of 
maternal urinary creatinine concentration to study challenges in the 
evaluation of iodine status during breastfeeding (paper 4). 
 
Table 1-1. Specified study objectives of the PhD thesis. 
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CHAPTER 2. BACKGROUND 
2.1. SOURCES OF DIETARY IODINE 
Iodine (I) is a mineral and a micronutrient required in humans for the synthesis of 
thyroid hormones [6]. The healthy human adult contains 15-20 mg iodine of which 
around 70% is stored in the thyroid gland [45]. The main sources of dietary iodine 
vary between countries and may also vary within the same country [7]. Fish, 
seafood and in particular seaweed are rich in iodine, thus, in populations with a high 
intake of fish, these food items are the major source of iodine. Milk and dairy 
products also contain iodine and these are the main sources of iodine in many 
populations including Denmark due to a generally high intake of these food items 
[7]. Finally, drinking water is an important source of iodine in some populations. 
The content of iodine in drinking water may vary within a country as is the case in 
Denmark [8,46] with a generally higher content of iodine in drinking water in East 
Denmark than in West Denmark divided by the great Belt (Fig. 2.1). However, with 
the exception that the content of iodine in drinking water in Skagen (the most 
northern part of West Denmark) is high [8].  
 
Fig. 2-1. Map of Denmark. The dotted line illustrates the division by the Great Belt into East 
Denmark with a higher content of iodine in drinking water and West Denmark with a lower 
content of iodine in drinking water. 
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2.2. IODINE METABOLISM 
2.2.1. GASTROINTESTINAL ABSORPTION 
Ingested iodine in other forms than iodide (e.g. iodate) is converted into iodide (I-) 
before it is absorbed. NIS is expressed on the apical surface of the enterocytes in the 
small intestine and mediates active uptake of iodide in rats [26]. NIS is also 
expressed in the gastric mucosa on the basolateral surface of the epithelial cells 
mediating the secretion of iodide from the blood to the gastric lumen, but whether 
the gastric mucosa is also capable of iodide uptake is not clarified [47]. Iodide is 
rapidly and almost completely absorbed. After oral administration of radioiodine in 
euthyroid individuals, it rapidly appeared in the circulating blood and reached the 
maximum level within two hours from ingestion (Fig. 2-2) [48]. Organic iodine is 
less completely absorbed. Absorption of an oral dose of Levothyroxine varies (e.g. 
depending on food intake) and has been reported up to 80% [49].    
 
Fig. 2-2. Oral administration of radioiodine in nine euthyroid subject. Reproduced from [48] 
with permission. 
 
2.2.2. PLASMA INORGANIC IODIDE  
After gastrointestinal absorption, organic iodine is primarily present in the blood as 
tetraiodothyronine (T4) [50]. Plasma inorganic iodide (PII) is the pool from which 
iodide is distributed (Fig. 2-3). The concentration of PPI is proportional to dietary 
iodine intake [51], and the size of the PII pool is primarily balanced between a) 
iodine intake and gastrointestinal absorption, b) uptake of iodide in the thyroid 
gland and metabolism of thyroid hormones, and c) renal excretion of iodide. Only 
small amounts of iodide are excreted in faeces, sweat and via respiration [51]. 
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Fig. 2-3. Inputs and outputs from the plasma inorganic iodide (PII) pool.  
 
2.2.3. THYROID UPTAKE 
In euthyroid individuals with an adequate intake of iodine, the uptake of iodide by 
the thyroid gland approximates 1/3 of an administered dose of radioiodine [52]. 
Transport of iodide from plasma into the thyroid gland is active and mediated by 
NIS which is located at the basolateral membrane of the thyroidal follicular cells 
(Fig. 2-4). From the cells, iodide is transferred to the colloidal follicle lumen at the 
apical membrane, and the chloride-iodide transporter (Pendrin) is thought to be 
involved in this transport [53].  
 
 
 
Fig. 2-4. Uptake of iodide in the thyroid gland and synthesis of thyroid hormones.  
In the colloidal follicle lumen, iodide is oxidized and incorporated in Tg resulting in 
the synthesis of monoiodotyrosine (MIT) and diiodotyrosine (DIT) [54]. This 
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process is catalyzed by the thyroid peroxidase (TPO) enzyme which also catalyzes 
the formation of triiodothyronine (T3) (DIT+MIT) and T4 (DIT+DIT). When 
thyroid hormones are released, Tg is endocytosed in the follicular cells, and T3 and 
T4 are released from Tg by proteolysis before being secreted into the blood. T4 is 
only produced in the thyroid gland, whereas T3 (80%) is produced by deiodination 
of T4 in extrathyroidal tissues. Metabolism of T3 and T4 by deiodinases releases 
iodide to the PII pool (Fig. 2-3) [54].    
 
2.2.4. RENAL EXCRETION  
Iodide is mainly excreted in the urine and > 90% of ingested iodine appears in the 
urine [51,55]. How iodide is excreted in the kidneys is not clarified in detail, but 
glomerular filtration and tubular reabsorption are presumed to be mechanisms 
involved [56]. The tubular reabsorption was previously assumed to be passive [56], 
but NIS expression has been demonstrated in the tubular system of the human 
kidney and active transport mediated by NIS has been proposed [24]. After oral 
administration of radioiodine in euthyroid individuals (Fig. 2-5), 2/3 of the dose 
was excreted in the urine within 48 hours and approximately half of the dose 
excreted in the urine was excreted within six hours [52]. Clearance is defined as the 
volume of plasma from which a substance is completely removed per unit time 
[57]. For the renal clearance of iodide this equals the urinary iodide excretion rate 
(UIC multiplied by the urine flow rate) divided by the PII concentration. The renal 
clearance of iodide was shown to be constant when a radioactive tracer with 
different quantities of carrier iodine was administered to 13 patients with 
exophthalmic goiter [58]. Thus, when the urine flow rate is unchanged, UIC is 
expected to fluctuate according to the PII concentration.  
 
Fig. 2-5. Urinary excretion of radioiodine in four euthyroid male subjects. Reproduced from 
[52] with permission. 
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2.3. EVALUATION OF IODINE STATUS 
Iodine status in a population can be assessed from different methods (Table 2-1). 
 
 
  
 
 
Table 2-1. Methods to assess iodine status in a population. 
2.3.1. THYROID SIZE 
Historically, evaluation of thyroid size by inspection and palpation was the method 
by which goiter prevalence in a population was estimated and iodine status was 
evaluated. However, in mild iodine deficiency, the evaluation of thyroid size by 
thyroid ultrasonography is preferable [38].  Thyroid size is a long-term indicator of 
iodine status (months to years) and although thyroid ultrasonography is non-
invasive and quickly performed, the method requires training and differences in 
technique can produce interobserver variation [59].  
2.3.2. SERUM THYROGLOBULIN  
Tg is a thyroid-specific protein exclusively synthesized in the thyroid gland. Serum 
Tg is a valid marker of iodine deficiency in population studies [34,35], but a high 
serum Tg concentration is not a specific sign of iodine deficiency and may also be 
present in various thyroid disorders and due to physiological changes in pregnancy 
[60]. The need for measurement of thyroglobulin antibodies (Tg-Ab) to examine 
possible interference with serum Tg should be considered [61].  
2.3.3. SERUM THYROID STIMULATING HORMONE  
Iodine deficiency tends to lower T4 and increase serum thyroid stimulating 
hormone (TSH), but TSH is not a sensitive marker of iodine deficiency in 
schoolchildren and adults, including pregnant women, because it is often remained 
within the normal range [1]. On the contrary, TSH tends to be lower with age in 
populations with mild to moderate iodine deficiency due to thyroid autonomy [62]. 
It has been suggested that TSH is a more sensitive indicator of iodine deficiency in 
neonates due to low iodine content in the neonatal thyroid gland and a high turnover 
of iodine [3], but this may be hampered by the use of iodine-containing skin 
disinfection in mothers at delivery [63].   
Method 
Thyroid size 
Serum thyroglobulin (Tg) 
Serum thyroid stimulating hormone (TSH) 
Urinary iodine excretion  
Dietary assessment of iodine intake 
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2.3.4. URINARY IODINE EXCRETION  
Urinary iodine excretion is an indicator of recent iodine intake (hours-days). In 
individuals, daily urinary iodine excretion varies considerably [64,65], and a single 
spot urine sample cannot be used to diagnose iodine deficiency in an individual 
[65]. The golden standard to quantify urinary iodine excretion is to collect urine in a 
full 24-hour sample [44], but for determination of iodine status in individuals, more 
than one 24-hour sample is preferable [64,65], and for determination of iodine 
status in a population, the collection of urine over 24 hours is often troublesome and 
may not be complete [66]. WHO, the United Nations Children’s Fund (UNICEF), 
and the International Council for the Control of Iodine Deficiency Disorders 
(ICCIDD) recommend the median UIC from spot urine samples to determine iodine 
status in a population (Table 2-2) [3]. 
UIC is calculated per urine volume and varies by fluid intake [44]. Creatinine is a 
product of muscle metabolism which is excreted in the urine at a relative constant 
rate, and it has been suggested to use the iodine/creatinine ratio (µg iodine/gram 
creatinine) to adjust for variation in urine volume [44]. But creatinine excretion 
varies with age and gender and a further adjustment has been proposed in which the 
iodine/creatinine ratio is multiplied by an estimated age- and gender specific 24-
hour creatinine excretion to calculate the estimated 24-hour urinary iodine excretion 
(µg iodine/24 hours) [67]. Another aspect is the variation in UIC during the day. In 
particular, UIC in a fasting morning spot sample tend to be lower [64]. 
 
 
 
 
 
Table 2-2. Assessment of population iodine status from median urinary iodine concentration 
(UIC) in schoolchildren ≥ 6 years and non-pregnant adults [3].  
2.3.5. DIETARY ASSESSMENT OF IODINE INTAKE 
Dietary assessment methods aim to quantify the habitual iodine intake. It is often 
difficult due to day-to-day variation [64], but the most significant dietary sources of 
iodine can be determined. One method is the food frequency questionnaire, which 
assesses the frequency and portion sizes of iodine-containing foods within a defined 
time frame [68]. Another method is the 24-hour food diary which assesses intake of 
iodine-containing foods in the previous 24 hours [69].  
Median UIC (µg/l) Iodine intake Iodine deficiency 
< 20 Insufficient Severe 
20-49 Insufficient Moderate 
50-99 Insufficient Mild 
100-199 Adequate - 
200-299 Above requirements - 
≥ 300 Excessive - 
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2.4. IODINE DEFICIENCY & EXCESS  
The recommended daily intake of iodine is 150 µg in non-pregnant and non-
lactating adults [3]. Both insufficient and excessive iodine intake may lead to the 
development of thyroid disease and the relation between iodine intake and thyroid 
disease in a population is U-shaped [70]. Worldwide iodine status in 2013 [5] 
indicated that substantial progress has been made in the elimination of iodine 
deficiency mainly through programs of universal salt iodization. Approximately 
70% of all households worldwide have access to adequately iodized salt (versus 
10% in 1990) [5]. Among countries with available data on UIC in schoolchildren, 
111 countries had adequate iodine status (versus 67 in 2003), 9 countries had 
moderate iodine deficiency, 21 countries had mild iodine deficiency and 10 
countries had excessive intake of iodine [5]. However, subgroups (e.g. specific 
dietary habits, no use of iodized salt, pregnancy and breastfeeding) may still be 
iodine deficient in countries classified as iodine sufficient.  
2.4.1. IODINE DEFICIENCY 
Iodine deficiency disorders refer to ‘all the consequences of iodine deficiency in a 
population that can be prevented by ensuring that the population has an adequate 
iodine intake’ [3]. Iodine deficiency is associated with a higher frequency of goiter 
and thyroid multinodularity [71]. The mechanisms involved in goitrogenesis are 
presumably secondary to iodide autoregulation which increases the activity and the 
growth of the thyroid gland [70]. Severe iodine deficiency can cause 
hypothyroidism [70]. In less severe iodine deficiency, the thyroid gland is able to 
keep thyroid hormone synthesis sufficient due to an increased activity, but this 
hyperactivity may lead to the development of thyroid autonomy and a higher rate of 
toxic multinodular goiter [72].  
Iodine deficiency during pregnancy and breastfeeding may affect both the mother 
and the fetus/newborn. Depending on the degree of iodine deficiency, iodine supply 
may be insufficient for thyroid hormone synthesis resulting in maternal and 
fetal/neonatal hypothyroxinemia (low T4, normal TSH) or hypothyroidism (low T4 
and high TSH) [1].  
2.4.2. IODINE EXCESS 
The upper tolerable level of iodine intake in non-pregnant and non-lactating adults 
has been set to 1,100 µg/day [6]. Sources of excess iodine include food items (e.g. 
seaweed), excessive iodization of salt, iodine-containing supplements, medications 
(e.g. amiodarone), and contrast agents [6]. The acute Wolff-Chaikoff effect was 
described in 1948 [73]. In rats exposed to high levels of iodine, a reduction in the 
synthesis of thyroid hormones was observed. The reduction was only transient 
(escape from the Wolff-Chaikoff effect), which may be caused by a reduced 
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expression of NIS [31]. Failure to escape from the Wolff-Chaikoff effect may lead 
to hypothyroidism, especially in individuals with thyroid autoimmunity or previous 
thyroid disease [70]. Hence, before the iodine fortification of salt in Denmark, the 
incidence of overt hypothyroidism was highest in East Denmark with the highest 
iodine intake [74] and was predominantly spontaneous autoimmune hypothyroidism 
[75]. Hyperthyroidism may develop in susceptible individuals (e.g. autonomous 
thyroid nodules, relapse of Graves’ disease) following high intake of iodine [70].   
Excessive intake of iodine during pregnancy and breastfeeding is less studied than 
iodine deficiency, but in China where iodine content of drinking water is high, 
excessive iodine intake was associated with maternal subclinical hypothyroidism 
(normal T4, high TSH) in late pregnancy [76]. Fetal and neonatal exposure to 
excessive amounts of iodine through placental transfer or breast milk can cause 
neonatal hypothyroidism [77].  
2.4.3. IODINE & BRAIN DEVELOPMENT 
The most serious and adverse effect of iodine deficiency is developmental brain 
damage [78]. Brain development is initiated in the very early pregnancy and 
continues throughout pregnancy and during the first years of life (Fig. 2-6) [79].  
 
 
 
Fig. 2-6. Illustration of events during early brain development. Reproduced from [79] with 
permission. 
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Thyroid hormones are essential regulators of brain development and involved in 
myelination, cell differentiation and migration [2]. T3 is the active hormone and 
acts by binding to intracellular receptors which are increasingly present in the fetal 
brain from gestational week 10 [2]. In the brain, 80% of T3 is generated locally 
from T4 by the type 2 iodothyronine deiodinase (D2), and D2 activity is regulated 
by T4 [2]. Before the onset of fetal thyroid hormone production, thyroid hormones 
involved in the regulation of early fetal brain development are of maternal origin 
(Fig. 2-6). But evidence suggests that maternal thyroid hormones are also 
transferred to the fetus after the onset of fetal thyroid hormone production [79]. In 
newborns unable to synthesize T4 due to a total defect in organification, T4 (which 
must be of maternal origin) was measured in cord blood [80]. Similarly, the paucity 
of neurological symptoms in newborns with congenital hypothyroidism due to 
failure of the thyroid gland, indicate a protective role of maternal thyroid hormones 
throughout pregnancy [78].  
Severe iodine deficiency can cause cretinism which is characterized by profound 
mental and physical disabilities [81]. Two clinical types of cretinism have been 
described [82]. The neurological cretinism is the most common type and 
characterized by irreversible neurological deficits such as spasticity and squint. The 
myxedematous cretinism is less common and dominated by signs of 
hypothyroidism with growth retardation and dry and thickened skin. Clinical 
characteristics often overlap between the two types, and it has been proposed that 
the clinical picture of cretinism results from two temporally different events caused 
by iodine deficiency (Fig. 2-6) [79]. The first is iodine deficiency in utero resulting 
in maternal hypothyroxinemia and the neurological features of cretinism. The 
second is the duration and severity of hypothyroidism after birth where prompt 
replacement therapy and iodine supplement will improve the symptoms.  
The neurodevelopmental consequences of mild to moderate iodine deficiency are 
less evident. One way to study this is to look at the impact of maternal iodine 
supplementation in pregnancy. Several studies have evaluated neurodevelopmental 
outcomes in children less than two years, but as reviewed in detail [83], studies 
were mainly observational and results were divergent with a lack of evidence. 
Another approach is the retrospective design with definition of exposure groups 
from maternal urinary iodine status in pregnancy. Two longitudinal observational 
studies from Australia [84] and the United Kingdom [85] assessed neuro-
developmental outcomes in children age 8-9 years according to maternal UIC in the 
pregnancy. In these studies, poorer educational outcomes and lower child IQ were 
observed in the group of children born to mothers who had median UIC below the 
recommended range in pregnancy.  
The association between maternal excessive iodine intake and brain development is 
less extensively studied, but evidence from studies in rats suggest that both lack and 
excess of iodine may affect early neurodevelopment [86].  
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CHAPTER 3. IODINE, PLACENTA & NIS 
3.1. NIS-MEDIATED IODIDE TRANSPORT 
NIS is a transmembrane glycoprotein which couples the inward transport of two 
Na+ ions along the electrochemical gradient (actively generated by the Na+/K+ 
ATPase) with the inward transport of one I- ion against its electrochemical gradient 
[22]. The gene encoding NIS was cloned in 1996 [21] and this has been followed by 
molecular characterization of NIS, investigations of NIS regulation, NIS expression 
in extrathyroidal tissues and the pathophysiological role of NIS (e.g. NIS mutation 
leading to congenital iodide transport defect [22]). 
3.1.1. REGULATION OF NIS 
TSH stimulates NIS-mediated iodide transport into the thyroid gland (e.g. via 
regulation of NIS expression) [22], but also other types of NIS regulation exist 
including autoregulation by iodide (escape from the Wolff-Chaikoff effect) which is 
shown to be mediated by downregulation of NIS expression [31]. Competitive 
inhibitors of NIS have been indentified such as the anions perchlorate (CIO4
-) and 
thiocyanate (SCN-) [22]. Perchlorate is among others a component of fireworks, 
matches and auto airbag inflation systems and environmental exposure is thought to 
be ubiquitous [87]. It is a more potent inhibitor of NIS than thiocyanate [88], but 
the low level of exposure found in the environment has not been convincingly 
related to adverse effects on thyroid function [87].    
In some populations (e.g. the Democratic Republic of Congo), the cassava plant is 
the major source of thiocyanate [36] and a high intake of cassava has been causally 
linked to a high prevalence of endemic goiter [89] and cretinism [90]. Another 
source of thiocyanate is rapeseed in feeds for cows which decreases the excretion of 
iodine into milk [91]. As dairy products constitute a major part of iodine intake in 
many populations, the feeding of cows may influence the iodine status of the 
population. The main source of thiocyanate in many countries including Denmark is 
tobacco smoking [36]. Cyanide in tobacco smoke is toxic and is detoxified in the 
liver to thiocyanate. The amount of cyanide produced in tobacco smoking is 
variable [92], and thiocyanate is not solely derived from smoking, thus, other 
markers of smoking such as the nicotine metabolite cotinine are preferable [93].    
NIS has been identified in a number of extrathyroidal tissues including the salivary 
gland, choroid plexus, ciliar body of the eye, sweat glands [22], gastric mucosa 
[47], intestine [26], kidney [24] and the lactating mammary gland [23], and NIS-
mediated extrathyroidal iodide transport has been proposed. It appears, however, 
that the local regulation of NIS might differ between tissues. In some extrathyroidal 
tissues, NIS activity seems to be autoregulated by iodide similar to the regulation of 
NIS in the thyroid gland. One example of this is the regulation of NIS-mediated 
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absorption of iodide in the intestine. In a study in rats [94], the intestinal NIS-
mediated iodide transport was autoregulated by downregulation of NIS expression 
in iodine excess. The importance of such regulation in humans remains to be 
clarified. In other extrathyroidal tissues, no autoregulation of NIS seems to take 
place. One example of this is the transport of iodide into breast milk in the lactating 
mammary gland. In a Danish clinical study [19] performed before the introduction 
of the Danish iodine fortification of salt, cotinine in urine and serum was used to 
classified mothers as smokers (n=50) and non-smokers (n=90). Smoking mothers 
had 50% lower breast milk iodine content on day five postpartum than non-smoking 
mothers, and the iodine content of their neonates’ urine was considerably lower 
(Fig. 3-1). Serum thiocyanate levels were higher in smoking mothers, and results 
were compatible with thiocyanate inhibition of NIS-mediated transport of iodide 
into breast milk. Results suggested that NIS in the lactating mammary gland is not 
autoregulated by iodide. If autoregulation was present, such difference in breast 
milk iodine content between smoking and non-smoking mothers was not to be 
expected.  
 
Fig. 3-1. Median maternal urinary iodine concentration, breast milk iodine concentration 
and neonate urinary iodine concentration stratified by maternal smoking status. Samples 
were obtained on day five after delivery. Reproduced from [19] with permission.  
3.1.2. PLACENTAL IODIDE TRANSPORT 
The human placenta is essential for fetal development and provides direct contact 
between the maternal and the fetal circulation. One important function is the 
transplacental transport of gases, nutrients, and other molecules including the 
transport of thyroid hormones and iodide. Classically, the human placenta was 
considered impermeable to the transport of maternal thyroid hormones, but the 
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study by Vulsma et al. [80] demonstrating that neonates unable to synthesize 
thyroid hormones had measureable T4 in cord serum, and studies showing the 
presence of T4 and T3 in fetal tissues before the onset of fetal thyroid hormone 
production [27,28] have provided evidence, that maternal thyroid hormones are 
transported across the placenta.  
Studies of the placenta from euthyroid women undergoing elective caesarean 
section have demonstrated that the human placenta contains iodine [95-97]. The net 
amount of maternal iodide transported into and across the placenta in pregnancy can 
be summarized by iodine deposited in the placenta (15-30 µg [97], assuming 
placental weight of 600 grams at birth [98]), in amniotic fluids (10-30 µg [99,100]), 
in the fetal thyroid gland at birth (100-300 µg [101]), and in fetal blood (10-15 µg 
[102], assuming mean birth weight of 3.500 grams [103], 10% of body is blood, 
50% of blood is serum, and 65% iodine content of T4). When these amounts are 
summarized relative to the period of pregnancy where placental iodide transport 
primarily takes place, the net placental deposit and transfer of iodide to the fetus is 
approximately 2 µg iodine per day. 
NIS expression has been demonstrated in the human placenta after the gene 
encoding NIS was cloned in 1996 [104-109]. Immunohistochemistry or polymerase 
chain reaction was used to demonstrate NIS in placental tissue samples and in vitro 
in cell cultures of cytotrophoblast cells and choriocarcinom cells. Human 
choriocarcinom cells have been used as an in vitro model of placenta to study the 
functional role of NIS in placental iodide transport [25]. In this study [25], NIS was 
detected, radioiodide uptake in the cells was inhibited by perchlorate, iodide and 
thiocyanate compatible with NIS-mediated iodide uptake, and confocal microscopy 
revealed that NIS was distributed at the maternal side of the cells. In the same study 
[25] expression of the chloride/iodide transporter (Pendrin) at the fetal side of the 
cell was shown suggesting that iodide is released via Pendrin.  
The regulation of NIS activity in placenta has been investigated in rats [32] and in 
vitro in choriocarcinom cells [33]. Both types of experimental studies suggested 
that NIS in placenta is autoregulated by iodide. In rats on a low iodine diet, NIS was 
up regulated in the placenta [32], and iodide inhibited NIS expression and iodide 
uptake in choriocarcinom cells [33].  
3.2. AUTOREGULATION OF PLACENTAL IODIDE TRANSPORT 
(PAPER 1) 
The first paper in the PhD thesis addressed the regulation of iodide transport in the 
human placenta. Previous studies have shown that NIS mediates iodide transport in 
the human placenta, and that this transport is inhibited by thiocyanate. Studies in 
rats and in vitro have suggested that NIS in placenta is autoregulated by iodide, but 
the extent of autoregulation is still to be elucidated in a clinical setting.  
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3.2.1. STUDY OBJECTIVE  
The aim of the study was by an indirect method to evaluate if placental iodide 
transport is autoregulated in humans. We assumed that iodide transport in the 
placenta is mediated by NIS and that this transport is inhibited by thiocyanate. The 
source of thiocyanate was maternal smoking in pregnancy, and we examined the 
impact of thiocyanate on the degree of iodine deficiency in the mother and the 
fetus. As a marker of iodine deficiency we used Tg in maternal serum (at arrival for 
delivery) and in cord serum (at delivery).  
Maternal iodine status and smoking status were expected to influence serum Tg 
(Table 3-1). Maternal iodine deficiency was expected to increase both maternal and 
cord serum Tg due to insufficient supply of iodine to the maternal and the fetal 
thyroid gland. Thiocyanate from maternal smoking was expected to inhibit NIS-
mediated iodide transport in the maternal thyroid gland, in placenta and in the fetal 
thyroid gland. The inhibition of NIS in the thyroid gland was expected to influence 
maternal and cord serum Tg in parallel. On the other hand, the inhibition of NIS in 
the placenta would reduce the transport of maternal iodide to the fetus and increase 
cord serum Tg exclusively. However, if NIS-mediated iodide transport in placenta 
is autoregulated, compensatory mechanisms would keep the iodide transport to the 
fetus sufficient despite thiocyanate inhibition of NIS, and the changes in maternal 
and serum Tg caused by maternal smoking would be more similar (Table 3-1).  
 
 Maternal 
serum Tg 
Cord 
serum Tg 
Maternal iodine deficiency ↑ ↑ 
Maternal smoking   
No autoregulation of NIS in placenta ↑ ↑↑↑ 
Autoregulation of  NIS in placenta ↑ ↑ 
Table 3-1. Illustration of the hypothetical impact of maternal iodine deficiency and maternal 
smoking on maternal and cord serum thyroglobulin (Tg) concentration.  
3.2.2. STUDY DESIGN 
The study was part of a cross-sectional study of iodine intake in Danish pregnant 
women performed in the years 1988-1990 before the introduction of the Danish 
mandatory iodine fortification of salt. The reasons for the use of previously 
collected data were the higher frequency of maternal smoking and the lower 
frequency of iodine supplement use. The higher frequency of maternal smoking was 
imperative to study our hypothesis, since the low frequency of smoking in Danish 
pregnant women today would make it very difficult to study our hypothesis in 
recently collected data. The lower frequency of iodine supplement use was also 
important in the way that the effect of a competitive inhibitor increases when the 
substrate concentration (in this case iodide) is low. 
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The pregnant women were consecutively recruited in five Danish hospitals when 
they arrived for delivery, and 140 pregnant women and their newborns were 
included in the study. Maternal serum was sampled on the day of arrival for 
delivery and cord serum immediately after birth. On day five after delivery, a spot 
urine sample and a breast milk sample were obtained from the mother and urine 
was collected from the newborn. Serum was analyzed for thiocyanate, cotinine, 
TSH, total T4, total T3, free T4, Tg, and Tg-Ab. Urine was analyzed for iodine and 
cotinine, and breast milk was analyzed for iodine. The pregnant women were asked 
about intake of iodine-containing supplement at the time of inclusion and classified 
as smokers or non-smokers from cotinine in serum and urine which showed 
consistent results with high or low cotinine concentrations in mother-child pairs 
[19]. The possible influence of thiocyanate not originating from tobacco smoking 
has previously been evaluated and was not apparent [19]. Passive smoking has not 
been associated with higher thiocyanate levels in pregnant women and newborns 
[110].  
 
3.2.3. STUDY RESULTS 
To examine our hypothesis, we analyzed maternal and cord serum Tg stratified in 
four groups by maternal iodine supplement intake and smoking status. Mean 
maternal and cord serum Tg were higher when the mother did not use iodine-
containing supplements. Mean maternal and cord serum Tg were also higher when 
the mother was smoking, but the mean Tg ratio ‘cord serum/maternal serum’ was 
similar in the smoking and non-smoking group. Thus, maternal smoking increased 
the risk of iodine deficiency in pregnant women and their newborns, but serum Tg 
increased to a similar degree in mother and child.   
 
3.2.4. STUDY DISCUSSION 
The study aimed to examine the regulation of human placental iodide transport in a 
clinical setting. Following our hypothesis, study results were compatible with 
autoregulation of NIS-mediated iodide transport in placenta since the degree of 
iodine deficiency caused by maternal smoking was similar in the mother and the 
fetus. However, our hypothesis was based upon underlying assumptions and 
evidence for or against our hypothesis should be considered. Hill’s viewpoints of 
causation (Table 3-2) are mainly used in the evaluation of causality in ‘traditional’ 
epidemiological studies, but they are also applicable in more general [111].  
We investigated the association between maternal smoking in pregnancy and iodine 
deficiency in the mother and the fetus as evaluated by serum Tg in maternal and 
cord serum. The assumptions were that a) NIS is present in placenta, b) NIS 
mediates placental iodide transport, and c) NIS is inhibited by thiocyanate from 
maternal smoking. Considering strength, specificity, and temporality, it is well-
established that thiocyanate is a competitive inhibitor of NIS in the thyroid gland 
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[22], and population studies have shown that smoking increases the risk of goiter 
with the strongest association in areas with the most pronounced iodine deficiency 
[112,113]. NIS is expressed in the fetal thyroid gland [114], and the concentration 
of thiocyanate was similar in maternal and cord serum suggesting that thiocyanate 
reaches and crosses the placenta [19]. NIS expression in the human placenta has 
been demonstrated in experimental studies [104-109], and dose-dependent 
inhibition of NIS-mediated placental iodide transport by both thiocyanate and 
perchlorate has been shown (biological gradient) [25,88,109].  
 
Hill’s viewpoints Description 
Strength Strong association between exposure and outcome 
Specificity Exposure associates with one specific outcome 
Temporality Outcome occurs after the exposure 
Biological gradient Dose-response between exposure and outcome 
Experimental evidence Similar findings in experimental studies 
Consistency Results repeatingly shown in different populations 
Analogy Alternative explanations 
Plausibility Plausible mechanism between exposure and outcome 
Coherence In line with the natural history of the outcome 
Table 3-2. Hill’s viewpoints of causation [111]. 
Experimental evidence from studies in rats and in vitro suggests that NIS-mediated 
placental iodide transport is autoregulated by iodide [32,33]. Several in vitro studies 
have investigated the regulatory role of the pregnancy-associated hormone human 
chorionic gonadotropin (hCG) in the thyroid gland [115] and in the placenta 
[33,109,116]. Results suggested that hCG increases iodide uptake in both tissues via 
increased expression of NIS, and the regulation of placental NIS by iodide might be 
via modulation of the hCG mediated NIS expression [33]. In studies of placental 
tissue samples, increasing expression of NIS was observed in first trimester samples 
[117], whereas no difference was observed between first trimester and term 
placenta [104,106]. However, in vitro both NIS and hCG expression were higher in 
cells obtained from first trimester than from term placenta [104].  
Still, many details on the regulation of placental iodide transport remains to be 
elucidated. Other regulatory mechanisms have been proposed including the 
transcription factor Paired-Box Gene 8 (PAX-8) which is expressed both in the 
thyroid gland and in the placenta [118], the oxygen level in placenta [119], oxytocin 
[109], and maternal thyroxine-binding globulin (TBG) [108].  
No previous studies have evaluated the hypothesis of autoregulation of placental 
iodide transport in a clinical setting and further clinical studies are needed to 
determine the consistency of our results. In a study from France [120], cord serum 
Tg was higher in smoking mothers who did not use iodine-containing supplements, 
but results were not presented so that the relative impact of maternal smoking on 
maternal and cord serum Tg could be determined.  
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Although many criteria are in favor of our hypothesis, the possibility of other 
alternative explanations (analogy) needs to be addressed. Our hypothesis was based 
on the assumption that placental iodide transport is mediated by NIS, but we cannot 
exclude that other iodide transporter not inhibited by thiocyanate may be involved 
in placental iodide transport e.g. the chloride/iodide transporter (Pendrin) [104], and 
the sodium-multivitamin transporter (SMVT) [121,122]. However, experimental 
studies of placental iodide transport have indicated kinetic and inhibitory 
characteristics compatible with a significant role of NIS [25,109].  
The consequence of fetal iodine deficiency may be severe. Considering plausibility 
and coherence, it seems reasonable that the placental transport of iodide is 
autoregulated to protect the developing fetus against iodine deficiency. The clinical 
type of brain damage occurring in populations with a high intake of thiocyanate 
from cassava may support the hypothesis of placental autoregulation. In the 
Democratic Republic of Congo with a high frequency of endemic cretinism, the 
majority of cases had myxedematous cretinism [90]. This type of cretinism is 
thought to be caused by neonatal hypothyroidism. Thus, the autoregulation of 
placental iodide transport may have kept the iodine supply to the fetus sufficient by 
overcoming thiocyanate inhibition of NIS. On the other hand, no autoregulation of 
NIS-mediated iodide transport into breast milk is apparent, and the iodine supply to 
the breastfed infant may be seriously impaired by thiocyanate exposure [19].  
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CHAPTER 4. IODINE & PREGNANCY 
Maternal iodine intake in pregnancy should cover not only the need of the pregnant 
woman but also the need of the developing fetus, and the consequences of 
inadequate maternal iodine intake may be severe. Pregnant women are at risk of 
being iodine deficient, and specific recommendations for this population subgroup 
have been established.  
4.1. IODINE METABOLISM IN PREGNANCY 
Pregnancy induces a number of physiological changes both in the thyroid gland and 
in renal function which result in an altered metabolism of iodine. The thyroid gland 
is challenged with an increasing demand of thyroid hormone synthesis in pregnancy 
[123]. TBG is the main thyroid hormone transport protein, and in early pregnancy 
elevated estrogen levels lead to an increase in circulating TBG and a concomitant 
increase in total serum T4 (Fig. 4-1). hCG is a glycoprotein increasingly secreted by 
the placenta in the first trimester of pregnancy (Fig. 4-1). hCG has stimulatory 
effect on the TSH-receptor with a concomitant increase in free T4 and decrease in 
TSH around the time of the hCG peak (Fig. 4-1). 
 
 
Fig. 4-1. Relative changes in maternal thyroid function in pregnancy. Reproduced from [123] 
with permission, copyright Massachusetts Medical Society.  
TBG; Thyroxine-binding globulin, T4; tetraiododthyronine, hCG; human chorionic 
gonadotropin, Thyrotropin; thyroid stimulating hormone.
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There is a need for transfer of thyroid hormones to the fetus and a change in the 
peripheral metabolism of maternal thyroid hormones in pregnancy [124]. Placenta 
contains D2 which catalyzes the conversion of T4 to T3, but it also contains 
abundant type 3 iodothyronine deiodinase (D3), which catalyzes the conversion of 
T4 to reverse-T3 and T3 to T2 [125]. D3 activity increases in early pregnancy and 
is higher than D2 activity throughout pregnancy [124]. 
Physiological changes occur in the kidneys in pregnancy [126]. There is an increase 
in the renal plasma flow which is 75% higher in midpregnancy [126] and an 
increase in the glomerular filtration rate (GFR) which is 50% higher than the non-
pregnant state at the end of the first trimester and maintained high throughout 
pregnancy [127]. In terms of iodine metabolism this leads to an increased renal 
clearance of iodide and a lower PII concentration in pregnancy (Fig. 4-2) [128].  
 
 Fig. 4-2. Relative changes in maternal renal iodine clearance, plasma inorganic iodide 
(PII), thyroid absolute iodine uptake (AIU) and thyroid clearance of iodine in pregnant 
women vs. controls. Data from [128].  
The increased thyroid hormone production in pregnancy can be approximated from 
the increase in Levothyroxine dose in pregnant women with known hypothyroidism 
prior to pregnancy [129]. In these women, the dose of Levothyroxine is increased 
by around 50%, corresponding to a 50% increase in the absolute iodine uptake 
(AIU) in the thyroid gland (Fig. 4-2). However, as illustrated in Fig. 4-2, the thyroid 
clearance of iodide is three times higher. Thus, the lower PII makes is more difficult 
for the thyroid gland to keep iodine uptake sufficient for thyroid hormone synthesis 
[128]. The normal thyroid gland is able to compensate for the increased demands, 
but if the function of the thyroid gland is impaired due to thyroid disease or if the 
iodine intake is insufficient, signs of thyroidal stress may develop.  
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It should be stressed that results presented in Fig. 4-2 were from a study performed 
in Scotland, where iodine status was inadequate [130]. The study included 13 
pregnant women and 13 controls and used indirect measurement of PII after 
intravenous injection of radioiodine [128]. In a study of 16 pregnant women with 
more than adequate iodine intake and direct measurement of PII, no decrease in PII 
during the pregnancy was observed [131]. 
4.2. RECOMMENDATIONS IN PREGNANCY 
4.2.1. DAILY IODINE INTAKE 
Due to the physiological changes in pregnancy, the recommended daily iodine 
intake is higher than in non-pregnant adult (Table 4-1).  
Authority µg iodine/day 
WHO, UNICEF, ICCIDD 2007 [3] 250 
US Institute of Medicine 2001 [132] 220 
European Food Safety Authority 2014 [133] 200 
Nordic Nutrition Recommendations 2012 [134] 175 
Table 4-1. Recommended daily iodine intake in pregnancy by different authorities.  
All authorities listed agreed on a daily intake of 150 µg iodine/day in non-pregnant 
adults, whereas the estimate of the additional iodine requirements in pregnancy 
varied between authorities.  
 
4.2.2. URINARY IODINE CONCENTRATION  
The range of median UIC indicating sufficient iodine intake in a population of 
pregnant women is different from non-pregnant adults (Table 4-2). The median cut-
off indicating adequate iodine intake in pregnant women is 150 µg/l, whereas in 
schoolchildren ≥ 6 years and non-pregnant adults it is 100 µg/l. 
 
 
 
 
Table 4-2. Assessment of population iodine status from median urinary iodine concentration 
(UIC) in pregnant women [3].  
Median UIC (µg/l) Iodine intake 
< 150 Insufficient 
150-249 Adequate 
250-499 Above requirements 
≥ 500 Excessive 
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4.3. PREVIOUS DANISH STUDIES 
Data on urinary iodine excretion in Danish pregnant women before the introduction 
of the Danish mandatory iodine fortification of salt have been reported in three 
investigations (Table 4-3) which all revealed that Danish pregnant women were 
iodine deficient.  
GA; gestational age 
1
Only reported as iodine/creatinine ratio. 
2
All women were thyroid peroxidase antibody positive. Subgroup with no iodine supplement intake prior 
to study inclusion (n=32) had median UIC: 46 µg/l. 
Table 4-3. Previous data on median urinary iodine (UI) excretion in Danish pregnant women 
with no use of iodine-containing supplements in pregnancy. 
Compared with non-pregnant controls in the same area, urinary iodine excretion 
was at the same level, but serum Tg was considerably higher in pregnant women 
[13]. The findings called for studies investigating the impact of iodine 
supplementation in pregnancy. In an intervention study by Pedersen et al. [14], 54 
pregnant women were randomized in gestational week 17-18 to 200 µg iodine/day 
until 12 months postpartum (n=28) or controls (n=26). Serum TSH, serum Tg and 
thyroid size increased significantly during pregnancy in the control group, whereas 
these changes were ameliorated in the iodine supplemented group. As expected, 
UIC increased and was significantly higher during pregnancy in the iodine 
supplemented group (gestational week 37; median UIC iodine supplemented group: 
108 µg/l vs. controls: 40 µg/l). Similar increase in UIC after iodine supplementation 
in pregnancy was observed in the study by Nohr et al. [18] (gestational week 35; 
median UIC iodine supplemented group: 105 µg/l vs. controls: 53 µg/l). 
Considering the use of iodine-containing supplements in pregnancy, an 
investigation in five cities in Denmark [15] in the years 1988-1990 showed that 
approximately one third of Danish pregnant women used iodine-containing 
supplements when asked upon arrival for delivery (range 20-50%). One of the 
concerns about iodine supplementation in pregnancy is the aggravation of thyroid 
autoimmunity and development of postpartum thyroid dysfunction (PPTD). This 
was investigated in a Danish study by Nohr et al. [18] in which 66 thyroid 
peroxidase antibody (TPO-Ab) positive women were recruited in gestational week 
11 and  randomized to 150 µg iodine supplementation in pregnancy (n=20), in 
pregnancy and postpartum (n=22) or no iodine supplementation (n=24). Altogether 
55% of the women developed PPTD and there was no significant difference in the 
frequency or severity and duration of PPTD in the three groups. 
Author, year of publication City n GA Median UI 
Pedersen et al., 1988 [13] Randers 20 34-38 52 µg/g creatinine1 
Pedersen et al., 1993 [14] Randers 54 17-18 53 µg/l 
Nohr et al., 2000 [18] Aalborg 66 ~ 11 51 µg/l2 
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4.4. IODINE STATUS IN DANISH PREGNANT WOMEN           
(PAPER 2) 
The second paper in the PhD thesis addressed the iodine status in Danish pregnant 
women. Before the mandatory iodine fortification of salt, Danish pregnant women 
were iodine deficient with signs of thyroidal stress. The fortification of salt has 
improved the iodine status in the Danish population in general, but no investigation 
of iodine intake in Danish pregnant women specifically has been performed after 
the introduction of the mandatory iodine fortification of salt.  
4.4.1. STUDY OBJECTIVE 
The study objective was to investigate the use of iodine-containing supplements and 
urinary iodine status in Danish pregnant women living in an area of Denmark with 
previously moderate iodine deficiency. The study was a regional investigation in 
the part of Denmark with the lowest iodine content in drinking water and previously 
most severe iodine deficiency. 
4.4.2. STUDY DESIGN 
The study was a cross-sectional investigation. The pregnant women were recruited 
when they arrived for obstetric ultrasound at Aalborg University Hospital. Aalborg 
University Hospital is located in the North Denmark Region and the yearly number 
of births was 3,251 in 2012 corresponding to 63.7% of births in the North Denmark 
Region and 5.6% of births in Denmark [135]. In Denmark, pregnant women are 
offered routine obstetric ultrasound in gestational week 11-14 (estimation of the 
nuchal fold thickness as part of the trisomi 13, 18 and 21 risk assessment) and in 
gestational week 19-21 (screening for fetal malformations). The rate of 
participation is high and in 2012 it was above 90% for both examinations [136].  In 
addition to the two routine ultrasound examinations, ultrasound is performed on 
specific indication (e.g. suspicion of deviant fetal growth, placenta position, fetal 
head position, cervical length, and flow in the maternal-fetal circulation). We 
recruited pregnant women arriving for routine ultrasound examination around 
gestational week 12, 20 and pregnant women arriving for ultrasound around 
gestational week 30. All pregnant women recruited, had a scheduled time of 
ultrasound between 8.20 am and 11.30 am (50% of the ultrasounds scheduled in 
one day) which was the period when staff was available for inclusion.  
Ten days prior to the start of a study inclusion week, a booking list of planned 
obstetric ultrasounds was retrieved from the Obstetric Department. From this list, 
pregnant women with scheduled ultrasound were selected for study inclusion. 
When multiple pregnancy or a need for translator was specified in the booking list, 
the women were not selected. When the number of women available for inclusion 
in one day was larger than staff could handle, selection was made by gestational 
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age, secondly by random. One week prior to the scheduled obstetric ultrasound, a 
letter was mailed to the pregnant women selected for inclusion. The letter included 
information about the study and the study questionnaire (Appendix A) which they 
were asked to complete and bring to the ultrasound examination together with any 
dietary supplement in current use. Upon arrival in the Obstetric Department, the 
pregnant women willing to participate delivered the questionnaire and were asked 
to make a spot urine sample. The questionnaire was reviewed and information on 
intake of iodine-containing supplements including time of most recent iodine 
supplement intake prior to the urine sampling was obtained by interview.   
The questions in the questionnaire were adapted from the questions used in the 
population-based Danish investigation on iodine intake and thyroid disease 
(DanThyr). The DanThyr study group adapted the questionnaires from the 
‘Glostrup Population Studies’ [137] and the ‘MONICA studies’ [138] and self-
constructed the questions concerning thyroid disease, as previously described [62]. 
Smoking questions from the MONICA study have been validated by the MONICA 
study group and questions concerning thyroid disease were validated by the 
DanThyr study group [62]. The questions about dietary habits were collected for 
future studies and not included in this PhD thesis.  
Obstetric data (the Astraia database) which are registered at the first pregnancy visit 
in general practice or at the time of obstetric ultrasound were obtained for each 
participant including ethnicity, ultrasound determined gestational age, pre-
pregnancy height and weight, smoking status, and parity.  
Data registration was performed manually in SPSS by two of the investigators using 
the same data registration protocol. Double data entry of the questionnaire 
(Appendix A) was performed in a 5% sub sample (1,020 data fields) and revealed a 
high agreement between the two individuals (99.9%).  
The iodine laboratory was certified by the U.S. Centers for Disease Control and 
Prevention EQUIP program, which includes measurement of external controls three 
times a year. UIC was determined by the cerium/arsenite method after alkaline 
ashing as described by Wilson van Zyl in 1967 and modified as previously 
described [139]. After thawing and brief mixing of the samples, alkaline ashing to 
combust organic material is followed by evaporation to dryness after which the 
samples are resuspended in water for iodine measurement. A standard iodine 
solution with a known concentration of iodine is used to make the standard curve 
which plots different iodine concentrations against the absorbance determined by 
spectrophotometry using the reagents cerium and arsenite. For analyses of the 
samples, arsenite and then cerium are added and the absorbance is determined after 
an exact time interval. Using the standard curve, the iodine concentration 
corresponding to the measured absorbance can be determined. The method has been 
evaluated as described in the method section of paper 2 and 3.  
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4.4.3. STUDY RESULTS 
Altogether 340 pregnant women were informed about the study by mail prior to 
obstetric ultrasound, 245 pregnant women gave informed consent to participate 
upon arrival in the Obstetric Department, and 238 women delivered a spot urine 
sample. The frequency of self-reported iodine supplement use at the time of 
inclusion was 84.1%. Overall, median UIC was 101 µg/l and stratified by iodine 
supplement intake, median UIC was considerably lower in the group of pregnant 
women with no intake of iodine-containing supplements (68 µg/l vs. 109 µg/l in 
iodine supplement users). Maternal education qualifying for a profession and lower 
maternal age were predictors of iodine supplement use in multivariate analysis.  
 
In paper 2, the pregnant women were grouped according to the type of obstetric 
ultrasound they attended (gestational week 10-15, 19-21 and 28-37). Another way 
to examine gestational age is to look at trimesters of pregnancy. In Denmark, the 
first trimester of pregnancy is defined as the first 12 weeks of pregnancy calculated 
from the first day of the last menstrual period; second trimester as the 13th to the 
28th week and third trimester as the remaining pregnancy period [140]. Gestational 
age by trimester was not a significant predictor of iodine supplement use (Table 4-
4). When results of urinary iodine evaluation were stratified by trimester, both 
median UIC and urinary creatinine concentration were higher in third trimester 
(Table 4-4), similarly in multivariate linear regression including other maternal 
predictors (age, education, iodine supplement use etc.). However, when urinary 
creatinine concentration was used to calculate estimated 24-hour urinary iodine 
excretion, no difference by trimester was observed (Table 4-4). 
 Trimester of pregnancy  
 1st 2nd 3rd p 
Gestational week (range)  10-12 13-28 29-37  
Pregnant women (n)  47 167 24  
Iodine supplement use (%)  85.1 81.9 92.0 0.5 
Urinary iodine concentration (µg/l)  103 94 140 0.01 
Urinary creatinine concentration 
(mmol/l)  
6.5 6.1 10.4 0.01 
Estimated 24-hour urinary iodine 
excretion (µg/24 hours)  
146 154 147 0.96 
Table 4-4. Median urinary iodine concentration, urinary creatinine concentration and 
estimated 24-hour urinary iodine excretion in Danish pregnant women stratified by 
trimesters of pregnancy.   
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4.4.4. STUDY DISCUSSION 
Danish pregnant women living in an area of Denmark with previously moderate 
iodine deficiency were still iodine deficient after the introduction of the mandatory 
iodine fortification of salt. Both iodine supplement users and non-users had median 
UIC below the range recommended in pregnancy. Iodine supplement non-users had 
mild iodine deficiency, whereas when iodine-containing supplements were used, 
the median UIC was within the range recommended in non-pregnant adults. 
The use of iodine-containing supplements in pregnancy had considerably increased 
compared with a previous study. In our study population, ~85% used iodine-
containing supplements whereas previously ~35% were iodine supplement users 
when they arrived for delivery [15]. In Denmark, no official recommendations for 
iodine supplement intake in pregnancy exist, but there are recommendations for 
intake of folic acid, vitamin D and iron which are often combined in a multivitamin 
pill [11]. The pregnant women all obtained iodine in a multivitamin pill, and the 
majority of iodine supplement non-users used dietary supplements, but these 
supplements did not contain iodine either because it was a single vitamin and/or 
mineral or because it was a multivitamin pill not containing iodine. 
For the assessment of predictors of iodine supplement intake our study was limited 
by sample size. The groups were small in the stratified analyses, and results of the 
multivariate analysis were subject to some uncertainty. Only sparse data are 
available on predictors of iodine supplement in pregnancy. In a study from 
Australia, the main predictors of iodine supplement use in pregnancy were general 
dietary supplement use and knowledge of the importance of iodine [141]. In the 
general population, a Danish study found that higher educational level versus 
primary school only was a significant predictor of iodine supplement use [142], in 
line with our findings for iodine supplement use in pregnancy. Also Danish studies 
of preconceptional folic acid and multivitamin use [143] and iron supplement use in 
pregnancy [144], reported higher educational level as a significant predictor. Lower 
maternal age was the other independent predictor of iodine supplement use in our 
study. For the use of dietary supplements in the Danish population [142], in Danish 
pregnancy planners [143] and for the use of iron in Danish pregnant women [144], 
higher maternal age was a significant predictor. However, it can be speculated if 
pregnant women with higher age and parity are less focused on following 
recommendations in pregnancy than nulliparous, younger women. Larger studies 
are needed to clarify predictors and possible interactions in detail.  
Dietary factors may influence iodine status of pregnant women and depending on 
the main dietary sources of iodine in a population; women with specific dietary 
habits may be more vulnerable to a low iodine intake [145,146].  The dietary data 
collected will be investigated in future studies. The habit of buying organic milk 
was associated with higher maternal age and higher educational level, but was not 
an independent predictor of iodine supplement intake. The incentive to include this 
variable was studies reporting a lower iodine content of organic milk [46,147]. 
Future studies including dietary data should investigate this aspect. 
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Internal validity is the extent to which results are correctly collected and analyzed 
within the study population. Concerning information bias, the data collection was 
performed using a questionnaire in which the majority of questions have previously 
been validated. The information letter was mailed to the pregnant woman one week 
prior to study inclusion and information was kept low grade to avoid influencing 
iodine supplement use prior to study inclusion. The intake of iodine-containing 
supplements was confirmed by interview at the time of study inclusion. We cannot 
exclude that misclassification of iodine supplement intake or other variables 
occurred, however, such misclassification is most likely to be non-differential. The 
urine samples were kept separately in the Obstetric Department and clearly marked 
to avoid the use of urine test strips which can be a source of iodine contamination 
[148]. The iodine laboratory is certified with several yearly external blind controls 
and urine samples were randomly measured including internal controls.  
Concerning selection bias, the rate of participation among women invited was high, 
but we cannot exclude that participants might have differed from non-participants. 
To elaborate on this, we obtained permission from the Danish Health and Medicine 
Authority to view the medical records of a random sample of pregnant women 
scheduled for obstetric ultrasound in the same hospital the following year. Maternal 
characteristics were compared with the pregnant women included in our study 
(Table 4-5). There was no significant difference in gestational age, obstetric 
consultation secondary to obstetric ultrasound, pre-pregnancy BMI, smoking, and 
area of living (the city of Aalborg versus outside of Aalborg). Significant 
differences were observed in maternal age, parity and ethnicity (Table 4-5).  
 
 Study participants Random sample p1
 
 n = 245 n = 107  
Maternal age, years n % n %  
< 25 27 11.0 12 11.2 0.034 
25-35 180 73.5 66 61.7  
> 35 38 15.5 29 27.1  
Parity2  n % n %  
1 130 53.1 43 41.0 0.022 
2 90 36.7 41 39.0  
≥ 3 25 10.2 21 20.0  
Ethnicity  n % n %  
Caucasian 242 98.8 97 90.6 < 0.001 
Non-Caucasian 3 1.2 10 9.4  
1
Result of the Chi-square test: study participants vs. random sample.  
2
Previous still- and live births including index pregnancy. Missing values (n=2) not included.  
 
 
Table 4-5. Maternal characteristics which were significantly different between participants 
in our investigation (2012) and a random sample of pregnant women arriving for obstetric 
ultrasound at Aalborg University Hospital in the same period the following year (2013). 
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The pregnant women included in our study tended to be younger and were more 
often expecting their first child. As expected, pregnant women with another 
ethnicity than Danish were underrepresented, because the questionnaire was in 
Danish and was not mailed to the woman if the booking list indicated a need for 
translator. The random sample included pregnant women arriving for obstetric 
ultrasound before (n=74) and after (n=33) noon. In such comparison, women living 
in the city of Aalborg tended to be overrepresented before noon. 
It was a priori decided to exclude women treated for thyroid disease. The hyper- 
and hypothyroid state influences iodine metabolism and Levothyroxine contains 
65% iodine [52]. We excluded women with gastrointestinal disease including 
gastric bypass, although a recent study showed that iodine absorption was not 
influenced by bariatric surgery [149]. 
External validity is the extent to which results are applicable to a larger study 
population than the one examined. We performed a regional investigation and we 
cannot exclude that the iodine status of Danish pregnant women in the Eastern part 
of Denmark with a higher content of iodine in drinking water is different. 
Concerning the use of iodine-containing supplements, the previous national 
investigation of pregnant women in five cities in Denmark did not report large 
geographical discrepancies [15]; neither did the investigation of the general Danish 
population in East and West Denmark [20].  
UIC shows a wide variation and a large number of spot urine samples are required 
for precise estimation of the median UIC in a population [65]. The total number of 
pregnant women included in our study was appropriate; however, in the stratified 
analyses, the numbers tended to be small.  
It has been discussed if gestation-specific reference intervals for UIC are needed. 
To elaborate on this, we performed stratified analyses of urinary measurements by 
trimester in our study population (Table 4-4), and we identified other studies 
reporting median value of UIC in each of the three trimesters (Table 4-6).  
No consistent pattern in median UIC by trimester of pregnancy was observed when 
comparing different studies (Table 4-6). In our Danish study (Table 4-4), median 
UIC and urinary creatinine concentration varied in parallel between trimester of 
pregnancy and estimated 24-hour urinary iodide excretion did not differ between 
trimesters. Only the studies from Japan in Table 4-6 [150,151] reported creatinine 
adjusted measurements (urinary iodine/creatinine ratio) which were either lower in 
the first trimester compared with later trimesters or similar in the three trimesters.  
Considering what determines UIC in pregnancy, there is some iodine retention due 
to the increased maternal T4 pool (TBG increase, tissue expansion and transfer of 
T4 to the fetus) and the transfer of iodide to the fetus, but it can be calculated that 
this represents only a few µg iodine per day. The renal clearance of iodide is 
increased from early pregnancy, but this is followed by a lower PII concentration 
and a new steady state is expected. Thus, the main determinants of UIC in 
pregnancy appear to be the dietary iodine intake and the fluid intake, and the 
diverse pattern of median UIC by trimesters of pregnancy (Table 4-6) may reflect 
differences in iodine intake and/or fluid intake during the pregnancy.   
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First author Year Country n Median UIC 
(µg/l) 
p1
 
    1st2
 2nd2 3rd2  
Cross-sectional data 
Caldwell [152] 2013 United States 176 109 128 172 < 0.05 
Fuse [151] 2013 Japan 563 227 259 205 ns 
Raverot3 [153] 2012 France 100 69 91 91 < 0.05 
Pettigrew [154] 2011 New Zealand 170 41 39 37 ns 
Garcia-Solis [155] 2011 Mexico 294 273 285 231 ns 
Andersson [156] 2010 Switzerland 648 116 166 156 ns 
Rezvanian [157] 2002 Iran 90 206 233 184 ns 
Smyth3 [158] 1997 Ireland 115 135 122 122 < 0.054 
Longitudinal data 
Fuse [151] 2013 Japan 65 216 136 148 < 0.05 
Ainy3 [159] 2007 Iran 298 193 159 141 < 0.05 
Smyth [160] 2005 Sri Lanka 19 194 104 74 ns4 
Kung [161] 2000 Hong Kong 230 107 115 124 < 0.05 
Smyth3 [158] 1997 Ireland 38 158 122 115 < 0.054 
Pedersen3 [14] 1993 Denmark 26 51 42 40 ns 
Mixed cross-sectional and longitudinal data 
Fuse [150] 2011 Japan 683 221 208 193 ns 
Stillwell [162] 2008 Tasmania 431 109 64 74 < 0.05 
1
Result of the comparison by trimesters.  
2
Trimesters of pregnancy (1st, 2nd, 3rd). 
3
Specified in the study that the participants did not use iodine-containing supplements.  
4
Result of the comparison to non-pregnant controls.  
 
Table 4-6. Median urinary iodine concentration (UIC) reported in different studies stratified 
by trimester of pregnancy (1st, 2nd, 3rd).  
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4.5. CHALLENGES IN EVALUATION OF IODINE STATUS IN 
PREGNANCY (PAPER 3) 
The third paper in the PhD thesis addressed challenges in the evaluation of iodine 
status in pregnancy. More specifically, it focused on factors that may influence 
urinary iodine status in a population of pregnant women when evaluated by spot 
urine samples. Certain aspects characterize studies in pregnant women compared 
with studies in non-pregnant population groups e.g. urine samples are often 
obtained during a routine hospital visit and iodine supplement use is often 
recommended. 
4.5.1. STUDY OBJECTIVE 
The main study of iodine status in Danish pregnant women was performed in a 
routine manner to strengthen the comparability with other studies. In the present 
study, we aimed to investigate if results of such evaluation would be different if 
spot urine sampling was instead performed at home or if time of most recent iodine 
supplement intake prior to spot urine sampling was considered.  In addition to this 
we aimed to compare urinary iodine status of pregnant women with that of their 
household members when spot urine sampling was performed under similar 
conditions.  
4.5.2. STUDY DESIGN 
The study was supplementary to the investigation of iodine intake in Danish 
pregnant women, and data were collected in two ways (Table 4-7). For method 1, 
the male partner was recruited at the same time as the pregnant woman in the 
hospital. For method 2, vials for sampling were brought home and the pregnant 
woman and members of the household made a non-fasting spot urine sample at 
home as close in time as possible. Thus, pregnant women participating with the 
household at home (method 2) delivered two urine samples; one in the hospital at 
inclusion and one another day at home (Table 4-7).  
Method Hospital urine 
sampling 
At home urine 
sampling 
Samples from each 
pregnant woman 
1 Pregnant woman 
Male partner 
 n=1 
2 Pregnant woman 
 
Pregnant woman 
Household members 
n=2 
 
Table 4-7. Illustration of urine samples collected in the hospital and at home.  
CHAPTER 4. IODINE & PREGNANCY 
35 
 
Urine samples from home were sent by mail immediately after collection. All male 
partners and children completed a questionnaire (Appendix B and C) constructed 
similar to the questionnaire for pregnant women. All participants were informed to 
note detailed information on iodine-containing supplements including time of most 
recent iodine supplement intake prior to spot urine sampling.  
 
4.5.3. STUDY RESULTS 
Individual comparison of the spot urine sample in the hospital and at home from 66 
pregnant women showed that UIC and urinary creatinine concentration, but not 24-
hour estimated urinary iodine excretion, were higher when sampling was at home. 
To further investigate these findings, we looked into the time of sampling in a 
posthoc analysis. Samples in the hospital were obtained before noon, whereas at 
home the majority of women had sampled in the afternoon/evening. When analyses 
were stratified by time of sampling at home before/after 5 pm, UIC was higher at 
home only when sampling at home was at or after 5 pm. The time span from most 
recent iodine supplement intake to spot urine sampling influenced UIC with the 
highest median value when iodine supplement intake was the same day. Urinary 
iodine status in the pregnant women versus male partners and children was 
ascertained by looking at the median UIC and by individual comparison between 
household members. Median UIC was not significantly different between pregnant 
women, male partners and children (Table 4-8). 
 All Iodine 
supplement 
No iodine 
supplement  
 n Median 
UIC (µg/l) 
n  Median 
UIC (µg/l) 
n  Median 
UIC (µg/l) 
Pregnant women 68 134 59  136  9  98  
Male partners 67 115 10  136  57   110  
Children 51 126 13  151  38  121  
Table 4-8. Median urinary iodine concentration (UIC) in pregnant women, male partners 
and children sampling at home. Pregnant women vs. male partners vs. children (Kruskal-
Wallis test): all (p=0.1), iodine supplement (p=0.5), no iodine supplement (p=0.4).  
Results were similar when analyses were restricted to households with participation from the 
pregnant woman, the male partner and 1-3 children.   
 
The use of iodine-containing supplements was much more frequent in pregnant 
women than in male partners and children (Table 4-8). Thus, in the majority of the 
female-male couples, only the pregnant woman used iodine-containing supplement. 
In this group, UIC was higher in the pregnant women than in the male partner, but 
in the groups were both or none used iodine-containing supplements no difference 
in UIC was observed.  
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4.5.4. STUDY DISCUSSION 
The study was a pilot investigation designed to examine challenges in the 
evaluation of urinary iodine status in pregnancy. The sample size was limited and 
results should be corroborated in other studies, but the study poses a number of 
important challenges which optimally should be considered and reported in the 
evaluation of urinary iodine status in pregnancy.   
The intention to include urine samples both during routine hospital visit and at 
home emerged from the examination of studies evaluating urinary iodine status in 
pregnancy. In the vast majority of studies, pregnant women were recruited during a 
routine hospital visit. Our investigation had several aims, and consequently the 
pregnant women were asked to sample urine at home at the same time as the other 
household members. Time of home sampling was not pre-specified to increase the 
rate of participation (except that it should be non-fasting). We were not able to 
distinguish between the role of sampling location and time of sampling in the 
present investigation. In our posthoc analyses it appeared that time of sampling at 
home was often in the afternoon or evening whereas sampling in the hospital was 
always scheduled before noon. We observed that UIC was influenced by time of 
sampling in line with some [64,163] and in contrast to other studies [164]. To 
evaluate if sampling location influences UIC, a study needs to be designed in which 
the sampling time is similar in the two locations and the timing of food and drink 
intake in relation to urine sampling should preferable be specified.   
When urinary creatinine concentration was used to calculate estimated 24-hour 
iodine excretion, the time dependent difference in urinary iodine excretion 
disappeared. Hydration status can be a confounder in the examination of UIC [165]. 
We observed that both UIC and urinary creatinine concentration were higher when 
sampling was performed later in the day. To calculate the estimated 24-hour urinary 
iodine excretion, the urinary iodine/creatinine ratio is multiplied by a measure of 
24-hour urinary creatinine excretion to account for age and gender specific values 
of urinary creatinine excretion. As specified in the method section of paper 3, we 
used previous measures of 24-hour urinary creatinine excretion in Danish pregnant 
women, Belgian men and German children. Another approach is to use the formula 
developed for the general Danish population with an individual estimation based on 
age, height and weight [166]. Using this formula for the male partners, the mean 
24-hour urinary creatinine excretion was 1.62 g creatinine/24 hours and not 
considerably different from the value applied (1.74 g creatinine/24 hours [167]).  
The investigation was designed to include as many non-pregnant household 
members as possible. Thus, vials were provided for sampling at home mainly if the 
couple already had children at home, otherwise the male partner participated in the 
hospital. Due to this design, pregnant women sampling both in the hospital and at 
home tended to be older with a higher parity, but gestational week at inclusion, 
educational level and use of iodine-containing supplements was not different from 
women participating in the hospital only.  
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The intention to include information on time of most recent iodine supplement 
intake prior to spot urine sampling emerged from the association between iodine 
intake and urinary iodine excretion (Fig. 2-5). Examination of studies evaluating 
urinary iodine status in pregnancy revealed that use of iodine-containing 
supplements is often recommended, but information on time of most recent iodine 
supplement intake prior to urine sampling often not included. We obtained 
information in four categories; the same day, the day before, several days ago or 
non-user. The stratification made the groups rather small, and we had to collapse 
the categories ‘several days ago/non-user’. Despite these limitations, results suggest 
that the time span from iodine supplement intake to spot urine sampling should be 
considered, but larger studies are needed to corroborate results. 
The intention to include urine samples from non-pregnant members of the 
household emerged from the discussion on whether iodine status of pregnant 
women can be evaluated from data on non-pregnant population groups. Wong et al. 
[39] examined 48 surveys with median UIC of pregnant women and schoolchildren 
and 26 surveys with median UIC of pregnant and non-pregnant women. The 
authors showed that when median UIC of schoolchildren or non-pregnant adults 
indicated adequate iodine intake, pregnant women had inadequate iodine intake in 
approximately half of the surveys. In the majority of surveys [39], data were 
obtained from the World Health Organization Vitamin and Mineral Nutrition 
Information System and no details on time and location of urine sampling were 
reported. Four surveys were identified by literature review [39] including a 
household study from Thailand [168] which has been followed by a study in India 
using the same design [169]. In these studies [168,169], median UIC was higher in 
the children than in the pregnant women, whereas in our Danish study, median UIC 
of the pregnant women was not significantly different from that of the children. In 
the study from India [169], the pregnant women and children shared all meals. We 
cannot exclude dietary differences among household members in our Danish study, 
but all household members were instructed to perform spot urine sampling at home 
at the same time. Urine sampling conditions were not controlled in the studies from 
Thailand [168] and India [169], and it can be speculated if differences in time and 
location of spot urine sampling could explain part of the disparity in median UIC 
observed between pregnant women and children.   
We observed a more frequent use of iodine-containing supplements in the pregnant 
women than in members of their household. The use of iodine-containing 
supplements was self-reported, and in general urinary iodine excretion was higher 
when iodine supplement use was reported. However, the impact of iodine 
supplementation on median UIC appeared less pronounced in the male partners, and 
we cannot exclude discrepancies in the self-reported iodine supplement use.  
Further studies are needed to clarify the relationship between urinary iodine status 
of pregnant women and that of non-pregnant population groups, and studies 
performed in different populations with different dietary habits and iodine status are 
needed. Optimally, both time of spot urine sampling, intake of iodine-containing 
supplements and dietary patterns should be considered in the study design.   
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CHAPTER 5. IODINE & BREASTFEEDING 
Maternal iodine intake during breastfeeding should cover not only the need of the 
mother, but also the need of the breastfed infant, and the consequences of 
inadequate maternal iodine intake may be severe. Breastfeeding women are at risk 
of being iodine deficient, and specific recommendations for this population 
subgroup have been established. 
5.1. IODINE METABOLISM DURING BREASTFEEDING 
Breastfeeding is associated with changes in maternal iodine metabolism (Fig. 5-1) 
[170]. During breastfeeding, around 40-45% of ingested iodine is excreted into 
breast milk (Fig. 5-1) and consequently < 90% of ingested iodine is excreted in the 
urine. NIS is expressed in the lactating mammary gland and mediates the transport 
of iodide into breast milk [23]. The transport is inhibited by thiocyanate from 
maternal smoking, but in contrast to transport of iodide in the thyroid gland and the 
placenta, the transport of iodide into breast milk is not autoregulated [19].  
 
Fig. 5-1. Iodine metabolism during breastfeeding. Reproduced from [170] with permission. 
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5.2. RECOMMENDATIONS DURING BREASTFEEDING 
5.2.1. DAILY IODINE INTAKE 
Different authorities have made recommendations for daily iodine intake in 
breastfeeding women and children < 2 years (Table 5-1). For breastfeeding women, 
the recommendation from WHO, UNICEF, ICCIDD and the European Food Safety 
Authority are similar to the recommendations in pregnancy. For children < 2 years, 
some authorities divide their recommendations into shorter age intervals taking into 
account changes in body weight and urine volume during the first years of life.  
 Breastfeeding 
mother 
Child  
< 2 years 
Authority µg/day µg /day 
WHO, UNICEF, ICCIDD 2007 [3] 250 90 
US Institute of Medicine 2001 [132] 290 90-1301 
European Food Safety Authority 2014 [133] 200 70-902 
Nordic Nutrition Recommendations 2012 [134] 200 50-70 
1
0-6 months: 110 µg/day, 7-12 months: 130 µg/day, 1-3 years: 90 µg/day. 
2
7-11 months: 70 µg/day, 1-3 years: 90 µg/day. 
Table 5-1. Recommended daily iodine intake by different authorities in breastfeeding women 
and children < 2 years.  
5.2.2. URINARY IODINE CONCENTRATION  
In breastfeeding women and children < 2 years, the recommendations for median 
UIC are similar to the recommendations for non-pregnant adults and children ≥ 6 
years (Table 5-2). Iodine requirements are increased during breastfeeding, but the 
fraction of ingested iodide excreted in the urine is lower due to the transport of 
iodide into breast milk. To ensure an adequate supply of iodine to the exclusively 
breastfed infant of 90 µg/day it can be estimated that MIC should be ≥ 110 µg/l 
assuming an average breast milk volume of 0.8 l/day [171]. When the infant is not 
or only partly breastfed, iodine is obtained via infant formulas. 
 
Table 5-2. Assessment of population iodine status from median urinary iodine concentration 
(UIC) in breastfeeding women and children < 2 years old [3] .  
 Breastfeeding women Children < 2 years 
Median UIC (µg/l) Iodine intake Iodine intake 
< 100 Insufficient Insufficient 
≥ 100 Adequate Adequate 
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5.3. PREVIOUS DANISH STUDIES 
Iodine status in Danish breastfeeding women and their newborns has been 
evaluated before the introduction of the mandatory iodine fortification of salt (Table 
5-3 and 5-4). Median values were in general low and below the level recommended, 
but higher in iodine supplement users.  
Table 5-3. Data on median urinary iodine concentration (UIC) in Danish breastfeeding 
women stratified by iodine supplement intake. 
Table 5-4. Data on median breast milk iodine concentration (MIC) in Danish breastfeeding 
women and median urinary iodine concentration (UIC) in their breastfed infants stratified by 
iodine supplement intake. Samples were obtained five days after delivery. 
Data on iodine content of infant formulas in Denmark are available from one 
previous investigation in which the median iodine concentration was 57 µg/l [8].   
 
5.4. IODINE STATUS IN DANISH BREASTFEEDING WOMEN 
(PAPER 4) 
The first part of the fourth paper in the PhD thesis addressed iodine status in Danish 
breastfeeding women. Danish breastfeeding women and their newborns were iodine 
deficient before the mandatory iodine fortification of salt, but no specific 
investigation of iodine intake in Danish breastfeeding women has been performed 
after the introduction of the mandatory iodine fortification of salt.  
Author, year of publication Sampling   Median UIC 
 Time after delivery + Iodine No iodine 
Pedersen et al., 1993 [14] 1 week 
6 months 
10 months 
45 µg/l 
115 µg/l 
85 µg/l 
30 µg/l 
55 µg/l 
45 µg/l 
Nohr et al., 1993 [15] 5 days 58 µg/l 35 µg/l 
Nohr et al., 2000 [18] 7 months 75 µg/l 43 µg/l 
Author, year of publication Median MIC Median UIC child 
 + Iodine No iodine + Iodine No iodine 
Pedersen et al., 1993 [14] 41 µg/l 28 µg/l 64 µg/l 27 µg/l 
Nohr et al., 1993 [16] 57 µg/l 34 µg/l 61 µg/l 32 µg/l 
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5.4.1. STUDY OBJECTIVE 
The study objective was to investigate the use of iodine-containing supplements and 
urinary iodine status in Danish breastfeeding women living in an area of Denmark 
with previously moderate iodine deficiency.  
5.4.2. STUDY DESIGN 
The study was a follow-up investigation of the women initially recruited in 
pregnancy. Participants who had given birth to a live-born child were contacted by 
phone in the postpartum period and a telephone interview was performed about 
intake of iodine-containing supplements, breastfeeding, and smoking. The women 
were asked to deliver a spot urine sample and a breast milk sample and/or a sample 
of prepared infant formula to the hospital. They were instructed to make the urine 
and breast milk sample non-fasting as close in time as possible. MIC was measured 
using the same method as for UIC and the analysis of MIC was evaluated as 
described in the method section of paper 4.  
 
5.4.3. STUDY RESULTS 
Altogether 209 women participated in a telephone interview postpartum, 183 of the 
women were partly or exclusively breastfeeding their child and 127 breastfeeding 
women delivered a spot urine and a breast milk sample. The frequency of iodine 
supplement use was 47% in the entire group and in the subgroup of breastfeeding 
women. Median maternal UIC was below the recommended range, and although 
higher in iodine supplement users, it was also below recommendations in this 
group. Median MIC was below the recommended range, but higher in iodine 
supplement users, where the median value was just within the recommendations. 
Median iodine concentration of infant formulas was 122 µg/l (range 62-167 µg/l).  
5.4.4. STUDY DISCUSSION 
In a regional investigation, Danish breastfeeding women were still iodine deficient 
after the introduction of the mandatory iodine fortification of salt and the content of 
iodine in breast milk was below the level recommended. The use of iodine-
containing supplements was less frequent during breastfeeding than in pregnancy 
and iodine deficiency was most severe in the ~50% of the mothers who did not use 
iodine-containing supplements during breastfeeding. No official recommendations 
for dietary supplements during breastfeeding exist in Denmark [12], whereas during 
pregnancy other recommendations often lead to the use of a multivitamin pill. One 
of the supplements was recommended by the manufacturer especially for 
breastfeeding women, but for reasons unknown, it contained only 45 µg iodine/day. 
The supplement was used by 7% of the women included in our study, and although 
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the group was small, results suggested that iodine intake was lower in this group 
compared with women using supplements that contained 150-175 µg iodine/day.  
The follow-up design induced the possibility that the women had more knowledge 
about iodine, and that the frequency of iodine supplement use was higher than in 
the general population. However, the information about iodine and the 
consequences of iodine deficiency was kept very low grade when the women were 
investigated in pregnancy, and they were not at this point informed about the 
postpartum investigation, but they accepted a subsequent contact by phone. The 
interview was performed at median 22 days after birth (range 9-146 days). No 
significant difference in the use of iodine-containing supplements was observed by 
the time of interview, but data were cross-sectional and we cannot exclude that 
some women used iodine-containing supplements only partly during breastfeeding. 
Women are encouraged to breastfeed their newborn child, but due to different 
circumstances it may not always be possible [12]. The public focus on 
breastfeeding could create bias in the information obtained by interview, but such 
misclassification is expected to be non-differential. The frequencies of 
breastfeeding are difficult to compare, but results seem compatible with general 
Danish data on breastfeeding four months after birth where 60% are fully 
breastfeeding, 25% are partly breastfeeding and 15% are not breastfeeding [12].  
In our study, breast milk samples were obtained from two weeks to five months 
after birth (90% within three months) and we did not observe significant changes in 
MIC with time from birth. For the first month variation, a higher content of iodine 
was found in colostrum decreasing to stable levels by 10 days postpartum [172]. 
During the first 6-month period of breastfeeding, both a decreasing trend [173,174] 
and stable levels have been reported [175].  
The iodine laboratory was certified by the U.S. Centers for Disease Control and 
Prevention EQUIP program. The recovery of added iodine to breast milk was 
93.6% (SEM 1.04%), which would underestimate MIC with ~6%. No correction for 
this disparity was made in the analyses.  
Aalborg University Hospital covers obstetric ultrasound in a large geographical area 
in the North Denmark Region. In the postpartum investigation, the women sampled 
urine and breast milk at home and delivery of the samples to the hospital was 
mainly possible for women living relatively close to the hospital. Following this, 
the number of women participating in the telephone interview was high, but the 
number of women delivering samples was lower. The women who did not 
participate in the telephone interview tended to be younger, more often nulliparous 
and to have lower educational level, but the use of iodine-containing supplements in 
pregnancy was similar to the women included. Compared with women who 
participated in the telephone interview only, the women who participated in the 
interview and delivered samples tended to be older with higher educational level, 
but the frequency of iodine supplement use was similar. Since our postpartum 
investigation was a follow-up study of the pregnancy cohort, women with other 
ethnicity than Danish were underrepresented, and the investigation was regional 
implying that results may not be generalized to other regions of Denmark.   
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5.5. CHALLENGES IN EVALUATION OF IODINE STATUS 
DURING BREASTFEEDING (PAPER 4) 
The second part of the fourth paper in the PhD thesis addressed challenges in the 
evaluation of iodine status during breastfeeding. As in pregnancy, certain aspects 
characterize studies of breastfeeding women which may challenge the interpretation 
of the results. One way to evaluate iodine status of newborns is to collect spot urine 
samples. It is, however, often difficult to obtain such urine samples from the 
newborns, and it has been considered whether maternal UIC could be used as a 
proxy for iodine supply to breastfed infants. But results have been inconclusive, and 
we speculated how maternal fluid intake would influence maternal UIC and MIC. 
5.5.1. STUDY OBJECTIVE 
The main study of iodine status in Danish breastfeeding women was performed in a 
routine manner to strengthen the comparability with other studies. In the present 
study, we aimed to investigate if results of such evaluation would be different if 
time of most recent iodine supplement intake prior to breast milk sampling and 
details on breast milk sampling were considered. We also evaluated how maternal 
fluid intake would influence maternal UIC and MIC as part of assessing whether 
iodine supply to exclusively breastfed infants can be evaluated from maternal UIC.   
5.5.2. STUDY DESIGN 
The study was part of the investigation of iodine status in Danish breastfeeding 
women. The 127 women who delivered a spot urine and a breast milk sample were 
asked to note detailed information on time of most recent iodine supplement intake 
prior to sampling and details about breast milk sampling (one or both breasts, 
before or after breastfeeding). A small group of women (n=13) was instructed to 
sample breast milk both before and after breastfeeding the child. Urinary creatinine 
concentration was measured and used as a proxy for maternal fluid intake.  
5.5.3. STUDY RESULTS 
The time span from most recent iodine supplement intake to breast milk sampling 
influenced MIC in a dose-dependent trend with the highest median MIC when 
iodine supplement intake was the same day prior to sampling. On the other hand, no 
significant trend in median UIC was observed (p=0.072). For the sampling of breast 
milk in relation to breastfeeding of the child, results were not consistent. In 
independent group-wise comparison, no difference in MIC was observed between 
sampling from one versus both breasts and between sampling before versus after 
breastfeeding. On the other hand, individual comparison of MIC in the subgroup of 
women who sampled breast milk both before and after breastfeeding suggested that 
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MIC was slightly higher in samples made before breastfeeding of the child. A 
strong correlation was observed between maternal UIC and urinary creatinine 
concentration, whereas maternal urinary creatinine concentration did not correlate 
with MIC. When urinary creatinine concentration was used to estimate 24-hour 
urinary iodine excretion, the correlation between maternal urinary iodine excretion 
and breast milk iodine excretion was stronger.  
 
5.5.4. STUDY DISCUSSION 
Results of the present investigation suggested that 40-45% of maternal ingested 
iodine is excreted into breast milk based on the mean ratio between 24-hour breast 
milk iodine excretion and maternal 24-hour urinary iodine excretion (Fig. 5-1). The 
transport of iodide into breast milk is mediated by NIS [23], and no autoregulation 
seems to take place. In smoking mothers, MIC was considerably lower than in non-
smoking mothers compatible with thiocyanate mediated inhibition of NIS [19], and 
in a study from Korea where it is common to serve seaweed soup to new mothers, 
the iodine content of colostrum (2-5 days postpartum) was high [176].   
We observed that breast milk iodine content was influenced by time of most recent 
iodine supplement intake with the highest median value when iodine supplement 
intake was the same day prior to sampling. In the group of women with iodine 
supplement intake the same day, the time span from iodine supplement intake to 
sampling ranged from 0.25 to 13 hours with a median of 3 hours, but no correlation 
between the time span in hours and MIC was observed. In a study by Leung et al. 
[41], acute intake of a high dose of iodine was associated with a rapid increase in 
MIC with peak within 6 hours. The observation period was 8 hours, and UIC 
remained stable during the period, in line with our finding that median MIC, but not 
maternal UIC was influenced by time of most recent iodine supplement intake prior 
to sampling. The groups were relatively small in our stratified analyses, and further 
studies are needed to corroborate results, but the findings encourage that details on 
iodine supplement intake during breastfeeding are collected and reported.   
MIC varies within and among individuals [177] and it can be speculated if the time 
of sampling in relation to breastfeeding of the child could influence results. This 
aspect has previously been ascertained in studies of eight [178] and 30 [179] 
breastfeeding women  in which no difference in iodine content of breast milk was 
observed before/after breastfeeding and sequentially during breastfeeding. 
However, data are limited, and our results were not conclusive (inter- versus 
intraindividual comparison). More data are needed considering the method of breast 
milk sampling for determination of iodine content.  
A sufficient number of breast milk samples is often difficult to obtain, and it may be 
even more difficult to obtain a urine sample from the newborn for determination of 
UIC. Therefore, it has been discussed if maternal UIC can be used as a proxy for 
iodine supply to the breastfed infant, but reports are few and not consistent (Table 
5-5). Our findings are in line with the study from Australia by Chan et al. [42] in 
which no correlation was observed between MIC and UIC, but a significant 
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correlation to MIC was observed when UIC was adjusted by the urinary creatinine 
concentration. Creatinine is excreted in the urine at a relatively constant rate, and 
urinary creatinine concentration can be used as a proxy for maternal fluid intake 
[44]. We observed a strong correlation between maternal urinary creatinine 
concentration and UIC. On the other hand, no correlation was observed between 
urinary creatinine concentration and MIC suggesting that maternal fluid intake does 
not influence MIC. The relationship between breast milk and fluid intake has 
mainly been ascertained to evaluate if an increase in fluid intake increases breast 
milk production which studies did not suggest [180,181].  
First author Country Year n r p 
Correlation with urinary iodine concentration  
Ordookhani [182] Iran 2007 42 0.43 0.004 
Bazrafshan [183] Iran  2005 100 0.44  < 0.001 
Chan [42] Australia 2003 49 0.19  0.2 
Correlation with urinary iodine/creatinine ratio  
Chan [42] Australia 2003 49 0.52  < 0.001 
Johnson [173] New Zealand 1990 93 0.44  < 0.01 
  
Table 5-5. Previous studies reporting correlation between breast milk iodine concentration 
and maternal urinary iodine concentration or maternal urinary iodine/creatinine ratio.  
 
We used urinary creatinine concentration to estimate 24-hour iodine excretion. 
Following this, the correlation with breast milk iodine content was stronger than for 
UIC alone. Hydration status can be a confounder when looking at UIC alone [165], 
and our results suggest that maternal estimated 24-hour iodine excretion could be a 
better proxy for iodine supply to the breastfed infant than UIC. It should be stressed 
that the calculation of estimated 24-hour iodine excretion is based upon 
assumptions, and the golden standard is to measure iodine excretion in a full 24-
hour urine collection. This is, however, often not possible in a population study. We 
used the mean urinary creatinine excretion previously measured in a small group of 
Danish pregnant women (mean 1.09 g/24-hours) [13] to estimate 24-hour iodine 
excretion during breastfeeding. However, when we looked into the urinary iodine 
excretion measured in a Belgian population study [167] for women age 25-34 years, 
it was very similar to the one applied (1.22 g/24 hours) and from a study in New 
Zealand of selenium status during pregnancy and lactation, 24-hour urinary 
creatinine excretion could be estimated and was not significantly different between 
pregnancy and the postpartum period [184]. Correlation analysis is a useful method 
to examine the relationship between two continuous variables, but it should be 
noted that the correlation coefficient measures the extent of a linear relationship and 
that it can be influenced by outliers in the data. 
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CHAPTER 6. PERSPECTIVES  
Iodine is an essential micronutrient for human health. The crucial role of thyroid 
hormones in early brain development emphasizes the importance of adequate iodine 
intake in pregnant and breastfeeding women to cover the need of the developing 
fetus and the breastfed infant. Meanwhile, pregnant and breastfeeding women 
constitute population subgroups that are vulnerable to iodine deficiency, and both 
iodine deficiency and iodine excess may interfere with the function of the thyroid 
gland. Adequate iodine intake in a population relies on a valid assessment of iodine 
status and efforts to ensure sufficient iodine intake e.g. programs of universal salt 
iodization and/or individual iodine supplementation.  
6.1. NATIONAL PERSPECTIVE 
The Danish mandatory iodine fortification of salt was introduced in the year 2000 
and urinary iodine status in the Danish population had improved when evaluated in 
2004-2005 (median UIC 101 µg/l) [9]. However, a small decrease was observed in 
the most recent investigation in 2008-2010 (median UIC 83 µg/l) suggesting that 
the current level of iodine fortification of salt in Denmark is not sufficient [20].  
Our regional investigation of pregnant and breastfeeding Danish women supports a 
need for a modest increase in iodine added to salt in Denmark as both iodine 
supplement users and non-users had median UIC below the level recommended. 
Median UIC was higher in pregnant and breastfeeding women with a use of iodine-
containing supplements, and the use of iodine-containing supplements should be 
officially recommended to pregnant and breastfeeding women in Denmark.  
Our investigation was regional and to increase the external validity, data are now 
being collected from Danish pregnant women living in East Denmark. Our results 
were limited by sample size in some of the stratified analyses, and the larger 
combined study population will make it possible to explore predictors of iodine 
supplement intake and urinary iodine status in more detail and to analyze the 
dietary data. The supplementary data collection in East Denmark also aims to 
include a larger number of women of different ethnic origin. 
One reason to be cautious about the level of iodine fortification is the risk of excess 
iodine intake in children. The number of children in our study was limited, and a 
Danish schoolchildren survey is needed. Such data would also add to the discussion 
on whether iodine status in non-pregnant subgroups can be used to evaluate iodine 
status in pregnant women. Another way to explore this in more details would be to 
compare the pregnant women randomly included in the Danish population studies 
(DanThyr) with non-pregnant women in the same age and region [10].        
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6.2. INTERNATIONAL PERSPECTIVE 
Besides human efforts to ensure adequate iodine intake, endogenous mechanism are 
involved in iodine metabolism. In the thyroid gland, NIS mediated iodide transport 
is autoregulated to keep iodine uptake sufficient for thyroid hormone synthesis, and 
studies in rats, in vitro and our clinical data suggest that similar autoregulation may 
take place in the placenta. Such mechanism seems biologically plausible to protect 
the fetus from iodine deficiency during the period of early brain development, but 
further studies are needed to investigate details on the regulation of placental iodide 
transport and to clarify the exact role of NIS and possibly other iodide transporters. 
A valid assessment of iodine status precedes human efforts to ensure adequate 
iodine intake and is also imperative in studies which aim to look at the long-term 
consequences of iodine deficiency in pregnancy for neurocognitive development of 
the child. Although the results of our pilot investigation are not conclusive, they 
pose a number of challenges in the evaluation of urinary iodine status in pregnant 
and breastfeeding women and encourage further studies to report and consider 
methodological details.  
The adverse consequences of severe iodine deficiency during pregnancy and 
breastfeeding are well-established, and in such regions iodine supplementation is 
indisputable. The worldwide efforts primarily through implementation of programs 
of universal salt iodization have considerably decreased the prevalence of iodine 
deficiency and eradicated severe iodine deficiency. Thus, the dilemma in many 
populations today is whether iodine supplementation during pregnancy and 
breastfeeding is beneficial in mild-moderate iodine deficiency, and which quantity 
of iodine the supplement should contain to avoid excess iodine intake. One of the 
concerns is that iodine supplementation in pregnancy may aggravate thyroid 
autoimmunity, but no increased risk of PPTD was observed in a Danish randomized 
study [18]. Randomized studies showing positive effects of iodine supplementation 
to pregnant women with mild to moderate iodine deficiency on child development 
are lacking. It has been proposed that randomized controlled trials of iodine 
supplementation should be performed [185]. However, others have argued that such 
studies would be unethical because iodine supplementation is often recommended 
by authorities [40]. For iodine supplementation after birth of the child, the transport 
of iodine via breast milk is significant, and maternal iodine supplementation is 
preferable when breastfeeding is possible as this will benefit both the mother and 
the child [170,186].  
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Appendix A. Questionnaire for 
pregnant women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Undersøgelse af jodindtag blandt gravide  
Spørgeskema gravide 
 
I det følgende vil vi stille dig en række spørgsmål af betydning for jodindtaget. 
Alle besvarede spørgsmål vil blive behandlet fortroligt ifølge reglerne om tavshedspligt for hospitalsansatte.  
De fleste spørgsmål besvares ved at sætte en cirkel om tallet ud for den svar mulighed, du selv synes er den 
mest rigtige. Enkelte spørgsmål besvares med ord eller tal på de markerede linjer. 
 
Obs! Der er spørgsmål på begge sider. 
 
A. Indledende oplysninger om dig 
 
1. Din fødselsdato ____________________________ 
 
2. Din højde _______________ cm   
 
3. Din aktuelle vægt _________ kg 
 
B. De følgende spørgsmål omhandler sociale forhold 
 
1. Hvor bor du? _______________________(postnummer, by) 
 
 
Har du altid boet i Jylland? 1. ja 2. nej 
 
Hvis nej, hvor mange år har du boet i Jylland _________ år 
 
Hvor boede du før ______________________________________________________ 
  
2. Hvor mange personer bor der i din husstand inkl. dig selv ____________ (antal) 
 
Antal husstandsmedlemmer < 15 år _________ 15-18 år ________ > 18 år _________  
 
3. Bor du sammen med en anden voksen?  1. bor med ægtefælle/samlever 
        2. bor alene 
 3. andet __________________ 
  
4. Hvad er din etniske baggrund?  1. dansk  
2. anden etnisk baggrund end dansk,  
angiv hvilken _________________ 
 
5.  Er du født i Danmark?    1. ja 2. nej 
 
Hvis nej, hvor er du født ___________________________  
 
Hvor mange år har du boet i Danmark _______________år 
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C. De følgende spørgsmål omhandler graviditet og fødsel 
 
 
1. Har du tidligere været gravid?   1. ja 2. nej 
 Hvis ja, hvor mange gange tidligere?   ___________ gange  
 Alder ved første graviditet   ___________ år 
 
2. Har du tidligere født?    1. ja 2. nej 
 Hvis ja, hvor mange gange?   ___________ gange  
 Alder ved første barns fødsel   ___________ år 
 
D. De følgende spørgsmål omhandler sygdomme i skjoldbruskkirtlen 
 
 
1. Har din læge nogensinde fortalt dig, at du havde: 
 for lavt stofskifte    1. ja 2. nej 
 for højt stofskifte    1. ja 2. nej  
 struma (forstørret skjoldbruskkirtel)   1. ja 2. nej 
 knude i skjoldbruskkirtlen   1. ja 2. nej 
 
2. Har du nogensinde været i behandling for: 
 for lavt stofskifte   1. ja, nu 2. ja, tidligere             3. nej, aldrig 
 for højt stofskifte   1. ja nu 2. ja, tidligere             3. nej, aldrig  
 Hvis ja, skriv hvilken behandling og hvornår _______________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 
 
E. De følgende spørgsmål omhandler tobak 
 
 
1. Ryger du?    1. ja, dagligt – gå videre til spørgsmål 3 
   2. ja, lejlighedsvist (mindre end en cigaret, cerut, 
cigar eller et pibestop dagligt) 
     3. nej  
  
Hvis du ikke ryger nu, har du røget tidligere? 1. ja, dagligt 
2. ja, lejlighedsvist (mindre end en cigaret, cerut, 
cigar eller et pibestop dagligt) 
     3. nej – fortsæt til spørgsmål 6 
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Hvilket år holdt du op med at ryge?   __________ (årstal) 
Hvis rygeophør inden for det seneste år, hvilken måned? __________ (måned) 
 
2. Hvis du kun ryger/har røget lejlighedsvis, hvor ofte ryger/røg du? _____ dage ugentligt 
 
3. Hvor meget ryger du i gennemsnit?   _____ cigaretter dagligt 
Skriv gerne flere steder.    _____ cerutter dagligt 
      _____ cigarer dagligt 
      _____ gram pibetobak ugentligt 
 
4. Hvor gammel var du, da du begyndte at ryge dagligt?  _____ år 
5. Hvor mange år har du røget regelmæssigt?  _____ år 
 
6. Hvor mange timer om dagen plejer du at opholde  1. mere end 5 timer om dagen 
dig i et rum, hvor der bliver røget?   2. 1 til 5 timer om dagen 
      3. ½ til 1 time om dagen 
      4. stort set aldrig 
 
F. De følgende spørgsmål omhandler arbejds- og uddannelsesforhold 
 
 
1. Hvilken erhvervstilknytning har du?  1. er i erhverv 
     2. har været i erhverv 
     3. har aldrig været i erhverv 
 
2. Hvad er din hovedbeskæftigelse for tiden? 1. selvstændig 
     2. medhjælpende ægtefælle 
     3. lønmodtager 
     4. studerende/elev/lærling 
     5. på bistandshjælp, kontanthjælp 
     6. førtidspensionist 
     7. hjemmegående husmor 
     8. arbejdsløs på arbejdsløshedsdagpenge 
     9. på sygedagpenge 
     10. andet _____________________________ 
 
3. Hvad er din stillingsbetegnelse ________________________________________________________ 
 
4.  Hvor mange år har du gået i skole? 1. Folkeskole eller tilsvarende (7-10 års skolegang)  
 2. Gymnasial uddannelse: gymnasium, HF og lignende  
 (10-12 års skolegang) 
4 
 
5.  Har du eller er du i gang med en erhvervs- eller videregående uddannelse? 1. ja, har gennemført 
   2. ja, er i gang med en 
   3. nej 
 
Hvis ja, hvilken af følgende uddannelser? 1. Erhvervsfaglig uddannelse  
   2. Kort videregående uddannelse (1-2 år) 
   3. Mellemlang videregående uddannelse (3-4 år) 
   4. Lang videregående uddannelse (5 år el. mere) 
   5. Anden uddannelse __________________________ 
 
G. De følgende spørgsmål omhandler kostvaner 
 
1. Er du vegetar?   1. ja 2. nej 
 
2. Har du ændret kostvaner under  
din nuværende graviditet?  1. nej 2. ja, lidt 3. ja, meget 
 
Hvis du har ændret kostvaner, har du ændret kostens indhold af: 
fedt     1. samme 2. mere 3. mindre 
fisk     1. samme 2. mere 3. mindre 
fedtstof på brød   1. samme 2. mere 3. mindre 
fedtfattige produkter   1. samme 2. mere 3. mindre 
kød     1. samme 2. mere 3. mindre 
 mælkeprodukter   1. samme 2. mere 3. mindre 
 grøntsager    1. samme 2. mere 3. mindre 
frugt     1. samme 2. mere 3. mindre 
brød     1. samme 2. mere 3. mindre 
salt     1. samme 2. mere 3. mindre 
 
3. Bruger du normalt salt ved madlavning? 1. ja 2. nej 
Hvis ja, hvor meget:   1. meget 2. moderat 3. lidt 
 Salter du normalt maden ved bordet?  1. ja 2. nej 
Hvis ja, hvor meget salter du:  1. meget 2. moderat 3. lidt 
 
4. Hvilken slags salt har I for tiden i hjemmet: 
Almindeligt bordsalt   1. ja 2. nej 
Specialsalt (fx Middelhavssalt eller Læsø salt) 1. ja 2. nej 
Hvis ja, skriv hvilken specialsalt:  _______________________________ 
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5. Hvor ofte spiser du brød?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du spiser brød hver dag, er det da  1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
6. Bager du selv dit brød?  1. altid 2. ofte 3. sjældent        4. aldrig 
Køber du brød hos bageren? 1. altid 2. ofte 3. sjældent        4. aldrig 
Køber du brød i supermarked el. lign.?  1. altid 2. ofte 3. sjældent        4. aldrig 
Får du brød andre steder fra?  
Skriv hvor _____________________________________________________________________ 
 
7. Hvor ofte spiser du fisk?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du spiser fisk hver dag, er det da  1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
8. Hvor ofte spiser du ost?   1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du spiser ost hver dag, er det da  1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
9. Hvor ofte indtager du mælkeprodukter? 1. Aldrig eller sjældent 
(mælk, yoghurt etc.)   2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du indtager mælkeprodukter hver dag, er det da 1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
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10. Køber du overvejende økologisk mælkeprodukter? 1. ja 2. nej 
   
H. Medicin, kosttilskud, vitaminer m.m. 
 
1. Skriv venligst her, hvad du får af medicin ____________________________________ 
(præparatnavn, dosis)   ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    
2. Skriv venligst her, hvad du tager af kosttilskud,   _____________________________________ 
vitaminer og lign. (præparatnavn, dosis) _____________________________________ 
    _____________________________________
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
 
3. Hvis du tager kosttilskud, vitaminer og lign. 
tog du også disse før din nuværende graviditet? 1. ja, alle 2. ja, nogle 3. nej, ingen 
 
4. Hvis du ikke tog alle kosttilskud, vitaminer og lign.  ______________________________________ 
før din nuværende graviditet, skriv venligst hvilke  ______________________________________ 
du er begyndt med i forbindelse med graviditeten  ______________________________________ 
og ca. hvornår i graviditeten, du begyndte at tage  ______________________________________ 
disse kosttilskud   ______________________________________ 
    ______________________________________ 
 
Ved behov for supplerende oplysninger, skriv gerne 
 
Tlf.: _______________________________________ 
 
E-mail: _____________________________________ 
 
Tak for hjælpen! 
 
Medbring venligst spørgeskemaet samt evt. medicin, kosttilskud, vitaminer og lign. til undersøgelsen. 
 
 
Appendix B. Questionnaire for 
household members ≥15 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Undersøgelse af jodindtag blandt gravide og deres husstand 
Spørgeskema husstand (≥15 år) 
 
 
I det følgende vil vi stille dig en række spørgsmål af betydning for jodindtaget. 
 
Alle besvarede spørgsmål vil blive behandlet fortroligt ifølge reglerne om tavshedspligt for hospitalsansatte. 
 
De fleste spørgsmål besvares ved at sætte en cirkel om tallet ud for den svar mulighed, du selv synes er den 
mest rigtige. Enkelte spørgsmål besvares med ord eller tal på de markerede linjer. 
 
Obs! Der er spørgsmål på begge sider. 
_______________________________________________________________________________________ 
 
A. Indledende oplysninger om dig 
 
1. Din fødselsdato ____________________________ 
 
2. Din højde _______________ cm   
 
3. Din aktuelle vægt _________ kg 
 
4. Køn: 1. Kvinde 2. Mand 
 
 
B. De følgende spørgsmål omhandler sociale forhold 
 
1.  Har du altid boet i Jylland? 1. ja 2. nej 
 
Hvis nej, hvor mange år har du boet i Jylland _________ år 
 
Hvor boede du før ________________________________________________________ 
  
2. Hvad er din etniske baggrund?  1. dansk  
2. anden etnisk baggrund end dansk,  
angiv hvilken _________________ 
 
3. Er du født i Danmark?    1. ja 2. nej 
 
Hvis nej, hvor er du født ___________________________  
 
Hvor mange år har du boet i Danmark _______________år 
 
C. De følgende spørgsmål omhandler sygdomme i skjoldbruskkirtlen 
 
 
1. Har din læge nogensinde fortalt dig, at du havde: 
 for lavt stofskifte    1. ja 2. nej 
 for højt stofskifte    1. ja 2. nej  
 struma (forstørret skjoldbruskkirtel)   1. ja 2. nej 
 knude i skjoldbruskkirtlen   1. ja 2. nej 
 2 
2. Har du nogensinde været i behandling for: 
 for lavt stofskifte   1. ja, nu 2. ja, tidligere             3. nej, aldrig 
 for højt stofskifte   1. ja nu 2. ja, tidligere             3. nej, aldrig  
 
 Hvis ja, skriv hvilken behandling og hvornår _______________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 
D. De følgende spørgsmål omhandler tobak 
 
1. Ryger du?    1. ja, dagligt – gå videre til spørgsmål 3 
   2. ja, lejlighedsvist (mindre end en cigaret, cerut, 
cigar eller et pibestop dagligt) 
     3. nej  
  
Hvis du ikke ryger nu, har du røget tidligere? 1. ja, dagligt 
2. ja, lejlighedsvist (mindre end en cigaret, cerut, 
cigar eller et pibestop dagligt) 
     3. nej – fortsæt til spørgsmål 6 
 
Hvilket år holdt du op med at ryge?   __________ (årstal) 
Hvis rygeophør inden for det seneste år, hvilken måned? __________ (måned) 
 
2. Hvis du kun ryger/har røget lejlighedsvis, hvor ofte ryger/røg du? _____ dage ugentligt 
 
3. Hvor meget ryger du i gennemsnit?   _____ cigaretter dagligt 
Skriv gerne flere steder.    _____ cerutter dagligt 
      _____ cigarer dagligt 
      _____ gram pibetobak ugentligt 
 
4. Hvor gammel var du, da du begyndte at ryge dagligt?  _____ år 
5. Hvor mange år har du røget regelmæssigt?  _____ år 
 
6. Hvor mange timer om dagen plejer du at opholde  1. mere end 5 timer om dagen 
dig i et rum, hvor der bliver røget?   2. 1 til 5 timer om dagen 
      3. ½ til 1 time om dagen 
      4. stort set aldrig 
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E. De følgende spørgsmål omhandler arbejds- og uddannelsesforhold 
 
1. Hvilken erhvervstilknytning har du?  1. er i erhverv 
     2. har været i erhverv 
     3. har aldrig været i erhverv 
 
2. Hvad er din hovedbeskæftigelse for tiden? 1. selvstændig 
     2. medhjælpende ægtefælle 
     3. lønmodtager 
     4. studerende/elev/lærling 
     5. på bistandshjælp, kontanthjælp 
     6. førtidspensionist 
     7. hjemmegående husmor/husfar 
     8. arbejdsløs på arbejdsløshedsdagpenge 
     9. på sygedagpenge 
     10. andet _______________________________ 
 
3. Hvad er din stillingsbetegnelse __________________________________________________________ 
 
4.  Hvor mange år har du gået i skole? 1. Folkeskole eller tilsvarende (7-10 års skolegang)  
 2. Gymnasial uddannelse: gymnasium, HF og lignende  
 (10-12 års skolegang) 
 
5.  Har du eller er du i gang med en erhvervs- eller videregående uddannelse? 1. ja, har gennemført 
   2. ja, er i gang med en 
   3. nej 
 
Hvis ja, hvilken af følgende uddannelser? 1. Erhvervsfaglig uddannelse  
   2. Kort videregående uddannelse (1-2 år) 
   3. Mellemlang videregående uddannelse (3-4 år) 
   4. Lang videregående uddannelse (5 år el. mere) 
   5. Anden uddannelse __________________________ 
 
F. De følgende spørgsmål omfatter kostvaner 
 
1. Er du vegetar?   1. ja 2. nej 
 
2. Bruger du normalt salt ved madlavning ? 1. ja 2. nej 
Hvis ja, hvor meget:   1. meget 2. moderat 3. lidt 
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3. Salter du normalt maden ved bordet?  1. ja 2. nej 
Hvis ja, hvor meget salter du:  1. meget 2. moderat 3. lidt 
 
4. Hvilken slags salt har I for tiden i hjemmet: 
Almindeligt bordsalt   1. ja 2. nej 
Specialsalt (fx Middelhavssalt eller Læsø salt) 1. ja 2. nej 
Hvis ja, skriv hvilken specialsalt:  _______________________________ 
         
5. Hvor ofte spiser du brød?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du spiser brød hver dag, er det da  1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
6. Bager du selv dit brød?  1. altid 2. ofte 3. sjældent        4. aldrig 
Køber du brød hos bageren? 1. altid 2. ofte 3. sjældent        4. aldrig 
Køber du brød i supermarked el. lign.?  1. altid 2. ofte 3. sjældent        4. aldrig 
Får du brød andre steder fra?  
Skriv hvor _____________________________________________________________________ 
 
7. Hvor ofte spiser du fisk? 1. Aldrig eller sjældent 
    2. 1-3 gange om måneden 
    3. 1-3 gange om ugen 
    4. Hver dag 
 
Hvis du spiser fisk hver dag, er det da 1. 1-2 gange om dagen 
    2. 3 eller flere gange om dagen 
 
8. Hvor ofte spiser du ost?  1. Aldrig eller sjældent 
    2. 1-3 gange om måneden 
    3. 1-3 gange om ugen 
    4. Hver dag 
 
Hvis du spiser ost hver dag, er det da 1. 1-2 gange om dagen 
    2. 3 eller flere gange om dagen 
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9. Hvor ofte indtager du mælkeprodukter? 1. Aldrig eller sjældent 
(mælk, yoghurt etc.)   2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis du indtager mælkeprodukter hver dag, er det da 1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
10. Køber du overvejende økologisk mælkeprodukter? 1. ja 2. nej   
 
G. Medicin, kosttilskud, vitaminer m.m. 
 
1. Skriv venligst her, hvad du får af medicin ____________________________________ 
(præparatnavn, dosis)   ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    
2. Skriv venligst her hvad du tager af kosttilskud,   _____________________________________ 
vitaminer og lign. (præparatnavn, dosis) _____________________________________ 
    _____________________________________
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
 
H. Det følgende spørgsmål skal først besvares når urinprøven er lavet 
 
1. Hvis du tager vitamin/mineral tilskud, hvornår har du sidst taget dette forud for urinprøven?  
1. samme dag  2. dagen før              3. flere dage før 
 
Ved behov for supplerende oplysninger, skriv gerne 
 
Tlf.: ________________________________________________________ 
 
E-mail: ______________________________________________________ 
 
Tak for hjælpen! 
 
 
 
Appendix C. Questionnaire household 
members <15 years 
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Undersøgelse af jodindtag blandt gravide og deres husstand  
Spørgeskema husstand (<15 år) 
 
 
I det følgende vil vi stille en række spørgsmål af betydning for jodindtaget. 
 
Alle besvarede spørgsmål vil blive behandlet fortroligt ifølge reglerne om tavshedspligt for hospitalsansatte. 
 
De fleste spørgsmål besvares ved at sætte en cirkel om tallet ud for den svar mulighed, du selv synes er den 
mest rigtige. Enkelte spørgsmål besvares med ord eller tal på de markerede linjer. 
 
Obs! Der er spørgsmål på begge sider. 
_______________________________________________________________________________________ 
 
A. Indledende oplysninger om barnet 
 
1. Barnets fødselsdato _________________________ 
 
2. Barnets højde _______________ cm   
 
3. Barnets aktuelle vægt _________ kg 
 
4. Køn: 1. Pige 2. Dreng 
 
B. De følgende spørgsmål omhandler sociale forhold 
 
1.  Har barnet altid boet i Jylland? 1. ja 2. nej 
 
Hvis nej, hvor mange år har barnet boet i Jylland ______ år 
 
Hvor boede barnet før ______________________________________________________  
 
2.  Hvad er barnets etniske baggrund?  1. dansk  
2. anden etnisk baggrund end dansk,  
angiv hvilken _________________ 
 
3. Er barnet født i Danmark?  1. ja 2. nej 
 
Hvis nej, hvor er barnet født ___________________________  
 
Hvor mange år har barnet boet i Danmark ______________ år 
 
C. De følgende spørgsmål omhandler sygdomme i skjoldbruskkirtlen 
 
1. Har din læge nogensinde fortalt dig, at barnet havde: 
 for lavt stofskifte    1. ja 2. nej 
 for højt stofskift    1. ja 2. nej  
 struma (forstørret skjoldbruskkirtel)   1. ja 2. nej 
 knude i skjoldbruskkirtlen   1. ja 2. nej 
2 
 
2. Har barnet nogensinde været i behandling for: 
 for lavt stofskifte   1. ja, nu 2. ja, tidligere             3. nej, aldrig 
 for højt stofskifte   1. ja nu 2. ja, tidligere             3. nej, aldrig  
 
 Hvis ja, skriv hvilken behandling og hvornår _______________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 ___________________________________________________________________________________ 
 
D. De følgende spørgsmål omfatter kostvaner 
 
1. Er barnet vegetar?   1. ja 2. nej 
 
2. Salter barnet normalt maden ved bordet? 1. ja 2. nej 
Hvis ja, hvor meget salter barnet:  1. meget 2. moderat 3. lidt 
 
3. Hvor ofte spiser barnet brød?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis barnet spiser brød hver dag, er det da 1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
4. Hvor ofte spiser barnet fisk?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis barnet spiser fisk hver dag, er det da 1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
 
5. Hvor ofte spiser barnet ost?  1. Aldrig eller sjældent 
     2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
 
Hvis barnet spiser ost hver dag, er det da 1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
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6. Hvor ofte indtager barnet mælkeprodukter 1. Aldrig eller sjældent 
(mælk, yoghurt etc.)   2. 1-3 gange om måneden 
     3. 1-3 gange om ugen 
     4. Hver dag 
Hvis barnet indtager mælkeprodukter hver dag,   
er det da    1. 1-2 gange om dagen 
     2. 3 eller flere gange om dagen 
E. Medicin, kosttilskud, vitaminer m.m. 
 
1. Skriv venligst her, hvad barnet får af medicin ____________________________________ 
(præparatnavn, dosis)   ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    ____________________________________ 
    
2. Skriv venligst her hvad barnet tager af kosttilskud,   _____________________________________ 
vitaminer og lign. (præparatnavn, dosis) _____________________________________ 
    _____________________________________
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
    _____________________________________ 
 
F. Det følgende spørgsmål skal først besvares når urinprøven er lavet 
 
1. Hvis barnet tager vitamin/mineral tilskud, hvornår har barnet sidst taget dette forud for urinprøven? 
1. samme dag  2. dagen før              3. flere dage før 
 
Tak for hjælpen! 
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Thyroglobulin in smoking mothers and their newborns at
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Abstract
Background: Placental transport of iodide is required for fetal thyroid hormone production. The sodium
iodide symporter (NIS) mediates active iodide transport into the thyroid and the lactating mammary
gland and is also present in placenta. NIS is competitively inhibited by thiocyanate from maternal
smoking, but compensatory autoregulation of iodide transport differs between organs. The extent of
autoregulation of placental iodide transport remains to be clarified.
Objective: To compare the impact of maternal smoking on thyroglobulin (Tg) levels in maternal serum
at delivery and in cord serum as markers of maternal and fetal iodine deficiency.
Methods: One hundred and forty healthy, pregnant women admitted for delivery and their newborns
were studied before the iodine fortification of salt in Denmark. Cotinine in urine and serum classified
mothers as smokers (nZ50) or nonsmokers (nZ90). The pregnant women reported on intake of
iodine-containing supplements during pregnancy and Tg in maternal serum at delivery and in cord
serum were analyzed.
Results: In a context of mild-to-moderate iodine deficiency, smoking mothers had significantly higher
serum Tg than nonsmoking mothers (mean Tg smokers 40.2 vs nonsmokers 24.4 mg/l, PZ0.004)
and so had their respective newborns (cord Tg 80.2 vs 52.4 mg/l, PZ0.006), but the ratio between Tg
in cord serum and maternal serum was not significantly different in smokers compared with
nonsmokers (smoking 2.06 vs nonsmoking 2.22, PZ0.69).
Conclusion: Maternal smoking increased the degree of iodine deficiency in parallel in the mother and
the fetus, as reflected by increased Tg levels. However, placental iodide transport seemed unaffected
despite high thiocyanate levels, suggesting that thiocyanate-insensitive iodide transporters alternative
to NIS are active or that NIS in the placenta is autoregulated to keep iodide transport unaltered.
European Journal of Endocrinology 168 723–731
Introduction
Thyroid hormones are essential for early growth and
brain development, and iodine is required for thyroid
hormone synthesis (1, 2). In the early weeks of
pregnancy, the developing fetus relies on maternal
thyroid hormones, but endogenous fetal thyroid
hormone production contributes increasingly from the
beginning of the second trimester and is dependent on
placental transport of iodide from the maternal to the
fetal circulation (3).
Placenta contains iodine (4, 5, 6) and evidence
suggests that a number of iodide transporters are
involved in placental iodide transport. Placental tissue
and cell culture studies have demonstrated that the
sodium iodide symporter (NIS) is expressed in different
types of placental cells (7, 8, 9) and a functional role of
NIS in placental iodide transport has been proposed
(10, 11). NIS is a member of the SLC5 family (SLC5A5)
of sodium solute symporters and it is well known that
NIS mediates the active transport of iodide into the
thyroid gland (12). NIS is also expressed in the lactating
mammary gland (13) mediating the active transport of
iodide into breast milk (14) and in some other extra-
thyroidal tissues including the intestine (15, 16).
Another member of the SLC5 family (SLC5A6), the
sodium multivitamin transporter (SMVT), has also
been demonstrated in various tissues including the
intestine (17) and the placenta (18). SMVT shares
high sequence similarity with NIS (12) and has been
demonstrated to mediate iodide transport in SMVT-
expressing oocytes (19).
In addition to SLC5 family transporters, sodium-
independent iodide transporters have also been
European Journal of Endocrinology (2013) 168 723–731 ISSN 0804-4643
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proposed to play a role in placental iodide transport.
Pendrin is a chloride–iodide transporter expressed in the
placenta and in the thyroid gland (7, 20).
One way to study iodide transport in humans is to
observe the effect of a known iodide transport inhibitor,
such as thiocyanate (21). In humans, thiocyanate
(SCNK) stems from various sources, but in many
populations, the most important source is tobacco
smoking. Thiocyanate competitively inhibits NIS-
mediated iodide transport in the thyroid gland; however,
the reduced thyroid iodide uptake is compensated by
iodide autoregulation that tends to keep thyroid
iodide uptake sufficient for thyroid hormone synthesis
(12, 14, 22). On the other hand, the increased thyroid
activity associated with autoregulation leads to
increased serum thyroglobulin (Tg) and increased risk
of goiter in smokers (22, 23).
By contrast, autoregulation of NIS in the lactating
mammary gland seems minimal or absent. Breast milk
iodine content parallels urinary iodine excretion over a
wide range of concentrations (24), and iodine supple-
ments lead to dose-dependent increases in milk iodine
content both in domestic animals (25) and in
breastfeeding women (26). In accordance with this,
we previously showed increased risk of iodine deficiency
in breast-fed newborns of smoking mothers with no
signs of NIS autoregulation in the lactating mammary
gland (14).
The aim of this study was to compare the impact
of maternal smoking on Tg levels in maternal serum
at delivery and in cord serum. We studied a unique
cohort of iodine-deficient pregnant women with a
high frequency of smoking and their newborns. Tg in
maternal serum at delivery and in cord serum was
used as a marker of iodine deficiency (27, 28, 29),
and we examined the impact of thiocyanate from
maternal smoking on the degree of iodine deficiency
in the mother and in the fetus by comparing serum
Tg in smoking and nonsmoking mothers and cord
serum Tg.
Materials and methods
Study design and study population
This is a cross-sectional study carried out from
November 1988 to March 1990 in five different cities
in Denmark (14, 24, 30, 31). As the time of study
enrollment was before the mandatory Danish iodine
fortification of salt introduced in the year 2000 (32), the
population had in general mild (East Denmark) to
moderate (West Denmark) iodine deficiency with the
majority of the women under study living in an area
of moderate iodine deficiency (78.6%). A total of 152
healthy pregnant women with no history of thyroid
disease, no visible goiter, and no recent exposure to
excess iodine and their newborn children were studied.
The pregnant women were consecutively recruited
when admitted for delivery after uncomplicated preg-
nancy in the Departments of Obstetrics in each of the
five cities (Copenhagen, nZ30; Aarhus, nZ30; Ring-
købing, nZ30; Randers nZ29; and Aalborg nZ33).
Six women were subsequently excluded from this study
due to intermittent intake of iodine supplements, and
another six women were excluded due to signs of a
change in smoking status before and after delivery, thus
leaving 140 pregnant women and their 140 newborn
Table 1 Characteristics of the mothers and their newborns.
Iodine supplementsa (nZ47) No iodine supplementsb (nZ93)
All (nZ140)
Smoking
(nZ16)
Nonsmoking
(nZ31) P c
Smoking
(nZ34)
Nonsmoking
(nZ59) Pd
Maternal age
(years)
Mean 27.3 27.4 28.2 0.60e 27.6 26.7 0.32e
S.D. 4.5 4.6 4.7 5.2 4.0
Parity
Median 1 1 1 0.82f 1 1 0.29f
Range 1–5 1–3 1–3 1–4 1–5
Gestational
age (weeks)
Mean 40.0 39.8 40.2 0.44e 40.1 40.0 0.63e
S.D. 1.5 1.9 1.4 1.6 1.4
Birth weight (g)
Mean 3520 3302 3699 0.01e 3367 3574 0.04e
S.D. 473 498 442 461 452
aMaternal daily intake of vitamin/mineral supplements containing iodine.
bNo maternal daily intake of vitamin/mineral supplement containing iodine.
cStatistical comparison of smokers and nonsmokers within the iodine supplement group.
dStatistical comparison of smokers and nonsmokers within the no iodine supplement group.
eIndependent sample t-test.
fMann–Whitney U test.
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children in the final study population. Informed consent
was obtained from each participant and the study was
approved by the Local Ethics Committee.
Data collection
When the pregnant women were admitted for delivery,
detailed information was obtained on intake of iodine-
containing vitamin and mineral supplements and the
women were instructed to continue their previous
vitamin and mineral supplementation during the
puerperal period. All women intended to breastfeed
their newborn child. Blood samples (nZ138) were
taken from the pregnant women by standard puncture
of a cubital vein shortly after admission for delivery.
Closure of the umbilical cord was performed within the
first minute after delivery, and mixed cord blood
(nZ133) was sampled from the placental part shortly
after. After sampling, blood was centrifuged and serum
was stored at K20 8C until analyses. One cord serum
sample had a limited amount of serum, which precluded
some of the analyses.
On day 5 after delivery, a breast milk sample (nZ136)
and a morning spot urine (nZ140) was collected from
the mother and a urine sample was collected in a small
self-adhesive plastic bag (Coloplast baby urine collector;
Coloplast, Espergærde, Denmark) from the newborn
child (nZ135). Urine samples were stored at K20 8C
until analyses.
Laboratory procedures
Classification of smokers was performed by measure-
ments of the nicotine metabolite cotinine in serum
(Immulite 2000 Nicotine Metabolite Assay; analytical
sensitivity 5 mg/l, cutoff to distinguish smokers 25 mg/l)
and urine (double antibody RIA Diagnostic Products
Cooperation; analytical sensitivity 9 mg/l, cutoff to
distinguish smokers 500 mg/l), as described previously
in detail (14). In participants, a clear separation of
smokers (nZ50) and nonsmokers (nZ90) was obtained
both when evaluated by cotinine in maternal serum
when admitted for delivery (median (range) smokers
164 (36–O600) vs nonsmokers !5 (!5–24) mg/l)
and in cord serum at delivery (164 (32–O600) vs !5
(!5–22) mg/l) as well as in urine from the mother on
day 5 postpartum (3480 (537–10 500) vs 53 (10–218)
mg/l). Differences between smokers and nonsmokers
Table 2 Thyroid function parameters and iodine status in mothers and their newborns stratified by maternal smoking status. TSH,
thyroglobulin, urinary iodine, and milk iodine were log transformed for calculation of geometric mean and 95% CI.
Mothers Newborns
All (nZ140)
Smokinga
(nZ50)
Nonsmokinga
(nZ90) Pb All (nZ140)
Smokingc
(nZ50)
Nonsmo-
kingc (nZ90) Pd
TSHe (mU/l)
Mean 2.07 2.05 2.08 0.85 8.07 7.21 8.60 0.12
95% CI 1.89–2.26 1.77–2.37 1.86–2.33 7.25–8.98 6.01–8.64 7.52–9.83
T3
f (nm/l)
Mean 2.39 2.47 2.35 0.16 0.84 0.86 0.84 0.55
95% CI 2.32–2.47 2.34–2.60 2.25–2.45 0.80–0.88 0.79–0.93 0.79–0.88
T4
f (nm/l)
Mean 177 175 178 0.58 162 169 159 0.054
95% CI 176–183 166–184 171–186 157–167 160–177 153–165
Free T4
e (pmol/l)
Mean 8.35 8.01 8.53 0.075 12.27 12.57 12.09 0.16
95% CI 8.07–8.61 7.49–8.54 8.22–8.84 11.94–12.60 11.92–13.24 11.73–12.46
Thyroglobuling (mg/l)
Mean 22.9 30.4 19.5 0.004 50.0 62.9 44.0 0.009
95% CI 19.7–26.5 23.4–39.4 16.4–23.2 43.9–57.0 50.2–78.7 37.6–51.4
Urinary iodineh (mg/l)
Mean 40.6 40.1 40.8 0.88 43.5 33.3 50.4 0.006
95% CI 36.0–45.7 34.1–47.1 34.6–48.1 37.8–50.1 26.8–41.5 42.1–60.3
Milk iodinei (mg/l)
Mean 41.4 26.0 53.8 !0.001 NA NA NA
95% CI 35.8–47.8 20.7–32.6 45.5–63.5
NA, not applicable.
aMothers classified as smokers or nonsmokers from cotinine in serum and urine.
bStatistical comparison of smoking and nonsmoking mothers (independent sample t-test).
cNewborns of smoking and nonsmoking mothers.
dStatistical comparison of newborns of smoking and nonsmoking mothers (independent sample t-test).
eMaternal serum samples (nZ138; smokers nZ49, nonsmokers nZ89). Cord serum samples (nZ133; smoking mother nZ48, nonsmoking mother nZ85).
fMaternal serum samples (nZ138; smokers nZ49, nonsmokers nZ89). Cord serum samples (nZ132; smoking mother nZ47, nonsmoking mother nZ85).
gMaternal serum samples (nZ137; smokers nZ49, nonsmokers nZ88). Cord serum samples (nZ131; smoking mother nZ47, nonsmoking mother nZ84).
hNewborn urine samples (nZ135; smoking mother nZ48, nonsmoking mother nZ87).
iBreast milk samples (nZ136; smokers nZ49, nonsmokers nZ87).
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were substantiated by measurement of thiocyanate in
maternal and cord serum by a manual method (33).
Thiocyanate concentrations were considerably higher
in smokers than in nonsmokers (mean (S.D.), maternal
serum: smokers 84.9 (25.4) vs nonsmokers 54.7
(18.2); cord serum: smoking mother 94.6 (31.9) vs
nonsmoking mother 48.3 (15.5) mmol/l) (14). Iodine in
urine and breast milk was measured by the colorimetric
method of the Sandell–Kolthoff reaction after alkaline
ashing, as described previously (34).
Tg in maternal and cord serum was determined by an
immunoluminometric assay (Behringwerke, Marburg,
Germany; detection limit !1 mg/l), including recovery
measurements. Tg antibodies (Tg-Ab) were measured
by a very sensitive radioimmunoprecipitation assay
(detection limit 20 U/l; Medical Research Council
standard reference code A 65193), as described
previously (31, 35). Tg-Ab was detectable in six
maternal serum samples (4.4%) and 14 cord serum
samples (10.6%). Because Tg-Ab may influence Tg
measurements (36), serum samples with Tg-Ab values
more than 200 U/l (maternal serum nZ1, cord serum
nZ2) were excluded from serum Tg analyses. Tg-Ab
levels up to 200 U/l have previously been shown not to
interfere with serum Tg measurements using this
assay (37), and our results were consistent when
limiting the analyses to samples without detectable
Tg-Ab (data not shown). Thyroid function parameters
were measured in maternal and cord serum: TSH by an
immunoluminometric assay (Berilux, Behringwerke),
total thyroxine (T4) and total tri-iodothyronine (T3) by
an RIA (Farmos, Turko, Finland), and free T4 by a
two-step method (RIA-gnost-FT4, Behringwerke), as
described previously (31).
Statistical analyses
Statistical analyses were performed using the Statisti-
cal Package for the Social Sciences (SPSS Statistics
version 19) and Stata 11 (StataCorp., College Station,
TX, USA). Concentrations of TSH, Tg, breast milk
iodine, and urinary iodine showed log-normal
distribution, and logarithmically transformed concen-
trations or ratios between concentrations were used
for calculating geometric means and making statisti-
cal comparisons. We used independent sample t-test
or Mann–Whitney U test when comparing either
mothers or newborns stratified by maternal smoking
and/or intake of iodine supplements, whereas Tg levels
in mother and child were compared using paired
t-tests. We also evaluated serum Tg in multivariate
linear regression models using logarithmically trans-
formed serum Tg concentrations and the ratio
between cord serum Tg and maternal serum Tg as
dependent variables and maternal smoking, maternal
intake of iodine supplements, and other variables
plausibly related to serum Tg as potential explaining
variables. We considered possible interaction between
maternal smoking and maternal intake of iodine
supplements by including an interaction term
(smoking x iodine supplement intake) in the models.
A 5% level of statistical significance was chosen.
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Figure 1 Thyroglobulin (Tg) concentrations in maternal and cord
serum stratified by maternal smoking status and maternal intake of
iodine supplements (no maternal iodine supplements, Tg maternal
serum smoking 40.2 (95% CI 31.1–52.0) vs nonsmoking 24.4
(19.9–30.0) and cord serum 80.2 (63.0–102.1) vs 52.4 (43.5–63.1)
mg/l; maternal iodine supplements, Tg maternal serum smoking
17.0 (10.1–28.7) vs nonsmoking 12.6 (9.7–16.4) and cord serum
35.4 (24.4–51.4) vs 32.1 (24.8–41.7) mg/l). Log-transformed serum
Tg concentrations were used for calculation of geometric mean and
statistical comparison; P values are results of independent sample
t-test. Bars represent C1 S.E.M.
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Figure 2 Ratio between thyroglobulin (Tg) in cord serum and
maternal serum stratified by maternal smoking status and maternal
intake of iodine supplements (no maternal iodine supplements,
ratio Tg smoking 2.06 (95% CI 1.56–2.71) and nonsmoking 2.22
(1.76–2.80); maternal iodine supplements, ratio Tg smoking 2.26
(1.42–3.59) and nonsmoking 2.48 (1.82–3.40)). Log-transformed
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calculation of geometric mean and statistical comparison; P values
are results of independent sample t-test. Bars represent C1 S.E.M.
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Results
Thyroid function and iodine status in the
mothers and their newborns
Smoking and nonsmoking mothers with and without a
daily intake of iodine-containing supplements had
similar age, parity, and gestational age whereas the
birth weight of the newborns was lower in children born
to smoking mothers (Table 1). The frequency of
maternal smoking in the iodine and no iodine
supplement groups was similar (no iodine supplements,
36.6% smokers; iodine supplements, 34.0% smokers)
and the frequency of intake of iodine supplements in
mothers was independent of maternal smoking status
(smoking mothers, 32.0% iodine supplements; non-
smoking mothers, 34.4% iodine supplements). All
iodine supplements contained 150 mg iodine/day.
Thyroid hormone levels in maternal serum collected
shortly before delivery and in cord serum collected at
delivery showed a similar pattern in smoking and
nonsmoking mothers as well as in their newborns
(Table 2). Urinary iodine was similar in smoking and
nonsmoking mothers (ratio smoking/nonsmoking
0.98, 95% CI 0.76–1.26), whereas in the breast-fed
newborns, urinary iodine was significantly lower in
newborns of smoking mothers (ratio smoking/non-
smoking 0.66, 95% CI 0.50–0.88). In addition, breast
milk iodine was reduced to approximately half in
smokers (ratio smoking/nonsmoking 0.48, 95% CI
0.37–0.64).
Tg in maternal and cord serum
Serum Tg showed different results depending on
maternal intake of iodine supplements and/or maternal
smoking status. Intake of iodine supplements in
mothers was associated with a lower Tg in maternal
serum (14.0 vs 29.3 mg/l if no iodine supplements,
P!0.001) and in cord serum (31.1 vs 61.6 mg/l,
P!0.001). Maternal smoking (Table 2) was associated
with considerably higher Tg in maternal serum (ratio
smoking/nonsmoking 1.56, 95% CI 1.15–2.10) and in
cord serum (ratio smoking/nonsmoking 1.43, 95% CI
1.10–1.86).
However, the impact of maternal smoking on serum
Tg was most striking in the no iodine supplement group
when stratified by both maternal smoking and maternal
intake of iodine supplements (Fig. 1). In the no iodine
supplement group, smoking mothers had higher
serum Tg (ratio smoking/nonsmoking 1.64, 95% CI
1.18–2.29) and cord serum Tg in newborns of smoking
mothers was higher (ratio smoking/nonsmoking 1.53,
95% CI 1.14–2.06). In the group taking iodine
supplements, the difference in serum Tg between
smoking and nonsmoking mothers was statistically
nonsignificant (ratio smoking/nonsmoking 1.35, 95%
CI 0.82–2.23) and cord serum Tg was similar (ratio
smoking/nonsmoking 1.10, 95% CI 0.71–1.72).
In general, Tg was higher in cord serum (mean ratio
cord serum/maternal serum 2.24, 95% CI 1.94–2.58,
P!0.001). To evaluate the degree of iodine deficiency
in smoking mothers and their newborns, we
compared serum Tg ratios, cord serum relative to
maternal serum, in individual pairs of mother and
child (Fig. 2). The ratios were similar in smokers and
nonsmokers independent of maternal intake of iodine
supplements.
The associations between serum Tg in mother and
fetus, maternal intake of iodine supplements, and
maternal smoking status were also studied in multi-
variate linear regression models (Table 3), which
further included maternal age at delivery, gestational
age, parity, and area of living as a proxy variable for
iodine intake (West Denmark with moderate iodine
deficiency vs East Denmark with mild iodine
deficiency). The models corroborated our findings
in the stratified analyses. To evaluate possible
interaction between maternal intake of iodine supple-
ments and maternal smoking, we included an
interaction term (smoking!iodine supplement
intake), which was not statistically significant in
any of the models (PO0.1).
Table 3 Predictors of serum Tg in multivariate linear regression models. Serum Tg and ratio Tg cord/maternal serum were log transformed
before analysis. Results are exponentiated b and 95% CI respectively.
Dependent variables Explanatory variables Multivariatea b (95% CI)
Maternal serum Tg Iodine supplementsb 0.48 (0.36–0.64)
Smokingc 1.52 (1.15–2.00)
Cord serum Tg Iodine supplementsb 0.57 (0.44–0.73)
Smokingc 1.38 (1.08–1.77)
Ratio Tg cord/maternal serum Iodine supplementsb 1.16 (0.85–1.57)
Smokingc 0.93 (0.69–1.26)
Tg, thyroglobulin.
aModels included maternal age (years), gestational age (weeks), parity, and area of living: West Denmark with moderate iodine deficiency (reference) vs East
Denmark with mild iodine deficiency.
bMaternal daily intake of iodine-containing supplements; yes/no (reference).
cMaternal smoking status classified from cotinine in serum and urine; smoker/nonsmoker (reference).
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Discussion
Study rationale and principal findings
Iodide autoregulation of NIS in the thyroid gland is well
known (12), whereas in the lactating mammary gland,
no autoregulation of NIS seems to occur (14). To
evaluate autoregulation of placental iodide transport,
we used Tg in maternal and cord serum at delivery as
markers of iodine deficiency in the mother and the fetus
respectively (27, 28, 29).
Thiocyanate inhibits NIS-mediated iodide transport
in cultured placental cells (11). In contrast to inhibition
of NIS in the thyroid, which affects iodide uptake in both
the maternal and the fetal thyroid, impaired placental
iodide transport would affect the iodide supply to the
fetus exclusively. We assumed that thiocyanate would
inhibit NIS and possibly other transporters involved in
placental iodide transport, and we hypothesized the
following scenarios: if no autoregulation of iodide
transport takes place in the placenta, thiocyanate
from maternal smoking would lead to a particular
worsening of fetal iodine deficiency with a relatively
higher increase in cord serum Tg. On the other hand, if
there is autoregulation of placental iodide transport, we
would observe the same degree of smoking-induced Tg
changes in the mother and the fetus.
Tg was higher in cord serum than in maternal serum,
which is a normal finding not related to iodine
deficiency (38). Tg in maternal and cord serum
increased to a similar degree as indicated by similar
ratios between cord serum and maternal serum Tg in
smoking and nonsmoking mothers and in accordance
with the identical levels of thiocyanate in maternal and
cord serum. Thus, placental iodide transport seemed
unaffected in smoking mothers, suggesting autoregula-
tion of placental iodide transport similar to autoregula-
tion of NIS in the thyroid gland. Thyroid function was
not affected by maternal smoking, neither in the mother
nor in the fetus, but maternal smoking led to high
serum Tg in both, which is consistent with autoregula-
tion of NIS in the thyroid.
On the other hand, the data collected on day 5
postpartum were related to iodide transport in the
lactating mammary gland and not in the placenta. As
previously published (14), breastmilk iodine content and
urinary iodine in the newborns on day 5 postpartumwere
low if the mother was a smoker, corresponding to lack
of NIS autoregulation in the lactating mammary gland.
Previous studies
Studies of placental tissue samples have demonstrated
that placenta contains iodine (4, 5, 6), and in vitro cell
culture studies have suggested a functional role of NIS
(10, 11) and SMVT (19) in placental iodide transport.
In addition, the chloride–iodide transporter pendrin has
been proposed to play a role (11).
Autoregulation of placental NIS in iodine-deficient
rats was found by Schrøder van der Elst et al. (39), and
Li et al. (40) demonstrated in the BeWo (human
trophoblast) cell line that iodide suppressed NIS
expression with a decrease in iodide uptake. They
suggested that iodide inhibition of NIS expression might
be through inhibition of human chorionic gonado-
trophin (hCG) action on NIS expression (40). Thus, our
results are consistent with previous findings of simi-
larities between the iodide autoregulation of NIS in the
thyroid and in the placenta.
Unlike iodide autoregulation, NIS in the placenta and
in the thyroid may be regulated differently by other
mechanisms. For example, TSH enhances NIS
expression in the thyroid (12) whereas hCG enhances
NIS expression in the placenta (10). Also, the paired-box
transcription factor PAX8 may affect thyroidal and
placental NIS differently (41), and recently, a regulatory
role of placental O2 concentrations on NIS expression in
placenta has been investigated (42). In addition, the
functional role of pendrin in iodide transport might
differ between the placenta and the thyroid (7).
Another transporter present in the placenta and
involved in iodide transport is the SMVT. SMVT
mediates the uptake of the micronutrients pantothe-
nate, biotin, and lipoate in placental cells (43), and in
SMVT-expressing oocytes, this transport was inhibited
by iodide (19). Moreover, SMVT-mediated sodium-
dependent iodide transport was demonstrated. Notably,
the transport was insensitive to perchlorate (CIO4
K),
which is a known competitive NIS inhibitor (12), but
the effect of thiocyanate was not investigated (19).
Burns et al. (5, 6) recently reported results indicating
that placenta is not only involved in transport but also
stores iodine and they suggested that this storage may
protect against fetal iodine deficiency. It is unknown
whether maternal smoking affects placental iodine
content.
Strengths and limitations
This study is to our knowledge the first study evaluating
autoregulation of placental iodide transport in a clinical
setting. The number of pregnant women studied in the
stratified analyses was rather low, but at the time of
enrollment, the frequency of smoking among pregnant
women in Denmark was much higher than today (44),
making it very difficult to repeat the study. Also, as the
study was conducted before the mandatory iodine
fortification of salt in Denmark (32), the pregnant
women suffered from mild-to-moderate iodine defici-
ency, which makes iodide transport by NIS or other
placental iodide transporters more sensitive to the
competitive inhibition by thiocyanate.
Thiocyanate crosses placenta as indicated by similar
serum thiocyanate levels in maternal and cord serum
(14). Thus, it seems unlikely that our results would be
explained by lack of thiocyanate access to placental
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iodide transporters. It has been demonstrated that
thiocyanate inhibits NIS-mediated iodide transport in
cultured placental cells (11) and structural similarities
between NIS and SMVT exist (12); however, it cannot
be excluded that placental iodide transport is primarily
mediated by transporters and/or mechanisms not
affected by thiocyanate. On the other hand, in vivo
findings in rats (39) and in vitro findings in placental
cultured cells of iodide-dependent regulation of
NIS expression in the placenta (40) are consistent
with our findings. Further studies are needed to
clarify exact roles of different transporters in placental
iodide transport.
We found higher serum Tg in smoking mothers and
their newborns compared with the nonsmoking groups,
but the effect of smoking was only significant in the
group without maternal intake of iodine supplements.
This observation is consistent with the biochemical
characteristics of competitive inhibition; its effect is
reduced by higher substrate concentration (45), in this
case iodide.
Tg in maternal serum collected at the time of
admission for delivery and in cord serum collected at
delivery was used as a marker of iodine deficiency in
mother and fetus respectively. Serum Tg was previously
shown to be a sensitive marker of iodine deficiency in
the general population (28, 29) and in pregnancy (27).
Tg is a thyroid-specific protein but is also released
from the thyroid gland due to other stimuli than iodine
deficiency. However, none of the participants suffered
from thyroid disease.
Conclusion
In a cohort of iodine-deficient pregnant women,
maternal smoking increased serum Tg in both mother
and fetus as a sign of aggravating iodine deficiency.
However, the degree of iodine deficiency varied in
parallel between smoking mother and fetus with no
signs of a particular worsening in the fetus. The results
therefore suggest autoregulation of placental iodide
transport similar to the thyroid but in contrast to the
lactating mammary gland, which further substantiates
that iodide transporters might display tissue-specific
autoregulation and inhibitory profiles. Moreover, it may
indicate that iodide transporters other than NIS,
insensitive to thiocyanate inhibition, are active in the
human placental iodide transport.
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INTRODUCTION: Maternal iodine requirements increase 
during pregnancy. Studies performed before the introduc­
tion of mandatory iodine fortification of salt in Denmark in 
2000 showed that pregnant women with no intake of iod­
ine­containing supplements were moderately iodine­defi­
cient and showed signs of thyroidal stress. We investigated 
the intake of iodine­containing supplements and urinary 
iod ine excretion in Danish pregnant women after the intro­
duction of iodine fortification of salt.  
MATERIAL AND METHODS: We conducted a cross­sectional 
study between June and August 2012 in an area of Denmark 
where iodine deficiency had previously been moderate. 
Pregnant women coming to Aalborg University Hospital for 
obstetric ultrasound were recruited consecutively. Partici­
pants filled in a questionnaire and handed in a spot urine 
sample for measurement of iodine and creatinine. 
RESULTS: Among the pregnant women included (n = 245), 
84.1% reported an intake of iodine­containing supplements, 
and compared with those not taking iodine supplements 
the median urinary iodine concentration was significantly 
higher in this group: 109  g/l (25th­75th percentile: 66­191 
µg/l). On the other hand, the median urinary iodine concen­
tration was considerably below the recommended level, 
even for the non­pregnant state in pregnant women with 
no iodine supplement intake: 68 µg/l (35­93 µg/l), p < 
0.001.
CONCLUSION: The majority of pregnant women took iodine­
containing supplements, but the subgroup of non­users was 
still iodine­deficient after the introduction of iodine fortifi­
cation of salt. Iodine supplement intake during pregnancy in 
Denmark should be officially recommended.  
FUNDING: The study was supported by a grant from Musik­
forlæggerne Agnes og Knut Mørks Fond and from Special­
læge Heinrich Kopps Legat. 
TRIAL REGISTRATION: not relevant.
Adequate maternal iodine intake is required for thyroid 
hormone synthesis, and thyroid hormones, in turn, are 
essential for foetal growth and development, especially 
for early brain development [1, 2]. Maternal iodine re­
quirements increase during pregnancy [3]. In their 
guidelines, the World Health Organization (WHO), the 
United Nations Children’s Fund (UNICEF) and the Inter­
national Council for the Control of Iodine Deficiency Dis­
orders (ICCIDD) define an adequate intake of iodine dur­
ing pregnancy as 250 µg/day, which corresponds to a 
median urinary iodine concentration of 150­249 µg/l in a 
population of pregnant women [4]. By contrast, a me­
dian urinary iodine concentration in the 100­199 µg/l 
range is considered a sufficient iodine intake in the non­
pregnant state [4]. 
Iodine intake may stem from drinking water and 
from dietary iodine contents, from food fortified with 
iod ine (typically salt), or from intake of iodine­containing 
supplements [5]. Denmark was previously iodine­defi­
cient with regional differences caused by regional vari­
ation in the levels of iodine in the drinking water: moder­
ate iodine deficiency was observed in Western Denmark 
and mild iodine deficiency in Eastern Denmark [6, 7].  
A mandatory iodine fortification of salt was introduced in 
the year 2000 [8], and this programme had increased 
urin ary iodine concentration to the lower threshold of 
the recommended level in the Danish population in 
2004­2005 [9]. On the other hand, a recent study per­
formed in 2008­2010 found that urinary iodine concen­
tration had again decreased in the Danish population 
[10]. 
In studies of Danish pregnant women before the 
year 2000,  pregnant women with no intake of iodine­
containing supplements had a low urinary iodine con­
centration corresponding to moderate iodine deficiency, 
increased thyroid volume and high serum thyroglobulin 
(Tg), and their serum thyroid­stimulating hormone (TSH) 
levels increased during pregnancy [11, 12]. In a study 
conducted in five Danish cities [13], 36% of the pregnant 
women reported an intake of iodine­containing supple­
ments when asked upon arrival for delivery. No previous 
study has specifically addressed the iodine intake and 
the use of iodine supplements during pregnancy in Den­
mark after the introduction of iodine fortification of salt. 
The aim of the present study was to investigate if 
pregnant women living in an area of Denmark with previ­
ously moderate iodine deficiency took iodine­containing 
supplements, to examine predictors of iodine supple­
ment intake and to evaluate iodine intake during preg­
nancy by measurement of urinary iodine concentration. 
maTERial and mEThOds
study population and design
We conducted a cross­sectional study between 13 June 
and 10 August 2012 in an area of Denmark with previ­
ously moderate iodine deficiency [8]. We consecutively 
recruited healthy, pregnant women referred to Aalborg 
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University Hospital for obstetric ultrasound as part of 
the antenatal investigation programme [14]. Two of the 
pregnant women were excluded (Figure 1), because 
they had a diagnosis of hypothyroidism and took levo­
thyroxin replacement therapy at the time of enrollment. 
None of the remaining women had a history of thyroid 
disease verified by a doctor.  
After providing informed consent, participants were 
asked to fill out a questionnaire including obstetric his­
tory, socio­demographics and smoking habits, and to list 
detailed information on any medication and intake of 
vita min and/or mineral supplements. Information about 
dietary supplements was verified by interview; and at 
the time of enrollment, the women were asked to pro­
vide a spot urine sample. The time of sampling was be­
tween 8 am and 1 pm, except for two women who had 
sampled the urine at home the same day prior to inclu­
sion into the study (at 6:00 a.m. and 7:10 a.m., respect­
ively). The study protocol was approved by the local  
ethics committee. 
laboratory procedures
Urine samples were stored at –20 °C until measurement 
of urinary iodine concentration in runs during the time 
of study inclusion. Urinary iodine concentrations (µg/l) 
were determined by the cerium/arsenite method after 
alkaline ashing, as previously described [15]. The analyt­
ical sensitivity was 2 µg/l. The iodine laboratory was cer­
tified by the U.S. Centers for Disease Control and Pre­
vention’s EQUIP Programme. Urinary creatinine 
concentrations (µmol/l) were measured immediately af­
ter urinary sampling on a Cobas 8,000 system. The 
equipment was calibrated according to the manufactur­
er’s instructions, and external standards were included. 
statistical analyses
Characteristics of the pregnant women according to in­
take of iodine containing supplements were compared 
using Fisher’s exact test, and predictors of iodine supple­
ment intake were examined in multivariate logistic re­
gression. Urinary iodine excretion was expressed as spot 
urine concentration (µg iodine/l), iodine/creatinine ratio 
(µg iodine/g creatinine) and estimated 24­h iodine ex­
cretion (µg iodine/24 h) calculated from the mean 24­h 
urinary creatinine excretion (1.09 g creatinine/24 h) pre­
viously measured in Danish pregnant women [11]. Urin­
ary iodine concentrations showed a skewed distribution, 
and the results were expressed as medians with 25th 
and 75th percentiles. Non­parametric tests were used to 
compare urinary iodine excretion stratified by iodine 
supplement intake (Mann­Whitney test) and by gesta­
tional week (Kruskal­Wallis test).  Statistical analyses 
were performed using Stata 11 (StataCorp, College Sta­
tion, TX, USA), and a 5% level of significance was chosen. 
Trial registration: not relevant.
FigURE 2
Overall urinary iodine 
excretion among the 
pregnant women (n = 
238). Horizontal lines 
illustrate median (solid 
line) and interquartile 
range (dashed lines).
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Urinary iodine concentra	ons in range from 460-1000 µg/liter (n=8) 
not illustrated.
Values were stra	fied into 40 bands in the range from 7-440 µg/liter; 
each band corresponding to 10.8 µg/liter.
FigURE 1
Flow chart illustrating the number of pregnant women invited, participating and included in the final 
study population.
a) Urinary samples (n = 238).
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Department
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(n = 245)
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REsUlTs
study population
A total of 245 women were included in the final study 
population (Figure 1), corresponding to 73.8% of the 
women invited to participate upon arrival at the Obstet­
ric Department. The median age at the time of enroll­
ment was 30.5 years (range 18.4­41.2 years), the median 
gestational age was week 20 (range week 10­37), and 
approximately half of the women were expecting their 
first child (Table 1).  
Use of iodine-containing supplements
Nearly all of the pregnant women used dietary supple­
ments (95.9%) at the time of enrollment, and 206 wom­
en (84.1%) reported a regular intake of iodine­contain­
ing supplements, whereas 39 women (15.9%) were 
taking either no vitamin and/or mineral supplements (n 
= 10) or vitamin and/or mineral supplements not con­
taining iodine (n = 29). 
The iodine containing supplements typically con­
tained 175 µg iodine/day (81.1%); less often 150 µg iod­
ine per day (17.0%); and a few women (1.9%) took iod­
ine­containing supplements different from the 
recommended dose (87.5 and 375 µg iodine per day, re­
spectively). The intake of the iodine supplement was of­
ten initiated during pregnancy (75.2%) at median gesta­
tional week 6 (range week 1­32), but some of the 
pregnant women had initiated iodine supplement intake 
in the year preceding the pregnancy (16.5%) at median 
10 weeks before conception (range 2­52 weeks), or 
more than a year before conception (8.3%). Among io­
dine supplement users, 38 women reported intake of 
another iodine­containing supplement before their cur­
rent supplement, and eight of the current non­users had 
stopped iodine supplement intake during the pregnancy 
before study inclusion. 
Predictors of iodine supplement intake
In the univariate analyses, only maternal age significant­
ly differed according to intake of iodine­containing sup­
plements (Table 1). In the multivariate analyses includ­
ing all variables listed in Table 1 as categoricals, lower 
maternal age (≤ 35 years, p = 0.001) and maternal edu­
cation, i.e. qualifying for a profession (vocational or 
higher education versus primary/secondary school only, 
p = 0.039), were significant predictors of maternal intake 
of iodine­containing supplements. On the other hand, 
the total number of years of education did not signifi­
cantly predict iodine supplement intake. 
Urinary iodine excretion
The overall median urinary iodine concentration (Figure 
2) was just within the recommended range for the non­
pregnant state (100­199 µg/l), but below the recom­
mended level during pregnancy (150­249 µg/l). The me­
dian urinary iodine concentration was higher in the 
group of pregnant women reporting an intake of iodine­
TaBlE 1
Characteristics of the pregnant women in the final study population at the time of enrollment and ac­
cording to intake of iodine­containing supplements.
all iodine supplements no iodine supplements
n % n % n % pa
Pregnant women 245 100.0 206 84.1 39 15.9 –
Gestational week  
at enrollment
0.51
10­15  87   35.5   74 35.9 13 33.3
19­21 133   54.3 109 52.9 24 61.6
28­37  25   10.2   23 11.2  2  5.1
Parityb 0.47
1 132   53.9 112 54.4 20 51.3
2  88   35.9   75 36.4 13 33.3
≥ 3  25   10.2   19  9.2  6 15.4
Age, years 0.006
< 25  27   11.0  24 11.7  3  7.7
25­35 180   73.5 157 76.2 23 59.0
> 35  38   15.5  25 12.1 13 33.3
Cohabitation 1.00
Living with partner 233   95.1 196 95.2 37 94.9
Not living with partner  12    4.9  10  4.8  2  5.1
Ethnicity 1.00
Danish 227   92.7 191 92.7 36 92.3
Other than Danish  18    7.3  15  7.3  3  7.7
Educationc 0.26
Basic  23    9.4  16  7.8  7 17.9
Low  64   26.1  56 27.2  8 20.5
Middle  98   40.0  83 40.3 15 38.5
High  60   24.5  51 24.7  9 23.1
Occupation 0.48
Employed 181   73.9 153 74.3 28 71.8
Student  28   11.4  25 12.1  3  7.7
Unemployed/not a student  36   14.7  28 13.6  8 20.5
Pre-pregnancy BMId, kg/m2 0.36
< 25.0 143   59.3 119 58.6 24 63.2
25.0­29.9  59   24.5  53 26.1  6 15.8
≥ 30.0  39   16.2  31 15.3  8 21.0
Smoking 0.92
Current  14    5.7  12  5.8  2  5.1
Previous  82  33.5  70 34.0 12 30.8
Never 149  60.8 124 60.2 25 64.1
Organic milke 0.26
Yes  79  32.2  63 30.6 16 41.0
No 166  67.8 143 69.4 23 59.0
BMI = body mass index.
a) Fisher’s exact test: iodine supplements vs. no iodine supplements. 
b) Previous live births and stillbirths including index pregnancy.
c) Highest educational level achieved or initiated. General education: “basic” (primary/secondary edu­
cation only; 9­13 yrs). General education and education qualifying for a profession: “low” (vocational 
education and training: 9­13 yrs), “middle” (short­ or medium cycle higher education: 14­16 yrs), “high” 
(long-cycle higher education: ≥ 17 yrs). 
d) Missing value on BMI (n = 4) not included, 7 women had a BMI < 18.5 kg/m2 (all iodine supplement 
users). 
e) Do you mainly buy organic milk? (yes/no). Included as an indicator variable for maternal food­buying 
habits.
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containing supplements (Table 2) and below the lower 
recommended level for even the non­pregnant state in 
the group with no iodine supplement intake. The find­
ings were similar when urinary iodine excretion was ex­
pressed as an iodine/creatinine ratio and estimated 24­h 
iodine excretion (Table 2). There was no significant dif­
ference in urinary iodine concentrations among iodine 
supplement users when stratified by gestational age; 
median urinary iodine week 10­15 (n = 73): 107 µg/l 
(25th­75th percentile: 66­197 µg/l), week 19­21 (n = 
103): 102 µg/l (65­170 µg/l), week 28­37 (n = 23): 140 
µg/l (91­252 µg/l), p = 0.06. 
discUssiOn
Principal findings
More than ten years after the introduction of mandatory 
iodine fortification of salt in Denmark, pregnant women 
living in an area previously characterized by moderate 
iodine deficiency had urinary iodine concentrations be­
low the level recommended during pregnancy. As ex­
pected, pregnant women who took iodine­containing 
supplements had a higher median urinary iodine con­
centration than pregnant women with no intake of iod­
ine supplements, and the median urinary iodine concen­
tration was within the recommended level for the 
non­pregnant state in this group. The frequency of iod­
ine supplement intake during pregnancy in Denmark had 
increased steeply compared with a previous study and 
was significantly predicted by maternal age and educa­
tion. However, a subgroup of women still took no iodine 
supplements during pregnancy, and in this group the 
median urinary iodine concentration was considerably 
below the level recommended even for the non­preg­
nant state.  
 
iodine supplement use in danish pregnant women
In a previous study [13] conducted in Denmark before 
the year 2000, nearly all pregnant women reported tak­
ing vitamin and/or mineral supplements (93.4%) when 
asked upon arrival for delivery, but only 36% reported an 
intake of iodine­containing supplements (150 µg iodine/
day). Thus, the frequency of dietary supplement during 
pregnancy before the year 2000 was comparable to that 
observed in our study population (95.9%), but the use of 
iodine­containing supplements had increased consider­
ably. The reasons for this increase are not completely 
clear. There are no current official recommendations on 
the intake of iodine­containing supplements during preg­
nancy in Denmark. Iodine supplement was obtained by 
intake of a multivitamin pill, and official recommenda­
tions on the intake of folic acid, vitamin D and iron during 
pregnancy do exist [14]. Thus, it seems likely that iodine 
supplement intake is incidental to other recommenda­
tions during pregnancy in Denmark. The gestational age 
of the women included in our study ranged 10­37 weeks. 
No previous study specifically addressed the use of iod­
ine supplements in early pregnancy in Denmark. 
Urinary iodine excretion in danish pregnant women
Several of the previous studies on urinary iodine excre­
tion in Danish pregnant women examined pregnant 
women living in Western Denmark, an area where mod­
erate iodine deficiency was previously observed. In the 
studies by Pedersen et al [11, 12], the median urinary 
iod ine concentration was low (approximately 50 and 40 
µg/l in gestational weeks 17 and 37, respectively) and 
serum Tg was high in pregnant women with no intake of 
iodine­containing supplements. Furthermore, thyroid 
volume as well as TSH tended to increase during preg­
nancy. These changes were ameliorated by iodine sup­
plement intake, and urinary iodine increased to 106 µg/l 
in late pregnancy after iodine supplement intake during 
the pregnancy [12], which was also shown in a study by 
Nohr et al [16]. 
TaBlE 2
Urinary iodine concentration, iodine/creatinine ratio and estimated 24­h iodine excretion according to 
maternal intake of iodine­containing supplements. 
iodine supplements no iodine supplements pa
Pregnant women, nb 199 39
Urinary iodine concentration, µg/l,  
median (25th­75th percentile)
109 (66­191) 68 (35­93) < 0.001
Iodine/creatinine ratio, µg/g, median 
(25th­75th percentile)
153 (105­257) 73 (54­100) < 0.001
Estimated 24­h iodine excretion, µg, 
median (25th­75th percentile)c
167 (114­280) 80 (59­109) < 0.001
a) Mann­Whitney test: iodine supplements versus no iodine supplements.
b) Pregnant women with no urinary sample (n = 7) not included.
c) Calculated from 24­h urinary creatinine excretion previously measured in Danish pregnant women: 
1.09 g creatinine/24 h [11]. 
Remember iodine!
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Thus, our results indicate that the median urinary 
iodine concentration has increased in pregnant women 
with no iodine supplement intake, which corresponds to 
the general increase in the median urinary iodine con­
centration after the introduction of iodine fortification 
of salt in Denmark [9]. However, pregnant women with 
no intake of iodine­containing supplements still have 
urinary iodine concentrations substantially below the 
recommended level for pregnancy [4] and even below 
the recommended range for the non­pregnant state [4]. 
In the Danish population, the iodine fortification of 
salt increased urinary iodine to the lower threshold 
within the recommended range, but results from the 
DanThyr study (The Danish investigation on iodine in­
take and thyroid disease) [8] recently showed a modest 
decrease in urinary iodine concentration [10].  The pres­
ent study confirms that the current level of iodization of 
salt in Denmark is insufficient, i.e. that it will not pro­
duce a urinary iodine concentration within the recom­
mended range. 
strengths and limitations
Urinary iodine excretion is a recommended marker of 
recent iodine intake [4], and spot urine samples can be 
used in population studies [17]. The relatively large 
number of pregnant women included in our study in­
creased the precision of the estimated iodine excretion 
[18]. However, the number of pregnant women in the 
stratified analyses was limited in some groups. 
Our study only included women referred to Aalborg 
University Hospital, and we cannot exclude that differ­
ences in the use of dietary supplements during preg­
nancy may exist across Denmark. In a previous study 
performed in five Danish cities, the frequency of iodine 
supplement intake during pregnancy ranged from 21% 
to 50% when stratified by city [13]. The level of iodine in 
drinking water and urinary iodine excretion in the area 
investigated in our study was previously reported to cor­
respond to the level observed in most parts of Western 
Denmark (i.e. west of the Great Belt) [6, 7].   
We consecutively recruited healthy, pregnant  
women and the rate of participation was high. However, 
we cannot exclude some degree of selection bias. 
cOnclUsiOn 
Danish pregnant women living in an area previously 
characterized by moderate iodine deficiency still have 
urinary iodine concentrations below the recommended 
level for the pregnant state after the introduction of the 
mandatory iodine fortification of salt in Denmark. Preg­
nant women with no intake of iodine­containing supple­
ments are at particular risk of insufficient iodine intake. 
Results indicate a need for more attention among 
healthcare professionals to ensure sufficient iodine sta­
tus in Danish pregnant women. Intake of iodine­contain­
ing supplements during pregnancy in Denmark should 
be officially recommended, and our results may indicate 
a need for a modest increase in the level of iodine added 
to salt in Denmark.
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INTRODUKTION
Jod indgår i syntesen af thyroideahormoner, som er 
essentielle udviklingsfaktorer, specielt hvad angår 
hjernens udvikling. Jodbehovet øges under gravidi-
tet, og WHO, UNICEF og ICCIDD definerer et til-
strækkeligt jodindtag ved en medianurinjodkoncen-
tration på 150-249 µg/l i en population af gravide. I 
modsætning hertil vurderes et sufficient jodindtag 
hos ikkegravide at være en medianurinjodkoncentra-
tion på 100-199 µg/l. 
I Danmark var der tidligere jodmangel med regi-
onale forskelle: mild jodmangel i det østlige Danmark 
og moderat jodmangel i det vestlige Danmark. Den 
obligatoriske jodberigelse af salt blev indført i 2000 
og førte til en stigning i medianurinjodkoncentratio-
nen i den danske befolkning målt i 2004-2005, men 
urinjodkoncentrationen var dog i seneste undersø-
gelse fra 2008-2010 igen lidt faldende. 
Tidligere undersøgelser af jodindtag hos gravide 
i Danmark ligger alle før den danske jodberigelse af 
salt. På daværende tidspunkt var det 36% af danske 
gravide, som tog jodholdigt kosttilskud, og gruppen 
af gravide, der ikke tog jodholdigt kosttilskud, havde 
moderat jodmangel og tegn på jodmangelinducerede 
ændringer i glandula thyroideas funktion og struktur 
med høj thyroglobulinkoncentration samt stigende 
koncentration af thyroideastimulerende hormon og 
stigende thyroideavolumen under graviditeten. 
Formålet med vores undersøgelse var at belyse, 
om gravide i Aalborgområdet i dag tager jodholdigt 
kosttilskud, samt at vurdere deres jodindtag ved må-
ling af urinjodkoncentration. 
MATERIALE OG METODER
Vi udførte en tværsnitsundersøgelse ved Aalborg Uni-
versitetshospital fra juni til august 2012 og inklude-
rede gravide, der var henvist til obstetrisk ultralyds-
skanning som led i et normalt svangreforløb. 
Undersøgelsen omfattede besvarelse af et spørge-
skema, og oplysninger om indtag af kosttilskud blev 
verificeret ved et interview på inklusionsdagen, hvor 
også en urinprøve blev afleveret. Urinprøven blev 
analyseret for jod og kreatinin. 
RESULTATER
I alt 245 gravide blev inkluderet i undersøgelsen (gra-
viditetsuge 10-37, medianuge 20). På inklusionstids-
punktet angav 84,1% af de gravide, at de indtog et 
jodholdigt kosttilskud, mens en mindre gruppe ikke 
tog jodholdigt kosttilskud (15,9%). Alder over 35 år 
og lavt uddannelsesniveau prædikterede manglende 
indtag af jodholdigt kosttilskud. 
Medianurinjodkoncentrationen var 101 µg/l 
(25-75-percentiler: 63-167 µg/l) og således under 
det anbefalede niveau for gravide. Urinjodkoncen-
trationen var signifikant højere blandt gravide, som 
tog jodholdigt kosttilskud: median 109 µg/l 
(25-75-percentiler: 66-191 µg/l), og var i denne 
gruppe inden for det anbefalede niveau for ikkegra-
vide. Derimod havde gruppen af gravide uden indtag 
af jodholdigt kosttilskud en medianurinjodkoncentra-
tion, der var væsentligt under det anbefalede niveau 
for ikkegravide: 68 µg/l (25-75-percentiler: 35-93 
µg/l), p < 0,001. 
KONKLUSION
Mange gravide tog jodholdigt kosttilskud, men en un-
dergruppe af gravide gjorde ikke, og denne gruppe 
havde fortsat jodmangel efter den danske jodberi-
gelse af salt. Der er behov for jodholdigt kosttilskud 
under graviditet i Danmark, hvilket officielt bør anbe-
fales, og resultaterne bidrager sammenholdt med den 
seneste befolkningsundersøgelse til overvejelser om, 
hvorvidt jodtilsætningen til salt i Danmark bør øges. 
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 Challenges in the Evaluation of Urinary Iodine 
Status in Pregnancy: The Importance of Iodine 
Supplement Intake and Time of Sampling 
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Margrethe Møller b    Peter Laurberg a, c  
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recent iodine supplement intake prior to sampling [same 
day (n = 79): 150 μg/l (95% CI 131–181 μg/l), the day before 
(n = 51): 105 μg/l (78–131 μg/l), several days ago/non-user
(n = 28): 70 μg/l (56–94 μg/l), p < 0.001]. The pattern was 
similar in the male partners. Apart from a more frequent io-
dine supplement intake in pregnancy (87.3% vs. partners 
15.9%), no systematic differences were observed in urinary 
measurements between the pregnant women and their 
partners.  Conclusions: Time of spot urine sampling and time 
span from iodine supplement intake to spot urine sampling 
should be considered when evaluating urinary iodine status 
in pregnancy.  © 2014 European Thyroid Association
 
Published by S. Karger AG, Basel 
 Introduction 
 Population median urinary iodine concentration 
(UIC) is the recommended method to assess iodine status 
 [1] . UIC in pregnancy is extensively studied and adequate 
maternal iodine intake is of major concern  [2–4] . Guide-
lines recommend the use of spot urine samples and the 
estimation of median UIC in a population of pregnant 
women, and results are compared to the recommended 
 Key Words 
 Urinary iodine concentration · Urinary creatinine 
concentration · 24-Hour urinary iodine excretion · 
Pregnancy · Household · Iodine supplement 
 Abstract 
 Objectives: Median urinary iodine concentration (UIC) is the 
recommended method to evaluate iodine status in pregnan-
cy, but several factors may challenge the interpretation of 
the results. We evaluated UIC in pregnant women according 
to (1) sampling in the hospital versus at home, (2) time of the 
most recent iodine supplement intake prior to sampling, and 
(3) members of their household.  Study Design: Danish cross-
sectional study in the year 2012. Pregnant women (n = 158), 
their male partners (n = 157) and children (n = 51) provided 
a questionnaire with detailed information on iodine supple-
ment intake and a spot urine sample obtained in the hospital 
and/or at home for measurement of UIC and urinary creati-
nine concentration.  Results: In the pregnant women provid-
ing a urine sample both in the hospital and at home (n = 66), 
 individual UIC (p = 0.002) and urinary creatinine concentra-
tion (p = 0.042), but not estimated 24-hour urinary iodine 
excretion (p = 0.79), were higher when sampling was at 
home. Median UIC was dependent on the time of the most 
 Received: May 20, 2014 
 Accepted after revision: June 6, 2014 
 Published online: August 29, 2014 
 Stine Linding Andersen 
 Department of Endocrinology 
 Aalborg University Hospital 
 Sdr. Skovvej 15, DK–9000 Aalborg (Denmark) 
 E-Mail stine.a   @   rn.dk 
 © 2014 European Thyroid Association
Published by S. Karger AG, Basel
2235–0640/14/0033–0179$39.50/0 
 www.karger.com/etj 
D
ow
nl
oa
de
d 
by
: 
Fo
rs
kn
in
ge
ns
 H
us
21
2.
88
.7
7.
68
 - 
10
/2
/2
01
4 
5:
06
:0
8 
P
M
 Andersen  /Sørensen  /Krejbjerg  /Møller  /
Laurberg  
 
Eur Thyroid J 2014;3:179–188
DOI: 10.1159/000365145
180
level during pregnancy (150–249 μg/l) defined by the 
World Health Organization (WHO), the United Nation 
Children’s Fund (UNICEF) and the International Coun-
cil for the Control of Iodine Deficiency Disorders
(ICCIDD)  [1] . Another method to study iodine intake is 
to measure iodine excretion in a full 24-hour urine collec-
tion or to estimate 24-hour iodine excretion based on 
measurement of both iodine and creatinine concentra-
tion in a spot urine sample  [5] .
 Physiological changes occur in both thyroid and renal 
function during pregnancy which may challenge the in-
terpretation of the results  [6] . We previously reported 
that iodine supplement intake in Danish pregnant wom-
en was frequent, but median UIC was low and below the 
level recommended in pregnancy both in iodine supple-
ment users and non-users, and also when UIC was ad-
justed by urinary creatinine to estimate 24-hour urinary 
iodine excretion  [7] .
 In our study  [7] and in the majority of studies evaluat-
ing iodine status in pregnant women, urine samples are 
obtained during a routine antenatal hospital visit. We 
speculated whether urine samples obtained at hospital 
were representative of daily life in pregnant women. Thus, 
we expanded our previous study to include both a urine 
sample obtained during the hospital visit for routine an-
tenatal ultrasound in pregnancy and a urine sample ob-
tained a subsequent day, when the pregnant woman was 
at home.
 It has been reported that the median UIC in family 
members such as schoolchildren are not representative 
for UIC in pregnant women  [8] . We speculated whether 
at least some of this difference might be caused by the 
pregnant women and their family member being investi-
gated under different conditions. To evaluate this hy-
pothesis, we sampled urine for iodine measurements both 
from the pregnant women and from members of their 
household under identical conditions.
 In our previous study  [7] , the majority of pregnant 
women took iodine supplements. Finally, we speculated 
whether the timing of the most recent iodine supplement 
intake prior to spot urine sampling would have an influ-
ence on the UIC obtained and thus the results of iodine 
status evaluation.
 Materials and Methods 
 Study Population and Design 
 The pregnant women enrolled in the present study took part in 
our investigation on iodine intake during pregnancy in an area of 
Denmark with previously moderate iodine deficiency  [7] . From 
June 13 to August 10, 2012, we consecutively recruited healthy, 
pregnant women referred to Aalborg University Hospital for ob-
Pregnant
women
included
(n = 68)
Male
partners
included
(n = 67 )
Children
included
(n = 51)
Pregnant women willing to participate in the obstetric department
(n = 253)
Pregnant women enrolled in the household study
(n = 192)
Participating in the hospital only
(n = 91)
Participating in the hospital and at home
(n = 101)
Households returning urine samples
(n = 71)
Female/male couples
(n = 64)
Female/male couples
(n = 89)
Pregnant
women
included
(n = 90) 
Male
partners
included
(n = 90)
 Fig. 1. Flowchart illustrating the selection 
of participants. Exclusions in the group 
‘participating in the hospital only’ were: no 
urine sample from the pregnant woman
(n = 1) and not a male partner (n = 1). Ex-
clusions in the group ‘participating in the 
hospital and at home’ were: pregnant wom-
an with gastric bypass (n = 1), pregnant 
women with inflammatory bowel disease 
(n = 1), pregnant woman with inconsistent 
information on iodine supplement intake 
between samplings (n = 1), partner did not 
complete the questionnaire (n = 2), and not 
a male partner (n = 2). 
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stetric ultrasound as part of the antenatal investigation program 
( fig. 1 ). After informed consent, the women were asked to fill out 
a questionnaire, to list detailed information on dietary supple-
ments and to deliver a spot urine sample.
 Members of their household were recruited in one of the fol-
lowing ways: (1) the partner filled out a questionnaire and deliv-
ered a spot urine sample in the hospital at the same time as the 
pregnant woman or (2) only the pregnant woman participated in 
the hospital and questionnaires and vials for urine sampling were 
handed out to the pregnant woman and her household members 
for sampling at home ( fig. 1 ). Thus, 66 pregnant women participat-
ing with the household at home delivered a urine sample both at 
the time of inclusion in the hospital and at home (2 women only 
delivered a urine sample at home). Participants were instructed to 
perform non-fasting urine sampling as close in time as possible for 
all household members and to list information on iodine supple-
ment intake including the time of the most recent supplement in-
take prior to urine sampling.
 The study protocol was approved by the local ethical commit-
tee.
 Laboratory Procedures 
 Urine samples were stored at –20  °  C until measurement of UIC 
in runs during the time of study inclusion. UIC was determined by 
the cerium/arsenite method after alkaline ashing, as previously de-
scribed  [9] . The analytical sensitivity was 2 μg/l and the recovery of 
iodine was 95.5% (SEM 2.4%). When a urine sample (UIC 93.9 
μg/l) was measured in triplicates in 18 assays, the intra-assay CV 
was 2.1% and the inter-assay CV was 2.7% for single determination 
 [10] . The iodine laboratory was certified by the US Centers for Dis-
ease Control and Prevention EQUIP program. Urinary creatinine 
concentrations were measured on a Cobas 8000 system (Roche, 
 Table 1.  Characteristics of the pregnant women and their household members at the time of inclusion in the study
Pregnant women Partners Children
(n = 158) (n = 157) (n = 51)
Male gender NA 157 (100.0) 26 (51.0)
Danish ethnicitya 151 (95.6) 149 (94.9) 49 (96.1)
Age, years 30 (19 – 41) 32 (23 – 49) 6 (1 – 14)
Weight, kgb 67 (48 – 114) 85 (56 – 135) 19 (9 – 70)
Height, cmc 169 (151 – 182) 183 (166 – 201) 115 (74 – 169)
BMId 23.4 (17.6 – 41.0) 25.3 (19.2 – 39.9) 15.5 (12.7 – 29.1)
<25  93 (60.0) 70 (45.2) 45 (97.8)
25 – 29.9 36 (23.2) 69 (44.5) 1 (2.2)
≥30 26 (16.8) 16 (10.3) 0 (0)
Smokinge
Current 6 (3.8) 27 (17.3) NA
Previous 52 (32.9) 33 (21.2) NA
Never 100 (63.3) 96 (61.5) NA
Educational levelf
Basic 11 (7.0) 26 (16.6) NA
Low 21 (13.3) 43 (27.4) NA
Middle 81 (51.3) 47 (29.9) NA
High 45 (28.4) 41 (26.1) NA
Supplement not containing iodine 13 (8.2) 15 (9.6) 2 (3.9)
Iodine supplement 138 (87.3) 25 (15.9) 13 (25.5)
175 μg/day 111 0 0
150 μg/day 24 22 0
70 μg/day 0 0 12
Othersg 3 3 1
Values are n, n (%) or median (range).  a Two children had 1 parent of Danish origin and 1 parent of non-Danish 
origin. b Values are pre-pregnancy weight for the pregnant women. Missing values on weight (n = 7) not included. 
c Missing values on height (n = 6) not included. d Missing values on BMI (n = 9) not included. Pre-pregnancy BMI 
for the pregnant women. e Missing value on smoking (n = 1) not included. f Highest educational level achieved or 
initiated. ‘Basic’ (primary/secondary education only; 9 – 13 years), ‘low’ (vocational education and training: 9 – 13 
years), ‘middle’ (short or medium cycle higher education: 14 – 16 years), ‘high’ (long cycle higher education: ≥17 
years). g Pregnant women: 87.5 μg/day (n = 2), 350 μg/day (n = 1); partners: 300 μg/week (n = 1), 300 μg/day (n = 
2); children: 75 μg/day (n = 1).
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Rotkreuz, Switzerland). Equipment was calibrated according to the 
manufacturer’s instructions and external standards were included.
 Statistical Analyses 
 Urinary iodine excretion was expressed as spot urine concen-
tration (μg iodine/l) and as estimated 24-hour iodine excretion (μg 
iodine/24 h) calculated from the reported mean 24-hour urinary 
creatinine excretion in a group of Danish pregnant women (1.09 g 
creatinine/24 h)  [11] , Belgian men aged 25–49 years (1.74 g cre-
atinine/24 h)  [12] , and German children  [13] (mean values by gen-
der and height; missing height (n = 4) was substituted by the aver-
age height for age in Danish children  [14] ).
 UIC showed skewed distribution, and results were expressed as 
medians with 25th and 75th percentiles (interquartile range, IQR) 
or 95% confidence interval (95% CI). The Mann-Whitney U test 
was used to compare median urinary measurements by indepen-
dent groups (iodine supplement vs. no iodine supplement and 
hospital vs. at home), and the Kruskal-Wallis test was used for 
comparison by time of the most recent iodine supplement intake. 
For paired analyses (two samples from the same pregnant woman 
and pregnant woman vs. male partner), the Wilcoxon signed-rank 
test was applied. For linear regression, logarithmically transformed 
urinary measurements were used.
 Statistical analyses were performed using Stata 11 (StataCorp, 
College Station, Tex., USA) and a 5% level of significance was
chosen.
 Results 
 Study Population 
 Among the pregnant women enrolled in the house-
hold study ( fig. 1 ), the median gestational week at the ini-
tial inclusion in the hospital was week 20 (range 11–37), 
 Table 2.  UIC, urinary creatinine concentration and estimated 24-hour iodine excretion in Danish pregnant women and their household 
members
All participants Iodine supplement  No iodine supplement pa
n median IQR n median IQR  n median IQR
UIC, μg/l
Pregnant women 158 119 67 – 180 138 130 69 – 203 20 76 55 – 132 0.008 
Sampling in the hospital 90 105 59 – 208 79 112 65 – 213 11 59 21 – 93 0.021
Sampling at home 68 134 85 – 177 59 136 93 – 180 9 98 62 – 132 0.10
Male partners 157 91 58 – 124 25 110 74 – 164 132 91 57 – 123 0.12
Sampling in the hospital 90 75 51 – 111 15 91 36 – 139 75 72 51 – 108 0.26
Sampling at home 67 115 80 – 150 10 136 91 – 175 57 110 77 – 137 0.23
Children 51 126 102 – 157 13 151 116 – 202 38 121 98 – 150 0.035
Urinary creatinine concentration, mmol/lb
Pregnant women 158 7.6 4.2 – 12.6 138 7.2 3.9 – 11.8 20 11.8 5.7 – 14.2 0.051
Sampling in the hospital 90 6.4 3.4 – 11.1 79 5.9 3.4 – 10.6 11 9.1 3.6 – 14.3 0.30
Sampling at home 68 9.2 4.8 – 12.8 59 8.1 4.5 – 12.7 9 13.1 10.8 – 14.2 0.052
Male partners 157 13.1 8.0 – 17.4 25 14.6 5.5 – 17.5 132 13.0 8.1 – 17.5 0.89
Sampling in the hospital 90 11.5 7.4 – 16.3 15 13.6 3.4 – 15.7 75 11.3 7.4 – 16.4 0.90
Sampling at home 67 14.6 9.6 – 19.2 10 15.7 12.6 – 26.7 57 14.6 9.6 – 18.9 0.62
Children 51 7.2 4.8 – 10.3 13 6.3 4.7 – 7.8 38 7.4 5.1 – 11.6 0.28
Estimated 24-hour iodine excretion, μg/24 h
Pregnant womenc 158 164 109 – 263 138 174 123 – 278 20 86 56 – 100 <0.001
Sampling in the hospital 90 164 114 – 309 79 172 121 – 346 11 83 54 – 109 <0.001
Sampling at home 68 159 105 – 211 60 175 123 – 228 9 87 77 – 96 <0.001
Male partnersd 157 113 85 – 145 25 136 102 – 217 132 110 82 – 137 0.013
Sampling in the hospital 90 105 82 – 136 15 136 102 – 323 75 103 81 – 125 0.020
Sampling at home 67 122 92 – 160 10 137 94 – 196 57 122 86 – 145 0.31
Childrene 51 63 49 – 101 13 66 59 – 103 38 63 48 – 82 0.19
 a p value from the Mann-Whitney U test: iodine supplement vs. no iodine supplement. b Urinary creatinine: 1 mmol/l = 0.1131 μg/l.
c Estimated from the 24-hour urinary creatinine excretion previously measured in Danish pregnant women: mean 1.09 g/24 h [11]. d Esti-
mated from the 24-hour urinary creatinine excretion previously measured in a Belgian population of men aged 25 – 49 years: mean 1.74 
g/24 h [12]. e Estimated from the 24-hour urinary creatinine excretion previously measured in a German population of children [13].
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and 62% were expecting their first child.  Table 1 describes 
characteristics of the pregnant women and their house-
hold members. Current smoking was more frequent 
among the male partners, and also the frequency of di-
etary supplement intake differed. Intake of iodine supple-
ment in pregnancy was common, and the iodine supple-
ments most frequently used contained 175 μg iodine/day. 
On the other hand, iodine supplement intake was less 
common among both male partners and children, and 
the iodine supplements used contained less iodine.
 Urinary Measurements 
 Overall, the median UIC among adults (pregnant 
women and male partners, n = 315) was 104 μg/l (IQR 
61–150) and the estimated 24-hour iodine excretion was 
129 μg/24 h (IQR 95–193). In general, both median UIC 
and estimated 24-hour urinary iodine excretion were 
higher when iodine supplement was used ( table 2 ).
 Urine Sampling in the Hospital versus at Home 
 In the pregnant women and in the male partners, both 
UIC and urinary creatinine concentration ( table 2 ) tend-
ed to be higher at home than in the hospital (at home vs. 
hospital: median UIC all pregnant women p = 0.17, all 
male partners p < 0.001; median urinary creatinine con-
centration: all pregnant women p = 0.060, all male part-
ners p = 0.006). On the other hand, when urinary creati-
nine concentration was used to estimated 24-hour uri-
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–400
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–100
0
100
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500
Sampling at home ‘at or after 5 p.m.’ (n = 42)
p < 0.001p = 0.73
Sampling at home ‘before 5 p.m.’ (n = 24)
p = 0.087 p = 0.42
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 Fig. 2. Bar charts illustrating the value at home minus the value in 
the hospital in UIC (upper row) and estimated 24-hour urinary 
iodine excretion (lower row) for the 66 pregnant women who de-
livered a spot urine sample both in the hospital at inclusion and 
later at home. Results are stratified according to the time of sam-
pling at home: left column was before 5 p.m. and right column was 
at or after 5 p.m. Differences in the range from –1 to –9 (n = 6) 
were set to –10 and differences in the range from 0 to 9 (n = 5) were 
set to 10 for illustration. p values are results of the Wilcoxon 
signed-rank test: at home versus in the hospital. 
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nary iodine excretion, the differences in results diminished 
(all pregnant women p = 0.25, all male partners p = 0.10).
 Individual comparison in the 66 pregnant women who 
delivered a urine sample both in the hospital and at home 
also showed that UIC and urinary creatinine concentra-
tion were higher at home (median UIC 133 μg/l vs. in the 
hospital 84 μg/l, p = 0.002; median urinary creatinine 
concentration 9.2 vs. 5.7 mmol/l in the hospital, p = 
0.042), whereas no difference in estimated 24-hour uri-
nary iodine excretion was observed (159 vs. 154 μg/24 h 
at home, p = 0.79).
 In a post hoc analysis, we evaluated whether the time 
of urine sampling could be involved in our findings. All 
children delivered the urine sample at home, and their 
time of sampling was at median 5 p.m. (IQR 4–6 p.m.). 
The pregnant women and male partners participated ei-
ther in the hospital or at home, and the time of sampling 
differed between the two locations: hospital: median 10 
a.m. (IQR 9–11 a.m.), home: median 6 p.m. (IQR 3–8 
p.m.). Thus, the majority of families had performed the 
sampling at home in the afternoon or evening, whereas 
sampling in the hospital was in the morning.
 We focused our post hoc analysis on the 66 pregnant 
women who delivered a urine sample both in the hospital 
and at home. Differences in UIC and estimated 24-hour 
iodine excretion in the 66 pregnant women who delivered 
a urine sample both in the hospital and at home are de-
picted in  figure 2 . The women were stratified according 
to the time of sampling at home: ‘before 5 p.m.’ (median 
2 p.m., IQR 10 a.m. to 4 p.m.) and ‘at or after 5 p.m.’ (me-
dian 7 p.m., IQR 6–9 p.m.). No difference was observed 
in UIC and estimated 24-hour iodine excretion between 
hospital and home samples when sampling at home was 
performed ‘before 5 p.m.’. On the other hand, when sam-
pling at home was performed ‘at or after 5 p.m.’, UIC was 
significantly higher at home, whereas no difference was 
observed in estimated 24-hour iodine excretion.
 Pregnant Women versus Members of Their Household 
 We performed a pairwise comparison of UIC in fe-
male/male couples stratified according to iodine supple-
ment intake. In the largest group, where only the preg-
nant woman took iodine supplement (n = 109 couples), 
UIC was significantly higher in the pregnant woman than 
in the male partner as might be expected (median UIC 
130 vs. 91 μg/l in the male partners, p < 0.001). On the 
other hand, no significant difference in UIC between the 
pregnant woman and her male partner was observed, 
when both (n = 24 couples; median UIC 122 vs. 91 μg/l in 
the male partners, p = 0.90) or none (n = 17 couples; me-
dian UIC 70 vs. 95 μg/l in the male partners, p = 0.20) took 
iodine supplement, with similar results for estimated 24-
hour urinary iodine excretion (data not shown).
 Median UIC in the children ( table 2 ) was not signifi-
cantly different from the median UIC in the pregnant 
women (p = 0.89) and in the male partners (p = 0.074) 
sampling at home and results were similar when stratified 
by iodine supplement intake (data not shown). In multi-
variate linear regression including age of the child 
(grouped by quartiles), gender of the child (male/female) 
and iodine supplement intake (yes/no), higher age was a 
significant predictor of higher urinary creatinine concen-
tration (p < 0.001), but not UIC (p = 0.45) and 24-hour 
estimated iodine excretion (p = 0.66). Gender of the child 
was not a significant predictor of UIC (p = 0.55).
 Altogether 29 families delivered a urine sample from 
the pregnant woman, the male partner and 1–3 children. 
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 Fig. 3. Median (95% CI) UIC (upper figure) and estimated 24-hour 
urinary iodine excretion (lower figure) in 158 pregnant women 
stratified by time of the most recent iodine supplement intake pri-
or to urine sampling. p values are results of the Kruskal-Wallis test: 
the same day with sampling before 5 p.m. versus the same day with 
sampling at or after 5 p.m. versus the day before versus several days 
ago/non-user. 
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Multivariate linear regression including iodine supple-
ment intake and type of family member did not indicate 
that UIC was significantly different between family mem-
bers [pregnant woman (reference), male partner (p = 
0.81), child (p = 0.50)].
 Time from Iodine Supplement Intake to Urine 
Sampling 
 Both UIC and estimated 24-hour iodine excretion 
were influenced by the timing of the most recent iodine 
supplement intake prior to urine sampling ( fig. 3 ). Me-
dian values were higher when iodine supplement intake 
was the same day prior to urine sampling (first and sec-
ond bar). Looking only at groups with iodine supplement 
intake the same day as urine sampling (first and second 
bar), results were different for UIC and estimated 24-
hour iodine excretion ( fig. 3 ). Considering this in relation 
to  figure 2 , UIC was influenced by both the time of sam-
pling and the time of the most recent iodine supplement 
intake, whereas mainly the time of the most recent iodine 
supplement intake influenced estimated 24-hour iodine 
excretion.
 Among the male partners, the trend was similar to that 
observed in pregnancy [iodine supplement intake the 
same day (n = 10): median UIC 152 μg/l (95% CI 94–296 
μg/l), the day before (n = 11): 124 μg/l (34–175 μg/l), sev-
eral days ago/non-user (n = 134): 90 μg/l (77–101 μg/l),
p = 0.004].
 Sensitivity Analyses 
 For the 66 pregnant women who delivered two urine 
samples, the interval between the two samples was median 
16 days (IQR 6–29). When analyses were stratified by the 
median time between samplings, results were the same as 
depicted in  figure 2 (data not shown). None of the 66 
women had made any change in iodine supplement intake 
between the two samples, and 57 women took iodine sup-
plement. Considering the time of the most recent iodine 
supplement intake prior to urine sampling, results ( fig. 2 ) 
were similar when analyses were restricted to the 44 wom-
en with iodine supplement the same time prior to both the 
first and the second sampling (data not shown).
 Discussion 
 Principle Findings 
 This study evaluates urinary iodine status in Danish 
pregnant women according to the location and time of 
spot urine sampling, the time of the most recent iodine 
supplement intake prior to spot urine sampling and in 
comparison to members of the household. Differences in 
urinary measurements between the hospital and at home 
sampling were largely explained by differences in time of 
sampling during the day. UIC and urinary creatinine con-
centration were higher when sampling was performed in 
the evening, but when UIC was adjusted by urinary cre-
atinine, the time-dependent differences leveled out. The 
time of the most recent iodine supplement intake prior to 
sampling was a predictor of UIC and in general, no sys-
tematic differences were observed between the pregnant 
woman and her male partner except that iodine supple-
ment use was much more frequent in pregnancy.
 Iodine Metabolism in the Pregnant versus the
Non-Pregnant State 
 Inorganic iodine is almost completely absorbed from 
the gastrointestinal tract  [15] , and plasma inorganic io-
dine is primarily balanced by iodine intake, transfer of 
iodine into the thyroid gland and renal excretion of io-
dine. UIC reflects iodine intake as >90% of ingested io-
dine is excreted into the urine  [1] . Physiologically, the 
pregnant state differs from the non-pregnant state by: io-
dine transport to the fetus across the placenta  [16] , in-
creased use of iodine in the thyroid gland  [17] , and in-
creased renal excretion of iodine (the glomerular filtra-
tion is 50% higher by the end of first trimester which is 
maintained throughout pregnancy  [18] ). Following this, 
the recommended range for median UIC in a population 
of pregnant women is 150–249 μg/l, whereas in the non-
pregnant state, median UIC in the range from 100 to 199 
μg/l indicates adequate iodine intake  [1] .
 In many populations, the use of iodine supplements in 
pregnancy is important to ensure adequate iodine intake 
 [7, 19, 20] , and it is of particular importance in women 
with a low intake of iodine-containing foods. Severe io-
dine deficiency in pregnancy can cause fetal brain damage 
 [1] , but recent studies have shown that also less severe 
iodine deficiency in pregnant women may associate with 
lower cognitive scores in the child  [3, 4] .
 UIC and Time of Sampling 
 Controversies in urinary iodine determinations have 
been discussed for years  [21] . One aspect is the time of 
sampling during the day. In a Danish study of 22 indi-
viduals  [22] , estimated 24-hour iodine excretion from a 
fasting morning spot urine sample was significantly 
lower than the actual iodine excretion measured in a 24-
hour sample. In a study from Switzerland  [23] , a total of 
3,023 spot urine samples were collected from 42 indi-
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viduals, and a circadian rhythm in UIC was observed 
with the lowest levels in the morning and increasing lev-
els in the afternoon and evening. UIC peaks occurred 
4–5 h after main meals, and the time of the peaks was 
different for children and adults. As discussed by the au-
thors, this may reflect different intake of iodine-contain-
ing food and a close relationship between recent iodine 
intake and the UIC profile. In our study, both UIC and 
urinary creatinine concentration were higher in samples 
obtained at or after 5 p.m. We speculate whether the eve-
ning meal may have influenced UIC and urinary creati-
nine concentration in samples obtained in the evening 
and/or if the urine production was smaller at that time 
of the day.
 The ‘golden standard’ to measure urinary iodine ex-
cretion is to collect one or preferably several full 24-hour 
urine samples  [1] . This would alleviate problems related 
to the time span between meals, supplement intake and 
spot urine sampling. However, a 24-hour full urine col-
lection is often unrealistic in field studies and optimally 
an objective marker such as  p -aminobenzoic acid should 
be used to verify the completeness  [24] .
 UIC and Recent Iodine Supplement Intake 
 In a study of 16 lactating women, Leung et al.  [25] 
showed that an acute, high intake of iodine gave rise to an 
increase in breast milk iodine concentration with a peak 
median 6 h after ingestion, but median UIC remained 
stable over the study period (8 h). We recently showed 
 [26] that breast milk iodine concentration was dependent 
on the time of the most recent iodine supplement intake 
(not acute high dose) in a similar pattern to what we now 
illustrate for median UIC in both the pregnant women 
and their male partners. However, more studies are need-
ed to corroborate results both in pregnant and non-preg-
nant populations.
 UIC in Pregnant Women versus Male Partners 
 The mandatory iodine fortification of salt was intro-
duced in Denmark in the year 2000, and the Danish
investigation of iodine intake and thyroid disease
(DanThyr) has monitored the iodine excretion in two 
regions of Denmark with a different iodine intake before 
the iodine fortification (moderate vs. mild iodine defi-
ciency)  [10] . The most recent data after the iodine forti-
fication (2008–2010) have shown an overall increase in 
iodine excretion in both regions, but with a median UIC 
just below the level recommended  [10] . The DanThyr 
study initially included women aged 18–65 years (main-
ly non-pregnant) and men aged 60–65 years, urine sam-
ples were obtained between 8.00 a.m. and 5.30 p.m., and 
35% of participants used iodine supplements  [10] . We 
examined only pregnant women, men in younger age 
groups, and part of the urine samples were obtained after 
5.30 p.m. Median UIC (women and men combined) was 
higher in our study (104 μg/l vs. DanThyr 83 μg/l  [10] ), 
which could be explained by the higher frequency of io-
dine supplement use, the later time of sampling, or both. 
When looking at the estimated 24-hour iodine excretion 
(129 μg/24 h vs. DanThyr 125 μg/24 h  [10] ) or at median 
UIC among no iodine supplement users only (89 μg/l vs. 
DanThyr 74 μg/l  [27] ), the difference in study results was 
less pronounced.
 The only disparity between the pregnant women and 
their male partners that we observed was the more fre-
quent use of iodine supplements in pregnancy. The cou-
ples appeared similar in terms of differences in urinary 
concentrations according to the time of sampling and the 
time of the most recent iodine supplement intake, and no 
significant differences were observed in the pairwise 
comparison of UIC when they both used or did not use 
iodine supplement. UIC reflects recent iodine intake, and 
our results indicate that the pregnant women and their 
male partners had comparable intake of iodine. Living in 
the same household implies the same drinking water and 
also to some extent the same diet. In our Danish study 
population, it did not seem as if the pregnant woman had 
changed her diet to a considerably different iodine intake 
from the male partner.
 UIC in Pregnant Women versus Children 
 Traditionally, the median UIC in schoolchildren has 
been the recommended method for the assessment of io-
dine status in populations, including pregnant women 
 [15] . A few studies have evaluated median UIC in school-
children as a proxy for iodine status in pregnancy in a 
household design  [8, 28] . In these studies, median UIC 
was higher in the children than in the pregnant women 
suggesting that median UIC in school-aged children 
should not be used for monitoring iodine status in preg-
nancy. In general, the median UIC in children is often 
higher than that of pregnant women, although it may be 
the other way around  [29] . Notably, none of the studies 
reported on the time of urine sampling. In one study  [8] , 
urine from the pregnant woman was sampled in the an-
tenatal clinic or factory, whereas the child sampled at 
home. Considering our results, this disparity may itself 
lead to differences in results when looking at UIC alone 
and not adjusted by urinary creatinine.
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 Our study is the first study to report data on urinary 
iodine excretion in Danish children. The median UIC was 
within the level recommended in both iodine supplement 
users and non-users  [1] . We were able to compare house-
hold members who sampled at home around the same 
time, and we found no significant difference in UIC when 
comparing children to pregnant (and non-pregnant) 
adults. However, the number of children was limited and 
an examination of schoolchildren in Denmark is needed. 
More studies in different populations should be per-
formed to clarify the use of non-pregnant populations as 
a proxy for iodine status in pregnancy.
 Perspective 
 This study was designed to evaluate some of the chal-
lenges in the interpretation of urinary iodine status in 
pregnancy. Although the number of pregnant women 
and household members recruited was sufficient for the 
evaluation of median UIC in a population  [30] , the dis-
parity in use of iodine supplements among pregnant 
women and male partners made the numbers small in 
some of the stratified analyses.
 The family members were instructed to perform the 
urine sampling at home as close in time as possible, and 
to facilitate this, the time of sampling was not specified 
except that they were instructed to make the urine sam-
ples non-fasting. Following this design, the majority of 
families had sampled the urine in the afternoon or eve-
ning. In our post hoc analyses it appeared that the time of 
sampling did influence the urinary measurements ob-
tained, and to evaluate the possible role of time and loca-
tion of sampling in more detail, it is preferable to design 
a study where the time of sampling is fixed and similar in 
both locations.
 More studies are needed to corroborate results, but the 
findings advocate that studies evaluating iodine status in 
pregnant women (as well as in non-pregnant popula-
tions) from spot urine samples optimally should report 
the time of urine sampling and the time of the most recent 
iodine supplement intake prior to urine sampling and 
measure urinary creatinine concentration.
 Disclosure Statement 
 The authors have no conflicts of interest to disclose.
 
 References 
 1 WHO, UNICEF, ICCIDD: Assessment of Io-
dine Deficiency Disorders and Monitoring 
Their Elimination. A Guide for Programme 
Managers. Geneva, WHO, 2007, pp 1–99. 
 2 Gunnarsdottir I, Dahl L: Iodine intake in hu-
man nutrition: a systematic literature review. 
Food Nutr Res 2012; 56: 19731. 
 3 Bath SC, Steer CD, Golding J, Emmett P, Ray-
man MP: Effect of inadequate iodine status in 
UK pregnant women on cognitive outcomes 
in their children: results from the Avon Lon-
gitudinal Study of Parents and Children
(ALSPAC). Lancet 2013; 382: 331–337. 
 4 Hynes KL, Otahal P, Hay I, Burgess JR: Mild 
iodine deficiency during pregnancy is associ-
ated with reduced educational outcomes in 
the offspring: 9-year follow-up of the gesta-
tional iodine cohort. J Clin Endocrinol Metab 
2013; 98: 1954–1962. 
 5 Vejbjerg P, Knudsen N, Perrild H, Laurberg 
P, Andersen S, Rasmussen LB, Ovesen L, Jor-
gensen T: Estimation of iodine intake from 
various urinary iodine measurements in pop-
ulation studies. Thyroid 2009; 19: 1281–1286. 
 6 Laurberg P, Andersen S, Bjarnadottir RI, Car-
le A, Hreidarsson A, Knudsen N, Ovesen L, 
Pedersen I, Rasmussen L: Evaluating iodine 
deficiency in pregnant women and young in-
fants – complex physiology with a risk of mis-
interpretation. Public Health Nutr 2007; 10: 
 1547–1552. 
 7 Andersen SL, Sorensen LK, Krejbjerg A, 
Moller M, Laurberg P: Iodine deficiency in 
Danish pregnant women. Dan Med J 2013; 
 60:A4657. 
 8 Gowachirapant S, Winichagoon P, Wyss L, 
Tong B, Baumgartner J, Melse-Boonstra A, 
Zimmermann MB: Urinary iodine concentra-
tions indicate iodine deficiency in pregnant 
Thai women but iodine sufficiency in their 
school-aged children. J Nutr 2009; 139: 1169–
1172. 
 9 Laurberg P: Thyroxine and 3,5,3 ′ -triiodothy-
ronine content of thyroglobulin in thyroid 
needle aspirates in hyperthyroidism and hy-
pothyroidism. J Clin Endocrinol Metab 1987; 
 64: 969–974. 
 10 Rasmussen LB, Jorgensen T, Perrild H, Knud-
sen N, Krejbjerg A, Laurberg P, Pedersen IB, 
Bjergved L, Ovesen L: Mandatory iodine for-
tification of bread and salt increases iodine 
excretion in adults in Denmark – a 11-year 
follow-up study. Clin Nutr 2013, Epub ahead 
of print. 
 11 Pedersen KM, Borlum KG, Knudsen PR, 
Hansen ES, Johannesen PL, Laurberg P: Uri-
nary iodine excretion is low and serum thyro-
globulin high in pregnant women in parts of 
Denmark. Acta Obstet Gynecol Scand 1988; 
 67: 413–416. 
 12 Kesteloot H, Joossens JV: On the determi-
nants of the creatinine clearance: a population 
study. J Hum Hypertens 1996; 10: 245–249. 
 13 Remer T, Neubert A, Maser-Gluth C: Anthro-
pometry-based reference values for 24-hour 
urinary creatinine excretion during growth 
and their use in endocrine and nutritional re-
search. Am J Clin Nutr 2002; 75: 561–569. 
 14 Tinggaard J, Aksglaede L, Sorensen K, Mou-
ritsen A, Wohlfahrt-Veje C, Hagen CP, Mie-
ritz MG, Jorgensen N, Wolthers OD, Heuck 
C, Petersen JH, Main KM, Juul A: The 2014 
Danish references from birth to 20 years for 
height, weight and body mass index. Acta 
Paediatr 2014; 103: 214–224. 
 15 Zimmermann MB: Iodine deficiency. Endocr 
Rev 2009; 30: 376–408. 
 16 Andersen SL, Nohr SB, Wu CS, Olsen J, Ped-
ersen KM, Laurberg P: Thyroglobulin in 
smoking mothers and their newborns at de-
livery suggests autoregulation of placental io-
dide transport overcoming thiocyanate inhi-
bition. Eur J Endocrinol 2013; 168: 723–731. 
 17 Aboul-Khair SA, Crooks J, Turnbull AC, Hyt-
ten FE: The physiological changes in thyroid 
function during pregnancy. Clin Sci 1964; 27: 
 195–207. 
D
ow
nl
oa
de
d 
by
: 
Fo
rs
kn
in
ge
ns
 H
us
21
2.
88
.7
7.
68
 - 
10
/2
/2
01
4 
5:
06
:0
8 
P
M
 Andersen  /Sørensen  /Krejbjerg  /Møller  /
Laurberg  
 
Eur Thyroid J 2014;3:179–188
DOI: 10.1159/000365145
188
 18 Davison JM, Hytten FE: Glomerular filtration 
during and after pregnancy. J Obstet Gynae-
col Br Commonw 1974; 81: 588–595. 
 19 Brantsaeter AL, Abel MH, Haugen M, Melt-
zer HM: Risk of suboptimal iodine intake in 
pregnant Norwegian women. Nutrients 2013; 
 5: 424–440. 
 20 Bath SC, Walter A, Taylor A, Wright J, Ray-
man MP: Iodine deficiency in pregnant wom-
en living in the South East of the UK: the in-
fluence of diet and nutritional supplements 
on iodine status. Br J Nutr 2014; 111: 1622–
1631. 
 21 Soldin OP: Controversies in urinary iodine de-
terminations. Clin Biochem 2002; 35: 575–579. 
 22 Rasmussen LB, Ovesen L, Christiansen E: 
Day-to-day and within-day variation in uri-
nary iodine excretion. Eur J Clin Nutr 1999; 
 53: 401–407. 
 23 Als C, Helbling A, Peter K, Haldimann M, 
Zimmerli B, Gerber H: Urinary iodine con-
centration follows a circadian rhythm: a study 
with 3,023 spot urine samples in adults and 
children. J Clin Endocrinol Metab 2000; 85: 
 1367–1369. 
 24 Jakobsen J, Ovesen L, Fagt S, Pedersen AN: 
Para-aminobenzoic acid used as a marker for 
completeness of 24 hour urine: assessment of 
control limits for a specific HPLC method. 
Eur J Clin Nutr 1997; 51: 514–519. 
 25 Leung AM, Braverman LE, He X, Heeren T, 
Pearce EN: Breast milk iodine concentrations 
following acute dietary iodine intake. Thyroid 
2012; 22: 1176–1180. 
 26 Andersen SL, Moller M, Laurberg P: Iodine 
concentrations in milk and in urine during 
breastfeeding are differently affected by ma-
ternal fluid intake. Thyroid 2014; 24: 764–772. 
 27 Krejbjerg A, Bjergved L, Pedersen IB, Carle A, 
Jorgensen T, Perrild H, Ovesen L, Rasmussen 
L, Knudsen N, Laurberg P: Iodine fortifica-
tion may influence the age-related change in 
thyroid volume – a longitudinal population-
based study (DanThyr). Eur J Endocrinol 
2014; 170: 507–517. 
 28 Ategbo EA, Sankar R, Schultink W, van der 
Haar F, Pandav CS: An assessment of progress 
toward universal salt iodization in Rajasthan, 
India, using iodine nutrition indicators in 
school-aged children and pregnant women 
from the same households. Asia Pac J Clin 
Nutr 2008; 17: 56–62. 
 29 Zimmermann MB, Aeberli I, Torresani T, 
Burgi H: Increasing the iodine concentration 
in the Swiss iodized salt program markedly 
improved iodine status in pregnant women 
and children: a 5-year prospective national 
study. Am J Clin Nutr 2005; 82: 388–392. 
 30 Andersen S, Karmisholt J, Pedersen KM, Lau-
rberg P: Reliability of studies of iodine intake 
and recommendations for number of samples 
in groups and in individuals. Br J Nutr 2008; 
 99: 813–818. 
 
D
ow
nl
oa
de
d 
by
: 
Fo
rs
kn
in
ge
ns
 H
us
21
2.
88
.7
7.
68
 - 
10
/2
/2
01
4 
5:
06
:0
8 
P
M
 
 
Appendix G. Paper 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correction page 769, column 2, line 20-22: Among women included, one woman 
had a low MIC (23 µg/L) in comparison to UIC (94 µg/L).  
 
 
 
PREGNANCY, POSTPARTUM, AND FETAL DEVELOPMENT
Iodine Concentrations in Milk and in Urine
During Breastfeeding Are Differently Affected
by Maternal Fluid Intake
Stine Linding Andersen,1 Margrethe Møller,2 and Peter Laurberg1
Background: Breastfed infants are dependent on iodine transport into breast milk for production of thyroid
hormones. Thyroid hormones are important regulators of brain development. It has been considered whether
breast milk iodine concentration (MIC) could be predicted by maternal urinary iodine concentration (UIC), but
reports on correlations have been inconsistent. We used urinary creatinine concentration as a proxy for maternal
fluid intake and speculated if this might differently influence UIC and MIC.
Methods: We examined 127 breastfeeding women after the introduction of the mandatory iodine fortification of
salt in Denmark. Maternal spot urine and a breast milk sample were obtained at a median of 31 days after
delivery (interquartile range: 25–42 days), and the women were asked about intake of iodine containing sup-
plements postpartum.
Results: Median UIC was 72 lg/L (46–107 lg/L) and higher in iodine-supplemented mothers (47.2% of par-
ticipants); 83 lg/L (63–127 lg/L) versus 65 lg/L (40–91 lg/L), p = 0.004. Median MIC was 83 lg/L (61–125 lg/
L) and also higher in iodine-supplemented mothers; 112 lg/L (80–154 lg/L) versus 72 lg/L (47–87 lg/L),
p < 0.001. There was a weak correlation between UIC and MIC (r = 0.28, p = 0.015). A strong correlation was
present between UIC and urinary creatinine concentration (r = 0.76, p < 0.001), whereas urinary creatinine con-
centration was not correlated to MIC (r = - 0.049, p = 0.58). When UIC and urinary creatinine were used to
estimate 24-h urinary iodine excretion, the correlation between this estimate and breast milk iodine excretion
was stronger (r = 0.48, p < 0.001).
Conclusions: Intake of an iodine supplement should be recommended in Danish breastfeeding women. Our
results indicate that UIC, but not MIC, depends on maternal fluid intake and that maternal estimated 24-h iodine
excretion may be a better indicator of iodine supply to the breastfed infant than UIC.
Introduction
Iodine is necessary for thyroid hormone production,and lack of thyroid hormones during infant brain devel-
opment may lead to permanent brain damage (1). Thus, ma-
ternal iodine requirements are increased during the period of
breastfeeding to ensure an adequate supply of iodine both to
the developing infant via breast milk and to the mother.
Consequently, the World Health Organization (WHO), Uni-
ted Nations Children’s Fund (UNICEF), and the International
Council for the Control of Iodine Deficiency Disorders (IC-
CIDD) define an adequate maternal intake of iodine as
250 lg/day during breastfeeding (2).
Population median urinary iodine concentration (UIC) is
the recommended method to assess population iodine intake
(2). In nonlactating women, around 90% of ingested iodine is
excreted into urine, whereas in lactating women, part of
plasma inorganic iodine is transported into breast milk by the
sodium iodide transporter (NIS) (3). Urinary iodine excretion
is consequently lower, and the median UIC indicating suffi-
cient iodine intake in breastfeeding women is similar to the
nonpregnant state ( ‡ 100 lg/L), although maternal iodine
requirements are increased (2).
WHO, UNICEF, and ICCIDD define an adequate intake of
iodine in children younger than two years of age as 90lg/day
(2). As previously reviewed in detail (3–5), a number of studies
have measured breast milk iodine concentration (MIC) and
found a wide range of median or mean concentrations. As
recently highlighted by Leung et al. (6), physiological mecha-
nisms may challenge the interpretation of studies of breast
milk iodine measurements. These authors illustrated a rise in
MIC following acute maternal dietary iodine intake.
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Another aspect previously considered is how reliably the
iodine supply to the breastfed infant can be evaluated by
maternal UIC (7,8). It has been shown that UIC, adjusted by
urinary creatinine as a proxy for fluid intake, might more
precisely estimate iodine intake in nonlactating women and in
men (9–11), and in a study from Australia of 50 breastfeeding
women, there was no significant correlation between UIC and
MIC, but MIC was significantly correlated with the urinary
iodine/creatinine ratio (12).
In Denmark, information on maternal iodine nutrition
during breastfeeding and infant iodine nutrition only exists in
studies (13,14) performed before the mandatory iodine forti-
fication of salt introduced in the year 2000 (15). In the present
study, we examined whether Danish women living in an area
with previously moderate iodine deficiency took iodine-
containing supplements postpartum, andwe evaluated iodine
status in breastfeeding women by measurement of maternal
urinary iodine excretion. In addition, we studied iodine con-
tent of infant feeding by measuring breast milk iodine excre-
tion and iodine content of infant formulas. Data were used to
investigate the relationship between urinary iodine excretion
and breast milk iodine excretion in breastfeeding women and
to study the feasibility of using urinary creatinine excretion to
adjust for differences in maternal fluid intake.
Materials and Methods
Study population and design
This study is a postpartum follow-up of women initially in-
cluded in the Obstetrics Department, Aalborg University Hos-
pital in pregnancy. From June toAugust 2012, we consecutively
recruited 245 healthy pregnant women referred to the Obstetric
Department for ultrasound as part of the prenatal investigation
program. The initial examination aimed at evaluating whether
Danish pregnant women living in an area of Denmark with
previously moderate iodine deficiency took iodine-containing
supplements and to evaluate iodine intake by measurement of
urinary iodine concentration in a spot urine sample (16).
In the present follow-up study, the women were contacted
by phone in the postpartum period after birth of a live-born
child. If willing to participate, a telephone interview was
performed, and thewomenwere asked about intake of iodine-
containing supplements in the postpartum period, smoking
habits, breastfeeding, and/or use of infant formulas. The same
interviewer performed all interviews.
Additionally, thewomenwere asked if it would be possible
to bring a spot urine and a breast milk sample to the hospital
within the coming weeks. If infant formulas were used, they
were also asked to bring a sample of prepared infant formu-
las. Vials for sampling were mailed to the women willing to
participate, and they were instructed to collect the urine and
breast milk sample nonfasting and as close together in time as
possible. The women were asked about the timing of sam-
pling in relation to breastfeeding of the child, timing of last
iodine supplement intake prior to sampling, and whether
milk was collected from one or both breasts. A small group of
women (n= 13) were instructed to collect breast milk samples
from the same breast both immediately before and after
breastfeeding of the child.
The study protocol was approved by the local ethical
committee, and informed consent was obtained from each
participant.
Laboratory procedures
Urine and raw breast milk samples were stored at - 20�C
from time of sampling until collection at home and until
measurement of UIC and MIC in batches during the time of
the study inclusion.
After thawing and brief mixing of the samples, UIC and
MIC were determined by the cerium/arsenite method after
alkaline ashing to dryness (combusting organic material), as
previously described (17). The analytical sensitivity of the
assay was 2 lg/L and the lowest standard above the zero
blank contained 10lg iodine/L. For urine samples, the re-
covery of iodine was 95.5% (SEM 2.4%) and the interassay CV
was 2.7%, as previously described (15). For breast milk sam-
ples, the recovery of iodine was 93.6% (SEM 1.04%), when
75lg iodine/L was added to 10 breast milk samples with a
median iodine concentration of 78lg/L (range 51–118 lg/L).
Serial dilution of 10 breast milk samples containing 51–118 lg
iodine/L gave curves parallel to the standard curve. The in-
terassay CV was 3.6% when seven breast milk samples were
measured in triplicate. The iodine laboratory was certified by
the U.S. Centers for Disease Control and Prevention EQUIP
program, which includes measurement of ‘‘blind’’ external
controls three times a year.
Urinary creatinine concentrations were measured on a
Cobas 8000 system (Roche, Switzerland). Equipment was
calibrated according to the manufacturer’s instructions, and
external standards were included.
Statistical analyses
Characteristics of the women according to intake of iodine
supplements were compared using the chi-square test or
Fisher’s exact test, and multivariate logistic regression was
used to examine predictors of iodine supplement intake
postpartum.
Urinary iodine excretion was expressed as spot urine con-
centration (lg iodine/L) and as estimated 24-h iodine excre-
tion (lg iodine/24 h) calculated from the mean 24-h urinary
creatinine excretion (1.09 g creatinine/24 h), previously mea-
sured in a group of Danish pregnant women (18). This cal-
culation was used for both pregnancy and postpartum
urinary iodine concentrations, as the 24-h urinary creatinine
excretion was almost identical to that found in a general fe-
male population aged 25–34 years (19). For calculation of 24-h
breast milk iodine excretion, a breast milk volume of 800mL/
24h was used (20).
UIC, MIC, and urinary creatinine concentrations showed
skewed distributions, and results were expressed as medians
with 25th and 75th percentiles (interquartile range, IQR). The
Mann–Whitney U test was used to compare urinary iodine
excretion stratified by iodine supplement intake and time of
sampling. The Wilcoxon signed rank test was used for com-
parison of related samples (pregnancy vs. postpartum and
before vs. after breastfeeding the child). Cuzick’s test for trend
was used to compare median 24-h estimated breast milk io-
dine excretion by timing of last supplement intake prior to
sampling. Urinary and breast milk iodine and urinary creat-
inine measurements were log-transformed for illustration of
correlations and calculation of Pearson’s correlation. The ratio
between 24-h estimated breast milk iodine excretion and
urinary iodine excretion was log-transformed for calculation
of the geometric mean with 95% confidence interval (CI). The
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Student’s t-test was used to compare the geometric mean ratio
by iodine supplement intake.
Statistical analyses were performed using Stata v11 (Sta-
taCorp, College Station, TX), and a 5% level of significance
was chosen.
Results
Study population
Figure 1 illustrates the selection of the women included in
the follow-up study postpartum. Amongwomen included in
pregnancy, 85.3% were interviewed by phone in the post-
partum period (median day 22 postpartum; range 9–146),
and in this group of women, 70.3% sampled breast milk
and/or urine at home. A total of 130 women delivered both a
urine sample in pregnancy and postpartum and a breast
milk sample. Three women were excluded because they re-
ported that they were smokers, thus leaving 127 women for
urine and breast milk analyses (Fig. 1). The time interval
between samplings (milk–urine) was a median of 0 minutes
(IQR: - 30 to 7 minutes). The women who delivered a urine
and breast milk sample were slightly older (median age 30
years vs. 29 years, p = 0.02) with a higher educational level
( p < 0.001), whereas no difference was observed in the use of
iodine supplements in pregnancy ( p = 0.78) and postpartum
( p = 0.90).
Iodine supplement intake
At the time of the postpartum interview, 117 of 209 women
(56.0%) reported intake of dietary supplements, and 98 of the
209 women (46.9%) took a vitamin and/or mineral supple-
ment containing iodine. In pregnancy, 174 of these 209 wo-
men (83.3%) were iodine supplement users.
Table 1 presents characteristics of the women interviewed
according to intake of iodine supplements postpartum. Only
iodine supplement use in pregnancy significantly predicted
iodine supplement intake postpartumwith similar findings in
multivariate analyses examining all variables in Table 1 as
categoricals. In addition, maternal cohabitation, ethnicity,
occupation, and prepregnancy BMI as reported in pregnancy
were examined in univariate andmultivariate analyses. None
of these variables significantly predicted iodine supplement
intake postpartum.
In pregnancy, almost all the iodine supplements used con-
tained 150 or 175lg iodine/day, and most women continued
such a supplement postpartum. However, a subgroup of the
iodine supplement users (n= 15) took a multivitamin pill that
was labeled by the manufacturer as ‘‘supplement for breast-
feeding women’’ and contained only 45lg iodine/day.
Urinary and breast milk iodine
Table 2 presents time of sampling and results of urinary
iodine and creatinine excretion and breast milk iodine
Included in pregnancy
n = 245
Abortion n = 1
Stillbirth n = 1
Giving birth to a live-born child
n = 243
Contacted by phone
n = 228
Interviewed by phone
n = 209
Milk/urine sampling set received
n = 157
Milk/urine samples returned
n = 147
Milk and urine analyses
n = 127
No contact information n = 12
Mother or child hospitalized n = 3
Not responding n = 17
Did not wish to participate n = 2
Living too far away n = 28
Did not wish to participate n = 24
Did not manage sampling n = 10 
No urine sample in pregnancy n = 4
No breast milk sample n = 13
Smoking postpartum n = 3 
FIG. 1. Flowchart illustrating the selec-
tion of the women participating in the
postpartum follow-up study.
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excretion in pregnancy and postpartum stratified bymaternal
intake of iodine supplements.
UIC postpartum ranged from 8 to 422 lg/L. In comparison
to women not taking iodine supplements, median UIC and
estimated 24-h urinary iodine excretion were significantly
higher in iodine supplement users both in pregnancy and
postpartum. When comparing related urine samples in
pregnancy and postpartum in individual mothers (Table 2),
UIC was lower ( p< 0.001) and urinary creatinine higher
( p < 0.001) in the postpartum period than in pregnancy.
MIC ranged from 19 to 301lg/L, as illustrated in Figure 2.
Median MIC and estimated 24-h breast milk iodine excretion
was higher in women taking iodine supplements postpartum
in comparison to nonusers (Table 2). When evaluating related
urine and breast milk samples postpartum in individual
mothers (Table 2), MIC was higher than UIC ( p= 0.013), but
when stratified by iodine supplement intake, only iodine
supplement users had significantly higher MIC (iodine sup-
plement intake: p= 0.016; no iodine supplement intake:
p= 0.33). Estimated 24-h breast milk iodine excretion was not
significantly different from estimated 24-h urinary iodine
excretion ( p= 0.29), nor when stratified by iodine supplement
intake.
Iodine content of the supplements differed, and urine and
breastmilk iodine excretionwas considerably lower inwomen
with the lowest iodine supplement intake (45lg/ day; n= 9) in
comparison to women with a higher intake of iodine from
supplements (150 or 175lg/day; n= 49); estimated 24-h uri-
nary iodine excretion: 58lg/24h (IQR: 50–87lg) versus
89lg/24h (61–147lg), p= 0.030; 24-h breast milk iodine ex-
cretion: 54lg/24h (51–85lg) versus 98lg/24h (74–123lg),
p= 0.048.
Among women with no iodine supplement intake post-
partum (n = 67), UIC andMICwere not significantly higher in
the group of women who had used iodine supplements in
pregnancy (n= 49) in comparison to women with no iodine
supplement intake either in pregnancy or postpartum (n = 18;
data not shown).
Correlations between urinary iodine, urinary creatinine
and breast milk iodine
Figure 3 illustrates the relationship between maternal uri-
nary iodine excretion postpartum, maternal urinary creati-
nine excretion postpartum, and breast milk iodine excretion.
Figure 3A depicts that UIC and MIC were only modestly
correlated. We hypothesized that this relatively weak corre-
lation might be caused by differences in maternal fluid intake.
As illustrated in Figure 3C, a strong correlation was observed
between urinary creatinine (a proxy for fluid intake) and UIC,
whereas no correlation was observed between MIC and uri-
nary creatinine concentrations (Fig. 3D). Thus, fluid intake as
evaluated by urinary creatinine influenced strongly on UIC,
but had no influence on MIC (Fig. 3C vs. Fig. 3D). As a con-
sequence of this disparity, the correlation between iodine
excretion in urine and breast milk was stronger, when UIC
was adjusted by urinary creatinine and expressed as 24-h
urinary iodine excretion (Fig. 3B vs. Fig. 3A).
To evaluate at the individual level how breast milk iodine
excretion could be determined from maternal urinary iodine
excretion postpartum, we calculated the ratio between esti-
mated 24-h breast milk iodine excretion and maternal 24-h
Table 1. Characteristics of the Mothers
Participating in the Postpartum Interview
at Initial Inclusion in Pregnancy, at Delivery,
and at the Time of the Postpartum Interview
According to Maternal Intake of Iodine
Supplements Postpartum
Iodine
supplement
postpartum
No iodine
supplement
postpartum
n % n % pa
Total participants
(N = 209)
98 46.9 111 53.1
At initial inclusion in pregnancy
Gestational week
10–15 38 38.8 33 29.7 0.38
19–21 49 50.0 65 58.6
28–37 11 11.2 13 11.7
Maternal age (years)
< 25 5 5.1 12 10.8 0.25
25–35 78 79.6 79 71.2
> 35 15 15.3 20 18.0
Maternal parityb
1 50 51.0 59 53.1 0.95
2 38 38.8 41 37.0
‡ 3 10 10.2 11 9.9
Maternal educationc
Basic 4 4.1 11 9.9 0.11
Low 25 25.5 32 28.8
Middle 48 49.0 38 34.2
High 21 21.4 30 27.1
Iodine supplement intake in pregnancy
Yes 90 91.8 84 75.7 0.002
No 8 8.2 27 24.3
At delivery
Gestational week
< 37 3 3.1 5 4.5 0.73
37–41 83 84.7 89 80.2
> 41 12 12.2 17 15.3
Method of delivery
Vaginal 80 81.6 89 80.2 0.79
Cesarean section 18 18.4 22 19.8
At the postpartum interview
Time of interview (days after delivery)
£ 14 17 17.4 13 11.7 0.50
15–28 46 46.9 57 51.4
> 28 35 35.7 41 36.9
Maternal smoking
No 92 93.9 105 94.6 0.82
Yes 6 6.1 6 5.4
Breastfeeding
Full 73 74.5 75 67.6 0.54
Partly 14 14.3 21 18.9
No 11 11.2 15 13.5
aChi-square test or Fisher’s exact test: iodine supplement postpar-
tum vs. no iodine supplement postpartum.
bPrevious live- and stillbirths including index pregnancy.
cHighest educational level fulfilled or initiated. General education:
‘‘basic’’ (primary/secondary education only; 9–13 years). General
education and education qualifying for a profession: ‘‘low’’ (voca-
tional education and training: 9–13 years), ‘‘middle’’ (short- or
medium-cycle higher education: 14–16 years), ‘‘high’’ (long-cycle
higher education: ‡ 17 years).
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urinary iodine excretion. The geometric mean ratio was 0.93
[CI: 0.85–1.03] and not significantly different when stratified
by iodine supplement intake (iodine supplement intake: 1.02
[CI 0.90–1.15]; no iodine supplement intake: 0.86 [CI 0.75–
0.99]; p= 0.076).
Sampling time
Time from delivery to sampling of urine and breast milk
ranged from 14 to 135 days. UIC (r = 0.20, p = 0.026) and uri-
nary creatinine concentration (r= 0.24, p= 0.008) correlated
with time from delivery, but when UIC was adjusted by uri-
nary creatinine to calculate 24-h urinary iodine excretion, no
correlation with time from delivery was observed (r = - 0.044,
p = 0.62). Similarly, estimated 24-h breast milk iodine excre-
tion did not correlate with time from delivery to sampling,
neither in iodine supplement users (r= - 0.17, p= 0.19), nor in
iodine supplement nonusers (r = - 0.11, p = 0.37).
Time of sampling during the day ranged from 00:20 to
23:50. Median estimated 24-h urinary iodine excretion was
slightly higher when sampling was performed in the late
afternoon/evening (4:01 p.m.–12:00 a.m., n = 34: 83lg/24 h
(65–122 lg); 8:01 a.m.–4:00 p.m. n= 81: 62 lg/24 h (48–94lg);
12:01 a.m.–8:00 a.m., n = 12: 63 lg/24 h (49–93lg); p = 0.031).
Time of sampling did not influence on estimated 24- breast
milk iodine excretion ( p = 0.42). As illustrated in Figure 4, a
trend was observed in 24-h breast milk iodine excretion ac-
cording to timing of maternal most recent iodine supplement
intake prior to sampling.
Breast milk sampling from one or both breasts did not in-
fluence median MIC, and no difference in median MIC was
observed when sampling was performed before or after
breastfeeding the child (data not shown). A small group of
women sampled breast milk both immediately before and
after breastfeeding the child (n= 13). The difference in MIC
(before - after) was small (median 4lg/L; IQR: 2–13 lg/L),
but the concentration was significantly higher before breast-
feeding, p = 0.017.
Infant formulas
A total of 35 infant formulas were obtained. The iodine
concentrations ranged from 62 to 167lg/L, and the overall
median iodine concentration was 122lg/L (IQR: 93–155 lg/
L). Stratified by brand, the median iodine concentrations
were: Nan-1, n = 20: 155 lg/L (137–158 lg/L); Allomin-1,
n = 9: 87lg/L (86–92lg/L); Althera, n = 5: 102lg/L (98–
103 lg/L), and Hipp Organic, n= 1: 98lg/L.
Discussion
Principal findings
In a follow-up study of women giving birth in an area of
Denmark with previously moderate iodine deficiency, iodine
supplement use postpartum was less frequent than in preg-
nancy. Urinary iodine and breast milk iodine concentrations
were below the levels recommended but significantly higher
with iodine supplement intake and higher than the levels re-
ported before the iodine fortification of salt in Denmark.
Among iodine supplement users, the subgroup of women
with the lowest iodine supplement intake was in particular at
risk of iodine deficiency.
Maternal UIC, but not MIC, was strongly dependent on
urinary creatinine concentration as a proxy for maternal fluid
intake, and results indicate that UIC adjusted for creatinine
more precisely predicts the iodine content of breast milk.
Comparison with previous Danish studies
Iodine content of breast milk was previously evaluated in
Denmark before the mandatory iodine fortification of salt
Table 2. Urinary Iodine and Breast Milk Iodine Excretion According to Maternal Iodine Supplement Intake
in Women who Delivered a Urine Sample both in Pregnancy and Postpartum and a Breast Milk Sample
All women Iodine supplement No iodine supplement pa
In pregnancy
Pregnant women 127 (100%) 106 (83.5%) 21 (16.5%)
Gestational week at sampling 20 (13–20) 20 (13–20) 20 (15–20) 0.99
Urinary iodine (lg/L) 91 (61–140) 98 (66–150) 63 (53–92) 0.003
Urinary creatinine (mmol/L)b 6.2 (3.0–11.8) 5.8 (3.0–10.9) 10.6 (3.0–14.3) 0.28
Estimated 24-h urinary iodine (lg)c 147 (93–260) 163 (113–278) 83 (55–109) < 0.001
Postpartum
Breastfeeding women 127 (100%) 60 (47.2%) 67 (52.8%)
Days after delivery at sampling 31 (25–42) 34 (26–44) 29 (25–41) 0.14
Urinary iodine (lg/L) 72 (46–107) 83 (63–127) 65 (40–91) 0.004
Urinary creatinine (mmol/L)b 10.1 (5.0–15.9) 9.6 (4.9–15.9) 10.3 (5.0–16.0) 0.91
Estimated 24-h urinary iodine (lg)c 69 (50–100) 87 (55–144) 60 (44–83) < 0.001
Breast milk iodine (lg/L) 83 (61–125) 112 (80–154) 72 (47–87) < 0.001
Estimated 24-h breast milk iodine (lg)d 66 (49–100) 90 (64–123) 58 (38–70) < 0.001
Urinary iodine < 100lg/L 92 (72.4%) 37 (61.7%) 55 (82.1%)
Breast milk iodine < 90 lg/24 h 89 (70.1%) 30 (50.0%) 59 (88.1%)
Values are expressed as n (%) or median (25th–75th percentile).
aMann–Whitney U test: iodine supplement vs. no iodine supplement.
bUrinary creatinine: 1mmol/L= 0.1131lg/L.
cCalculated from mean 24-h urinary creatinine previously measured in a group of Danish pregnant women: 1.09 g creatinine/24 h (18).
dCalculated from previously estimated average daily breast milk intake: 800mL/24h (20).
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introduced in the year 2000 (15). In a study by Pedersen et al.
(13) performed in an area of Denmark with previously mod-
erate iodine deficiency, 53 pregnant women (30% smokers)
were randomized to 200 lg iodine/day (n= 27) or controls
(n = 26) from gestational week 17–18 until 12 months after
delivery. Median MIC day 5 postpartum was significantly
higher in iodine-supplemented mothers (41 vs. 28lg/L in
controls). In another study by Nohr et al. (14), 148 mothers in
five cities of Denmark were included (35% smokers). The
women reported on intake of iodine supplements at arrival
for delivery and were instructed to continue their current
supplement intake in the postpartum period. Sampling of
breast milk was also performed five days after delivery in this
study. Median MIC was significantly higher in iodine sup-
plemented mothers (57 vs. 34lg/L) with regional differences
(higher values in East Denmark with previously mild iodine
deficiency). In addition to this, it was illustrated that smoking
mothers had considerably lower MIC than nonsmoking
mothers (26 vs. 54 lg/L) (21).
Median MIC was also higher in iodine supplemented
mothers in our study (112 vs. 72lg/L) and had increased in
comparison to the previous studies. In our study, breast milk
samples were collected later in the postpartumperiod, but our
results were not dependent on time from delivery to sam-
pling, neither in iodine supplement users nor in nonusers.
Studies evaluating breast milk iodine content at different time
points postpartum either reported a significant decrease or no
difference according to time after delivery (22–24).
Mechanisms of iodine excretion in breast milk
Iodide is transported into breast milk by the sodium io-
dide transporter (NIS) (25). NIS is present in various tissues
including the thyroid gland and the placenta (26). NIS is
competitively inhibited by a number of chemicals, and in
Denmark themost frequent NIS inhibitor is thiocyanate from
smoking. In the thyroid gland (26), and presumably also the
placenta (27), inhibition of NIS-mediated iodide transport is
autoregulated by iodide. However, in the lactating mam-
mary gland, no autoregulation of NIS seems to occur, as
illustrated by lower breast milk iodine concentrations in
smokers (21). The frequency of maternal smoking was much
lower in our present study than in the previous Danish
studies. Smokers (n = 3) were excluded from urine and breast
milk analyses in our study. Among women included, one
woman had a low UIC (23 lg/L) in comparison to MIC
(94 lg/L). She reported smoking cessation a few weeks be-
fore the interview.
Maternal fluid balance
Iodine status should be assessed by measurement of urinary
iodine concentration rather than dietary intake (28). Spot urine
samples are the easiest and recommended method in popula-
tion studies, and median UIC is considered a valid marker for
population iodine intake (2). In general, it has been much dis-
cussed whether urinary iodine concentration should be ad-
justed for differences in fluid intake by urinary creatinine (11).
Our study suggests that UICs are dependent on fluid intake in
breastfeeding women, whereas MIC is not. Thus, MIC was not
dependent on maternal fluid intake, an observation in line with
studies indicating that breast milk volume is not influenced by
maternal fluid intake (29,30). On the other hand, maternal fluid
intake influenced UIC, as illustrated by the strong correlation
with urinary creatinine concentration. Thus, the iodine status of
breastfeeding women might be more precisely estimated when
UIC is adjusted by differences in fluid intake, as previously
suggested for nonlactating women and for men (9,10). Fur-
thermore, the correlation with breast milk iodine excretion was
stronger when urinary iodine content was adjusted by creati-
nine in accordance with a previous study (12).
Infant formulas
Iodine content of infant formulas used in Denmark was
previously reported in 1999 (31). In that study, infant for-
mulas in dry preparation were prepared using iodine-free
demineralized water, whereas in our study the mothers
prepared the infant formulas at home according to the
manufacturers’ instructions. The median iodine concentra-
tion was considerably higher in our study (122 vs. 57 lg/L),
as well as for the individual brands that were measured in
both studies, even taking the iodine content of tap water into
account. The content of iodine in the infant formulas corre-
sponded to the breastmilk iodine concentrationsmeasured in
iodine supplement users.
Breast milk iodine concentration (µg/L)
83µg/L  
0
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FIG. 2. Dotplot illustrating all breast milk iodine concen-
trations (n = 127). Black dots illustrate iodine supplement
users; white dots illustrate iodine supplement nonusers. The
solid line represents the median; dotted lines are the 25th and
75th percentiles. Values were stratified into 30 bands, in the
range from 19 to 301lg/L, each band corresponding to
9.4 lg/L.
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Strength and limitations
The strength of our study is the high rate of participation
among invited women in the postpartum interview and the
relatively large number of urine and breast milk samples
obtained (10). However, participants differed slightly from
nonparticipants in some characteristics, and numbers in
subgroups after stratification were limited. We are aware
that the study is a postpartum follow-up of women initially
included in pregnancy and that, according to ethical re-
quirements, the women were informed about the impor-
tance of iodine intake at the initial visit. This informationwas
kept low grade, and data on urinary iodine concentrations in
pregnancy and press releases were not reported until after
the last inclusion postpartum. Our study only included
women in one region of Denmark. However, we found no
significant predictors of iodine supplement intake besides
iodine supplement intake in pregnancy, and we find it un-
likely that iodine supplement use in Danish women would
considerably differ between regions (32). We did not have
information on maternal dietary habits postpartum, and we
do not know if differences in maternal fluid intake were
caused by differences in intake of iodine containing drinks
such as dairy products or water-based drinks such as tea or
coffee. The level of iodine in drinking water in the region
investigated is low and corresponds to the level in western
Denmark (31).
National perspective
Intake of iodine supplements fell by nearly half comparing
pregnancy to the postpartum period. Iodine was obtained in a
multivitamin pill, and during pregnancy official recommenda-
tions exist on intake of folic acid, iron, and vitamin D often
leading to intake of a multivitamin pill. On the other hand, no
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FIG. 3. Scatter plots of 127 sam-
ples illustrating the correlation be-
tween (A) maternal postpartum
urinary iodine concentration and
breast milk iodine concentration,
(B) estimated 24-h breast milk io-
dine excretion and maternal post-
partum 24-h urinary iodine
excretion, (C) maternal postpartum
urinary creatinine and urinary io-
dine concentrations, and (D) ma-
ternal postpartum urinary
creatinine and breast milk iodine
concentrations. All values were log-
transformed for illustration and
calculation of Pearson’s correlation.
Values on the axes are antilogged.
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FIG. 4. Median estimated 24-h breast milk iodine excretion
with confidence intervals stratified by timing of maternal
most recent iodine supplement intake prior to breast milk
sampling, p < 0.001 for trend, excluding nonusers; p= 0.05.
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official recommendations exist on intake of dietary supple-
ments during breastfeeding in Denmark. Women with no
intake of iodine supplements and women with an intake of
iodine supplements with low iodine content (45lg/day) were
particularly at risk of being iodine deficient. Thus, iodine sup-
plement intake in Danish breastfeeding women should be of-
ficially recommended. One of the concerns about iodine intake
in pregnancy and postpartum has been the risk of exacerbating
thyroid autoimmunity (33). A previous study in Denmark did,
however, not detect an increased risk of postpartum thyroiditis
from iodine supplement in thyroid peroxidase antibody-posi-
tive mothers (34). The 24-h iodine excretion in breast milk was
below the level recommended in the women not using iodine
supplements. In iodine supplements users, it was estimated to
be 90lg/24h, which corresponds to the recommended iodine
intake in children younger than two years of age (2). On the
other hand, maternal UIC was below the level recommended
both in iodine supplement users and nonusers. Together with
the findings in Danish pregnant women (16), and findings from
the general Danish population (35), these results may indicate a
need for a modest increase in the level of iodine added to salt in
Denmark.
Conclusion
Maternal estimated 24-hour urinary iodine excretion
showed a better correlation to maternal MIC than did ma-
ternal UIC. This may suggest that estimated 24-h urinary
iodine excretion is a useful indicator of maternal iodine status
during breastfeeding and of iodine supply to the breastfed
infant. However, more studies on the usefulness of this indi-
cator are warranted in populations with different dietary or
environmental habits.
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Iodine is required for the synthesis of thyroid hormones, which are crucial 
regulator of early brain development. The source of iodine in the fetus and 
the breastfed infant is maternal iodine, and adequate iodine intake in pregnant 
and breastfeeding is of major concern. Severe iodine deficiency can cause 
irreversible brain damage, whereas the consequences of mild to moderate io-
dine deficiency are less clear. Denmark was previously iodine deficient with 
regional differences (mild iodine deficiency in East Denmark and moderate 
iodine deficiency in West Denmark), and also pregnant and breastfeeding 
women suffered from iodine deficiency. A mandatory iodine fortification of 
household salt and salt used for commercial production of bread was intro-
duced in Denmark in the year 2000. The PhD thesis investigates intake of 
iodine supplements and urinary iodine status in Danish pregnant and breast-
feeding women after the introduction of the mandatory iodine fortification 
of salt in a region of Denmark with previously moderate iodine deficiency. 
Additionally, the PhD thesis addresses mechanisms of iodide transport to the 
fetus across the placenta and methodological challenges in the evaluation of 
urinary iodine status in pregnant and breastfeeding women. 
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